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Objective: Generally, the purpose of this thesis project is to develop an effective electronic disease 
surveillance system, which is capable of detecting a cluster of people with elevated blood glucose 
(BG) levels within a specific region and timeframe by analyzing diabetes data. Specifically, we 
mainly focus on developing an early outbreak detection algorithm that can analyze BG data and 
detect individuals with elevated BG levels (aberrant patterns) using continues BG measurement 
(CGM) and the mobile-phone based diabetes patients’ historical data – the diabetes diary. 
Material: This thesis project was conducted using data from two individuals with type-1 diabetes. 
The Dexcom continuous glucose monitoring device (CGM)) was used for the data collection. The 
collected data were CGM (in 5 minutes’ intervals) for a period of one month. We used these 
datasets to train and validate the developed system. After training and validating the system, for 
its goodness of fit to the individual BG dynamics, in the non-infection status of the two subjects 
using normal BG values, we tested our system with artificially simulated datasets, which resemble 
the individual BG evolution during infections. The simulated datasets were consisted of elevated 
or high BG values of varies size, duration and shape through a course of time, i.e. a week or more. 
It was simulated so as to resemble the elevated BG after one is infected, by considering various 
increments per minutes (∆BG/ (minutes (t))) and various durations of elevated BG. The system 
was developed using Matlab version R2015b. 
Method: We presented a system that is consisted of four modules: the data collection module, the 
blood glucose prediction, the outbreak detection, and the information dissemination and reporting 
module. There are two types of early outbreak detection approaches incorporated in the system, a 
type of statistical control (prediction interval based) algorithm and a moving window based z-
score process. The first approach, the prediction interval based algorithm combined a novel 
mechanism for BG prediction, which is an interval prediction based on a set of autoregressive 
models and predicts the expected BG intervals for an individual with diabetes. The actual BG 
value is compared against the predicted intervals, which is generated using auto-regressive (AR) 
and Autoregressive moving average (ARMA) methods. We evaluated and compared the 
performance of these methods using the mean square errors (MSE) and root mean square errors 
(RMSE) functions. The second approach, the moving window based z-score process calculates a 




standard deviation are used to check the agreement of the current BG reading with the previous 
trend in the window. The performance of the process was evaluated based on the accuracy of 
detecting the specific surveillance case definition, i.e. sensitivity, specificity and positive predictive 
value (PPV).  
Result: Both the prediction interval based algorithm and the moving window based z-score 
process were tested against the artificially simulated datasets and were capable of detecting 
statistically significant BG deviation of various sizes and durations. The prediction methods were 
capable of predicting the single step - ahead BG values with a reasonable accuracy, which were 
tested against validation datasets (unseen datasets during training). All the methods, 
autoregressive (AR), autoregressive (AR) with ratio of consecutive data as inputs, and 
autoregressive moving average (ARMA) have attained minimum root mean square errors (RMSE) 
for both subjects. However, the second methods predicts well attaining the lowest RMSE for both 
subjects, which demonstrates the advantage gained through the use of ratio of consecutive data 
points rather than the raw blood glucose data. Moreover, we accurately monitored the BG 
fluctuations of both individuals with a significance level of α =0.01. However, there were 
differences in window size and RMSE attained by these subjects for a comparable interval width, 
where the first subject attained smaller than the second subject. In addition, for comparable 
detection capability, the size of the moving window used to calculate the z-score for the first subject 
is less than the second subject. These differences in window size clearly show the effect of personal 
behavior towards diabetes management on the detection capability, which is mainly due to the 
significant fluctuations of BG readings as a result of poor personal behavior in managing his/her 
diabetes. 
Conclusion: Generally, both of our early outbreak detection approaches have produced optimal 
detection results and were capable of detecting statistically significant BG deviation of various 
size and duration. However, considering flexibility, simplicity, computational time, and needs of 
computational power the moving window based z-score process is better than the prediction 
interval based algorithm. Moreover, both the approaches are found to be affected by the quality 
of personal behavior towards diabetes management and this needs to be taken into account during 
large scale implementations. Besides, these results have clearly shown the effectiveness of the 
proposed approaches for detecting a cluster of people with similar patterns. Consequently, after 




way for the development of the early outbreak detection system (prototype) based on inputs from 
people with diabetes, which is considered to be the next generation electronic disease surveillance 
system. 
Keywords: Diabetes Mellitus, Diabetes diary, Blood glucose prediction, Autoregressive models, 































































Last year I had a course work on Advanced Tele-medicine and eHealth, which gave me deep 
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detection. In most cases, when an outbreak is detected, it has been transmitted to a lot of people 
with in the community. Currently, an early outbreak detection is the major concern of researchers 
in the area of electronic disease surveillance systems. As part of this task force, the objective of 
this thesis project is to design and develop an early outbreak detection system based on inputs from 
people with diabetes. Our approach incorporated a novel mechanism for tracking BG fluctuations 
on an individual basis.  We tested our approach based on real datasets from a small group of type-
I diabetes subjects.  
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Chapter one: Introduction 
1.1. Background and Motivation 
Major infectious disease threat to the public health are either naturally occurring or artificially 
induced bioterrorist attack. Infectious diseases have been and also be the burden of any public 
health authority, which needs well preparedness, proper monitoring and early detection of an 
outbreak before it spreads. Earlier, disease surveillance systems have been relied on paper based 
reporting, which have a great impact for its delayed response (Wickramasinghe et al., 2012). 
However, with the advent of information and communication technology, the availability of 
electronic based reporting has revolutionized the disease surveillance systems. The availability of 
such data facilitates early detection and also leaves ample space (time) for further investigation 
and action to be taken by the responsible body (Wickramasinghe et al., 2012). One of such a kind 
is syndromic surveillance, which uses data after the incubation period but prior to laboratory or 
physicians verification such as absenteeism (Weng et al., 2015), chief-complaint data (Wagner et 
al., 2004 ), over-the-counter and prescription pharmacy sales (Xiaohui et al., 2004), internet search 
volumes (Zhou et al., 2013; Zhou et al., 2011) and others. Moreover, various bio-sensors network 
based disease surveillance systems have been put in place (Chung-Kuo et al., 2005). However, 
electronic disease surveillance system that detects infectious disease outbreak during incubation 
period (before the onset of the first symptoms) is not yet developed and is currently under research 
stage. For example, let us assume that you are working as both epidemiologist and public health 
official in a large city, where you are the focal person of the city’s office for monitoring and 
controlling of infectious disease outbreaks. It is obvious that your office will be definitely looking 
for an early outbreak detection system that is capable of detecting any infectious disease outbreak 
within days after the first person is infected. Let us say on Thursday in a specific part of the city, 
there were some people infected with respiratory infections such as influenza. According to the 
current disease surveillance systems, the detection might take some days even more than weeks 
until the first symptoms are confirmed, which might put some lives in danger. In contrast, let us 
say that you woke up on Friday morning and ask “the mirror”: How are we today? (“we” stands 
for the whole population in the city). “The mirror” then visualizes the health status for the citizens 
based on daily data from people with diabetes, who are registered in the system. “The mirror” 




diabetes, which is unique for detecting disease outbreaks during the incubation period. The system 
is capable of analyzing daily data and generating daily information, which is made available for 
every citizens. For instance, if you are a person with diabetes, you may want to know whether the 
risk of infections has increased, and if possible, in which areas of the city.   
Currently, diabetes is escalating worldwide and according to WHO1, its global prevalence had 
reached 8.4% in 2014 and the projection shows that it will become the 7th leading cause of death 
in 2030. Consequently, as part of the disease management, a lot of diabetes self-management 
applications including continuous blood glucose monitoring (CGM) and mobile applications have 
been developed to help individuals to manage their blood glucose, of which almost all of them 
take the ubiquities nature of mobile as an advantage to base the development of the apps (Arsand 
et al., 2010; Issom et al., 2015; Quinn et al., 2008; Waki et al., 2014).  Moreover, recently mobile 
diabetes self-management application has shown integration with the electronic health record of 
patients (Benhamou, 2011; Veinot et al., 2010; Walseth et al., 2005). This integration coupled with 
the availability of timely data on CGM and mobile apps can further enhances the opportunity of 
establishing a successful electronic disease surveillance system based on inputs from people with 
diabetes. 
Previous findings indicated that blood glucose levels are elevated due to any exposure to pathogens 
(Lauritzen et al., 2011). Årsand et al. demonstrated an elevation in Blood glucose levels for both 
type 1 and type 2 diabetes individuals after being infected by Influenza, Cholera, Plague, Ebola, 
Anthrax, or SARS viruses (Årsand et al., 2005). Botsis et al. also described the positive correlation 
between BG elevation and infections in people with type 1 diabetes (Botsis et al., 2007). These 
findings suggest the potential use of the Blood glucose parameters for the early detection of disease 
outbreaks in the general population (Botsis et al., 2007). Other physiological parameters (such as 
body temperature, white blood cell count and blood pressure) are directly associated with the 
presence of infections in the body (Botsis et al., 2010; Uzedhe  et al., 2014). Multiple incidents 
with abnormal values for the above parameters in the population may indicate the presence of an 
outbreak (Adam et al., 2007; Lauritzen et al., 2011). We therefore argue that the incorporation of 
all these parameters into advanced modeling solutions can potentially support the early detection 
of outbreaks. The objective of this thesis project is to design and develop an electronic disease 





surveillance system based on inputs from people with diabetes, and that can track the blood glucose 
values of each individuals separately and detect a cluster of people with statistically significant 
deviation. The main goal here is to use people with diabetes as a source of information in a disease 
surveillance system and to effectively detect an infectious disease outbreak during the incubation 
period. We mainly focused on the development of algorithm that can track BG dynamic and detect 
any abnormal elevation at an individual level. An interval based blood glucose prediction and a 
moving window based z-score algorithms are proposed to control and monitor the statistically 
significant deviation of the blood glucose readings from its most recent trends. The proposed 
algorithms are developed and tested based on data from two type-one diabetes individuals’ and are 
capable of predicting and detecting statistically significant blood glucose deviations, which shows 
the effectiveness of the proposed approach.    
1.2. Research Problem Statement  
1.2.1. Main Problem 
To prevent the spread of contagious diseases, early detection is important. Today, when an 
outbreak is diagnosed, many people may already be infected. Therefore, it is necessary to develop 
a system that can detect an infectious disease outbreak at a very early stage. We proposed the use 
of blood glucose as an indicator of infections and to build a mechanism that can effectively track 
and detect high blood glucose levels at an individual level. 
 [P1] How to design and develop an early outbreak detection system based on blood glucose 
inputs from people with diabetes?  
In this thesis, we will focus on the important techniques and parameters that can be geared 
towards an effective early outbreak detection system. Moreover, we give emphasis on modelling 
of the underlying system architecture for the electronic disease surveillance system based on 
inputs from people with diabetes.   
1.2.1.1. Sub-Problem One 
To develop the diseases surveillance system, it is necessary to compute the expected baseline data 
used for monitoring. Therefore, we need to develop a BG prediction approach to be used in the 
developed system. Various researchers have tried to develop BG prediction services for several 
purposes designed for people with diabetes such as hypoglycaemia and hyperglycaemia alerts, 




As a result, we need to develop a personal blood glucose prediction model for our defined purpose. 
The problem we are addressing in this section is: 
 [SP1] What are the important techniques that can be used in developing a successful personal 
blood glucose prediction model and how to design and develop such a technique that can be 
accurately used in the electronic disease surveillance system based on inputs from people with 
diabetes?  
1.2.1.2. Sub-Problem Two 
An effective disease outbreak detection systems need to be well designed in terms of its sensitivity, 
specificity, and positive predicative value (PPV). Therefore, we need to consider and develop a 
mechanism that can effectively detect any aberrations or statistically significant deviation from the 
normal blood glucose evolution of an individual with diabetes. As a result, here we study 
techniques of detecting the individual’s consecutive high BG readings from the normal BG 
readings, which occurred during the presence of infections. Moreover, means of cheeking the 
degree and severity of the individual’s BG deviations and possibly means of producing the 
required alarm are dealt under this sub-problem:  
 [SP2] How to design and develop an early aberrations detection systems based on the 
individual’s blood glucose data and how to formulate an excellent working threshold for the 
electronic disease surveillance system considering some constraints or limitations. 
1.3. Objective  
1.3.1. General objective 
The goal of this thesis project is to design and develop an early outbreak detection algorithm 
and, therefore to design a system based on the blood glucose inputs from people with diabetes.  
1.3.2. Specific objective  
 To design a system architecture for the electronic disease surveillance system based on 
inputs from people with diabetes. 
 To specify the use case model for the system and its associated requirements specification. 
 To design and develop an early aberration detection algorithm. 
 To develop blood glucose prediction model (Personal blood glucose profile).  




1.4. Materials, Methods and Scope of system evaluation 
This thesis work has been conducted using both Friedman, the tower of achievements in medical 
informatics (Friedman, 1995) and the Engineering approach described by Denning et al. (Denning 
et al., 1989). This involves model formulation including defining requirements and specifications, 
and system development including system design and implementation along with system 
evaluation techniques including testing of the system for performance (Friedman et al., 2006). The 
requirements and specifications were defined following Volere’s standards (Robertson et al., 
2000). 
1.4.1. Materials and Methods 
1.4.1.1. Datasets  
This thesis work was conducted using data from two individuals with type 1 diabetes. The Dexcom 
CGM and the diabetes diary2 that have been developed by Norwegian Center for E-health Research 
(previously known as NST) were used for the data collection. These modules are part of a mobile 
application designed for diabetes management. The collected data included continuous BG 
measurements from the Dexcom CGM (in 5 minutes intervals) for a period of one month. We used 
these datasets to train and validate the developed system for its goodness of fit to the BG dynamics 
of the two subjects in their non-infection status. We subsequently tested our system with a 
simulated dataset that included consecutive patterns of high BG values; this resembled the CGM 
during the infection period. Various increments per minutes ( ∆ ( )) and various time intervals 
of elevated BG were considered.  
1.4.1.2. Methods  
This project work was carried out in three phases, which involves model formulation, model 
development and system evaluation. The first phase is model formulation, which includes 
literatures review and system modelling. In addition, discussions with two diabetes experts and 
other diabetes individuals were held to model the artificially simulated datasets. The second phase 
is model development, which is divided into research and application development components. 
We mainly focus on the research component, which involves the development of the mathematical 






models and algorithms in Matlab programming language. However, we thoroughly defined the 
requirements and specifications of the required application, which its development is not 
considered in this thesis. The last phase is system evaluation, which includes system testing and 
evaluation.  
The developed system has two compartments, the personal BG profile and the early aberration 
detection compartment. The first compartment, the personal BG profile involves predication of the 
individual’s BG evolution. For prediction purpose, we have proposed an interval BG prediction 
mechanism that can predict the step ahead BG values of an individual. Thus, the goal of the 
prediction interval is to obtain a 100(1 − )% forecast interval single-step-ahead into the future 
for BG response at a given input level of past BG. These intervals were calculated based on the 
empirical error distribution (variance) of the recent history of errors (with a specific window size) 
between the predicted and measured BG values. The developed BG prediction models were a type 
of linear time series models, which includes Autoregressive (AR) and Autoregressive Moving 
Average (ARMA). The second compartment, the early aberration detection involves the detection 
of any cluster of people with elevated BG readings within a specific region and timeframe. This 
compartment is capable of comparing the measured/observed BG values against the interval 
predicted by the first compartment. Furthermore, this compartment is capable of calculating the 
moving window based z-score values as an alternative means of detecting statistically significant 
BG deviations from its most recent trends.  
1.4.2. Scope of system evaluation 
According to (Friedman et al., 2006), evaluation of a system in medical informatics is conducted 
for five major reasons, promotional, scholarly, pragmatic, ethical, and medicolegal purposes. “One 
or more of these factors should be the driving force for every evaluation study to be carried out; 
otherwise, the study will lose its value as it has been called a “triple blind study,” in which neither 
evaluators, participants, nor readers of the report can fathom why it was done” (Friedman et al., 
2006). Among these deriving factors we considered, the pragmatic purpose, which involves 
solving the puzzle by justifying which techniques or methods are more effective, or why certain 
approaches failed. This reason was justified as it has a lot of input in enhancing the clarity 
regarding the contribution and significance of our approaches. Compartments based evaluation 
were conducted for the entire system. The first compartment, which is the BG prediction 




and comparison were carried out based on these parameters. The second compartment, which is 
the early outbreak detection mechanisms were evaluated based on different criteria such as 
specificity, sensitivity, and positive predicative value (PPV). In addition to this, the outbreak 
detection mechanisms were also evaluated based on the capability of the algorithm to detect the 
individual’s consecutive high BG readings from the normal BG readings. Moreover, a Receiver 
Operating Characteristic (ROC) was used to determine the best operating threshold of the system. 
1.5. Significance and Contribution 
Early detection of infectious disease outbreaks is the main and important goal of any public health 
surveillance, as this can provide ample time for controlling and prevention action to be taken by 
the responsible bodies, i.e. public health authority and hospitals. Today, when an outbreak is 
diagnosed, many people may already be infected. Therefore, it is necessary to have a system that 
can detect an epidemic outbreak at a very early stage. Recently, lots of researchers have developed 
different kind of infectious disease outbreaks detection mechanisms. These mechanisms mainly 
relied on various kinds of data such as chief-complaint data (Wagner et al., 2004 ), disease related 
search volumes in different search engine such as google (Zhou et al., 2013; Zhou et al., 2011), 
over-the-counter and prescription pharmacy sales (Xiaohui et al., 2004), school absenteeism 
(Weng et al., 2015), and emergency calls (Adam et al., 2007), and other different physiological 
indicators including reported symptoms such as body temperature and blood pressure. However, 
disease outbreak detection mechanisms that focus on the incubation period, before the onset of the 
first symptoms, have not been developed yet. To our knowledge, an early disease outbreak 
detection mechanism that rely on BG evolution is a new concept that will provide significant input 
for the scientific arena, in the broad sense of an early outbreak detection mechanism and blood 
glucose prediction techniques in particular. We designed and built a system that can detect disease 
outbreak during the incubation period, before the onset of the first symptoms, which is the novel 
and unique characteristic of this thesis project. We developed a unique and novel mechanism for 
monitoring an individual blood glucose fluctuations based on an interval BG prediction. To our 
knowledge, a BG prediction mechanism that predicts an interval based on the empirical 
distribution of errors between the predicted and observed BG values is the first of its types. In 
addition, we introduced and developed the moving window based z-score process for detecting 
individual’s consecutive high BG readings from the normal BG readings. Moreover, this thesis 




thesis project, the author has published a conference paper, journal article and also conducted a 
comprehensive systematic literature review on the available BG prediction and outbreak detection 
mechanisms. First of all, in order to assess the available data sources for the implementation of the 
proposed system, the author has conducted and published a systematic literature review on mobile 
diabetes self-management apps, which is published in Future Medicine - Diabetes management 
journal, entitled “A systematic review of mobile applications for people with diabetes published 
between 2010 and 2015” (Issom et al., 2015). In addition, in order to strengthen and support our 
approach, the author has also conducted a comprehensive systematic review of literatures on BG 
predictions and early outbreak detection mechanisms, which is included as part of this thesis 
report. Moreover, the author has also published part of this thesis work in a conference proceeding, 
which is entitled “Electronic Disease Surveillance System Based on Inputs from People with 
Diabetes: An Early Outbreak Detection Mechanism” (Woldaregay et al., 2016), which is presented 
at Scandinavian health informatics conference (SHI2016, Gothenburg, Sweden). 
1.6. Assumptions, Biases and Limitations 
The major limitation of this project is the absence of large sample size. We have relied our 
experiments and simulation based on two type-one individuals, which might affect the 
generalizability of our results. Moreover, a “holiday effect” is another major limitation of this 
project. In some circumstances such as during holidays, the recorded BG value may fail to indicate 
the presence of infection, which is known as the “Holiday effect” (Lauritzen et al., 2011). The main 
cause of the “Holiday effect” is the bad eating style of the majority of the population including 
peoples with diabetes during this period. This may result in an artificial increase in the BG value 
for the individuals with diabetes. This BG variation might result in generating false alarms, and 
false outbreak detections. The absence of frequent blood pressure measurements, white blood cell 
counts and temperature readings from these individuals further aggravates this limitation as it was 
previously shown (Botsis et al., 2009; Botsis et al., 2010). Considering that body temperature, 
count of white blood cells and blood pressure can be indicators for the presence or absence of 
infections in the body, these measurements can be used to compromise the elevated BG values and 
bypass the generation of false alarm during holidays. However, the data source we are using does 







The rest of the thesis is organized as follows: 
 Chapter 2: Theoretical framework and State of the art: - This chapter describes the basic 
theoretical concepts and framework of the thesis project. It briefly disuses BG metabolism, 
diabetes mellitus along with its complications in the presence of infections. In addition, it 
describes the concept behind BG predictions and early outbreak detection mechanisms. Most 
importantly, it gives a brief description of the state of the art system that consider in using BG 
for an early outbreak detection.   
 Chapter 3: Literature Review: - This chapter presents a systematic literature review on BG 
prediction mechanisms and early outbreak detection mechanisms. It gives an overview of the 
current available methods for developing the required BG predictions and early outbreak 
detections mechanisms. 
 Chapter 4: Materials and Method: - This chapter presents the materials and methods used in 
this thesis project.  
 Chapter 5: Requirements specification: - This chapter describes the necessary requirements 
and specifications of the electronic disease surveillance system based on inputs from people 
with diabetes. 
 Chapter 6: Design: - This chapter describes the strategies and techniques used to develop the 
mathematical models for the BG predictions, interval predictions and early outbreak detection 
mechanisms.   
 Chapter 7: Implementation and Testing: - This chapter presents the implementations of the 
models designed in the previous chapter (Chapter 6) and the taste settings and test results of 
the BG predictions, interval predictions and the early outbreak detection mechanisms.   
 Chapter 8: Discussion: - This chapter discusses the evaluations, comparisons and analysis of 
the test results and the research findings. 
 Chapter 9: Further works/Recommendations: - This chapter describes research gaps that the 
author had identified during this thesis project and believes to be considered for future 
research.  




 References: - This section presents list of references used in this thesis project.  
 Appendix: - This section contains the list of conference paper and journal article published by 




























Chapter Two: Theoretical framework and State of the Art 
2.1. Introduction  
This chapter mainly discusses about the theoretical frameworks and concepts, which are basis for 
developing the dedicated electronic disease surveillance system based on inputs from people with 
diabetes. Moreover, it describes the state of the art systems that argue to use blood glucose levels 
as an indicator of infections and for possible outbreak detection purposes. The entire chapter is 
organized as follows; the first section presents terminologies, preliminaries and definitions that are 
fundamental for this thesis project. The second section discusses basic concepts concerning blood 
glucose metabolism, diabetes mellitus, infections and blood glucose levels in diabetes, diabetes 
management and factors that affect blood glucose values, and prediction approaches. The third 
section discusses issues related with electronic disease surveillance systems and early outbreak 
detection. The last section gives an overview of the state of the art system that consider blood 
glucose levels as an early indicator of infections. 
2.2. Terminologies, Preliminaries and Definitions 
This section describes basic terminologies, preliminaries and definitions that are fundamental for 
this thesis project and are also used throughout this thesis project. It also gives the reader a clear 
insight to pinpoint the basics of our surveillance case definition.  
2.2.1. Definitions 
Specificity: is defined as “the proportion of true non-events correctly classified as such, the inverse 
being the false alarm rate” (Drewe et al., 2012).   
Sensitivity: refers to “the proportion of actual cases in a population that are detected and notified 
through the system”(WHO, 2006).  
Positive predicative value (PPV): refers to “the proportion of the people, who actually have the 
disease and correctly classified as such by the disease surveillance system” (WHO, 
2006). 
Prediction Interval (PI): is the predicted range of values containing upper and lower boundaries. 
Simulated dataset: is an artificially simulated BG data containing successive high BG values. 





Prediction error: is the difference between observed or measured blood glucose values and     
predicted blood glucose values within the same prediction horizon. 
Prediction horizon: is the number of steps in the future for which prediction is made, is also known 
as lead time. 
2.2.2. Terminologies and mathematical assumptions 
Throughout this project, an observed time series, containing n observations, is denoted 
by , , … … . . . Let us say that we want to predict , where the integer h is called the 
lead time (or the prediction horizon) (Chatfield, 1993). The point prediction of  made 
conditional on data up to time n for h steps ahead will be denoted by (ℎ), when regarded as a 
random variable and by (ℎ), when it is a particular value determined by the observed data. 
Whenever possible, it is necessary to specify both the horizon (lead time) and the time at which 
the prediction is made (Chatfield, 1993). 
2.2.3. Surveillance case definition 
The proposed electronic disease surveillance system is based on inputs from people with diabetes, 
which is required to capture any statistically significant deviations of individual’s blood glucose 
readings from the CGM-DEXCOM devices (possibly could be used with any other CGMs). 
Consequently, the surveillance case definition requires consecutive and successive elevated (high) 
blood glucose readings from a cluster of people within a specific region /area and timeframe. This 
spatio-temporal nature of the proposed system is believed to exclude individual’s elevated blood 
glucose readings due to other factors, i.e. menstruation cycle, alcohol consumption and others.  
2.3. Glucose Metabolism 
The human body is consisted of different kinds of metabolic reactions, which is important to 
maintain the normal physiological states. Blood glucose metabolism is one of such a kind, which 
controls the proper amount of glucose concentration in the blood (Cescon, 2011). Pancreas is both 
exocrine and endocrine gland, which is the central point of glucose metabolism. It is consisted of 
cells known as islet of Langerhans, which contains both the alpha and beta cells. As shown in the 
Figure 1, when there is external perturbation like intake of food and others, the blood glucose 
levels raises, which in turn initiates beta cells in pancreas to secrete insulin in the blood. The 
secreted insulin in turn initiates the uptake of glucose by body cells and conversion of glucose into 




bloodstream (Cescon, 2011). Moreover, when there is external perturbation like heavy physical 
activity or exercises and others, the blood glucose fall from its normal state. This initiates alpha 
cells in pancreas to secrete glucagon, which causes conversion of glycogen to glucose in liver and 
muscles. This will increase the proper amount of blood glucose concentration and return it to its 
normal state (Cescon, 2011). 
 
Figure 1: Glucose metabolism.  
( Figure 2.1, (Cescon, 2011)) 
2.4. What is blood glucose level/concentration and the factors that affect it? 
Blood glucose level or concentration is the amount of blood glucose that reside in the blood, which 
is also known as plasma blood glucose level. It can be expressed using either milligram per deci-
litters (mg/dl) or milli-mole per liters (mmol/l)3 (Agafonov et al., 2015). The normal blood glucose 
levels of an individual are within a narrow range being highest after meal and lowest in the 
morning. There are different factors that can directly affects the amount of blood glucose 
concentration, among which amount of injected insulin, amount of physical activity, previous 
history of blood glucose values and dietary intakes are the prominent ones (Agafonov, 2015; 
Cescon, 2011). Moreover, blood glucose concentration is also affected by other factors such as 





body mass index of the individual, stress level, sleeping time, presence of illness and some other 
medication, smoking habit, periods (menstruation), alcoholism, allergies, and effect of altitude 
(Agafonov, 2015; Cescon, 2011; Cescon, 2013). There are other factors, which is not quantified 
here but still have effect on blood glucose concentration.  
2.5. Diabetes  
2.5.1. What is diabetes? 
Diabetes mellitus is a chronic disease that causes blood glucose metabolic disorder (WHO, 2015a). 
The person who suffers from diabetes lacks the capability to control the proper amount of glucose 
in his/her blood, either due to the failure of pancreas beta cells to produce insulin or the failure of 
the body to use insulin in the right way (Liao et al., 2004; Richesson et al., 2013), which are known 
to be type I and type II diabetes respectively. Type I diabetes (also known as juvenile-onset or 
insulin-dependent diabetes) mostly affects children and it is caused by the failure of pancreas to 
produce little or no insulin (Richesson et al., 2013). Type II diabetes (also known as adult-onset or 
non–insulin-dependent diabetes) can happen to anyone irrespective of age but it mostly occurs 
during adulthood and it is due to the failure of the body to use insulin that resides in the blood 
(Richesson et al., 2013). This kind of complication can arise due to several factors such as lack of 
exercise, being overweight (Taylor et al., 2015), nutrition and mostly due to inactive personal 
lifestyle (Liao et al., 2004; Richesson et al., 2013).  
2.5.2. How does an infection affect blood glucose level in an individual with diabetes? 
During infections, it is a normal activity of the body to produce certain hormones, such as cortisol 
and adrenaline, as a response for the stress within the body4. The action of glucose metabolising 
hormone, insulin are greatly affected by the work of these hormones. As a result, the body loses 
control of glucose production that results in a high blood glucose concentrations. Consequently, 
the high blood glucose concentration causes the white blood cells to be unable to “mop up” bacteria 
since they can’t move around at their usual speed and do not reach the infection site as quick as 
possible to engulf and kill the bacteria and other pathogens. For non-diabetes person, this might 
not have any problem since extra insulin is produced to counter back these effects. However, for 
diabetes persons this is not possible as a result hyperglycemia persists and ketoacidosis can occur. 





Diabetes by itself aggravates susceptibility to various infections. Diabetes patients are believed to 
be affected more frequently than the non-diabetes peoples (Casqueiro et al., 2012). Generally, the 
following infections are common for diabetes patients4, as given in the Table (Casqueiro et al., 
2012). 
Table 1: Major infections associated with diabetes mellitus.  
( Table 1, (Casqueiro et al., 2012))  
Respiratory infections 




Urinary tract infections 
 Asymptomatic bacteriuria 
 Fungal cystitis 
 Emphysematous cystitis 
 Bacterial pyelonephritis 
 Emphysematous cystitis 
 Perinephric abscess 
Gastrointestinal and liver infections 
 H.pylori infection 
 Oral and esophageal candidiasis 
 Emphysematous cholecystitis 
 Hepatitis C 
 Hepatitis B 
 Enteroviruses 
Skin and soft tissue infections 
 Foot infection 
 Necrotizing fasciitis 
 Fournier’s gangrene 
Head and neck infections 
 Invasive external otitis 
 Rhinocerebral mucormycosis 





2.5.3. Diabetes Management  
Diabetes is fatal and can bring a lot of complications, i.e. blindness, kidney failure and even death, 
if not properly controlled and managed. Therefore, it is necessary to have a proper management, 
which can reduce the fatality significantly and avoids further complications. This includes 
controlling diet, recording blood glucose, doing physical exercise and injecting proper amount of 
insulin when the blood glucose is elevated (Liao et al., 2004; Richesson et al., 2013). Currently, a 
lot of mobile diabetes self-management application has been developed to help the individuals to 
manage his/her blood glucose, of which almost all of them take the ubiquities nature of mobile as 
an advantage to base the development of the apps (Arsand et al., 2010; Issom et al., 2015; Quinn 
et al., 2008; Waki et al., 2014).  Moreover, recently mobile diabetes self-management application 
has shown integration with the Electronic health record of a patient (Benhamou, 2011; Veinot et 
al., 2010; Walseth et al., 2005), which is believed to extend the reach of physicians to the patients.  
2.6. Prediction approaches  
“Prediction is very difficult, especially if it’s about the future” – Nils Bohr 
Prediction is defined as the process of projecting the future based on the past and present data and 
trends5. Generally, prediction can be carried out using either of these prediction approaches, i.e. 
Structural and Black box approaches (Chatfield, 2000). The first approach, structural, requires an 
extensive knowledge of the underlying systems dynamics, which in this case requires modeling of 
the internal blood glucose-insulin dynamics. The second approach, black box , doesn’t require an 
extensive knowledge about the internal systems dynamics, however, it only requires playing with 
the input and output data from the system to model a satisfactory prediction (Chatfield, 2000). 
Moreover, depending on the specific purpose at hand, the background knowledge and types of data 
available, prediction methods can be classified into three distinct categories (Chatfield, 2000). This 
category includes univariate (which depend only on the past values of a single variable), 
multivariate (which depends on the past values of two or more variables, called predictor or 
explanatory variables) and judgmental (Chatfield, 2000). Moreover, the prediction method can be 
automatic, without requiring human intervention and non-automatic methods. Furthermore, a more 
useful distinction between methods is that involves fitting an ‘optimal’ probability model and those 






that do not. There are two ways of achieving the prediction models output stated in the literatures, 
i.e. point prediction and interval prediction (Chatfield, 2000). Pont prediction is the most used 
form of prediction in literatures rather than interval prediction, however the latter is more desirable 
and appropriate even if it is not mostly used approach (Chatfield, 1993). A prediction interval (PI) 
is defined as an estimate of an (unknown) future value that can be regarded as a random variable 
at the time the forecast is made (Chatfield, 1993). Prediction interval (PI) is mostly used for 
assessing and supplementing point prediction with the future uncertainty involved in different 
parameters. Moreover, it can be used to compare different methods thoroughly and to plan different 
strategy based on the range of possible values within the interval (Chatfield, 1993).   
2.6.1. Blood glucose prediction Models 
Blood glucose prediction has a lot of advantage to the patient, physicians and family of the patient 
in general. Diabetes management involves controlling the blood glucose concentration as close as 
possible to the normal (euglycemia). In particular, blood glucose concentration prediction can 
provide the immediate future blood glucose value depending on the previous history of the patient, 
thereby avoiding any further complication from hypoglycemia and hyperglycemia. According to 
(Naumova et al., 2012), blood glucose prediction model are divided into two groups, i.e. 
compartmental (physiological) models and data driven predictive (black box) models.  The first 
group, compartmental (physiological) models involves a deeper understanding of the underlying 
blood glucose dynamics. This kind of model is highly dependent on the true physiological model 
selected and are generally a representative of an average subject and may not provide accurate 
result to an individual scenario (Naumova et al., 2012). The second group, data driven predictive 
(black box) models are capable of predicting the future blood glucose based on the available 
information of the previous and present history of the individual patient including amount of 
insulin, blood glucose concentration, diet and physical activity to mention some. This kind of 
models require less understanding of the inner glucose-insulin dynamics and are tunable towards 
an individual. There are three available methods for implementing this kind of models, which 
include linear extrapolation, time-series and machine learning methods (Naumova et al., 2012). 
Currently, there a lot of blood glucose prediction algorithms have been put in practice, such as 
autoregressive model (Daskalaki et al., 2012; Jabali, 2013), causal probabilistic network (CPN) 
and Bayesian network model (Andreassen et al., 1994; Ståhl, 2012), artificial neural network 




2014), support vector regression model (SVR) (Plis et al., 2014), Wiener block-oriented model 
(Kotz, 2011; Rollins  et al., 2011) and others. The data driven predictive (black box) models are 
the most widely used models for blood glucose prediction and it is also believed to be the future 
candidate of diabetes management.  
2.6.2. Time-series Methods 
A time-series is a set of observations or measurements made sequentially through time. These 
observations or measurements can be taken on a continuous time or on a discrete time interval. As 
a result, can be divided as a continuous time series, i.e. Continuous Glucose Measurement (CGM), 
and a discrete time series. This mainly characterizes the time axis and not about the measured 
quantity. For example, blood glucose is a continuous quantity, however can be taken as a 
continuous or discrete time series. There are different kinds of time series in a real world 
circumstance such as the set of temperature at a particular location on successive days, the amount 
of measured electricity on a successive months and the amount of blood glucose concentration 
measured on successive days (Chatfield, 2000). Within the time series context, prediction involves 
forecasting or estimating the future values, the next (one step) or (two or more steps) of the time 
series. Recent development in time series based blood glucose prediction shows the potential of 
the method in predicting an individual blood glucose evolution such as the autoregressive model 
(Daskalaki et al., 2012; Jabali, 2013). 
2.6.2.1. Autoregressive models 
An autoregressive model6 can be defined as the representations of a random time varying process, 
where the output from the process are designated as a linear combination of past values and 
unexplained random (stochastic) term. It is a group of time series models, which can be a univariate 
(involving a single variables) and multi-variate (involving more than two variables) as input and 
output of the processes. There are various version of an autoregressive approach including AR 
(involving one output with no input), ARX (involving both output and input), ARMA (involving 
one output with no input) and ARMAX (involving both output and input) (Jabali, 2013; Stahl et 
al., 2009). Here only the version of autoregressive models that involves an output without any 
input are discussed here. Let  be a time series data with a set of sequence of measurements {t 





=1, 2, 3, 4…….n}, where n is the size of the time series. An autoregressive equation of order  are 
designated as ℛ( ) and given as follows: = + ∑ + ℰ   ………………………………………………..Eq.1 
Where  are the parameters of the model,  is a constant, and ℰ  is white noise. The maximum 
lag of the autoregressive equations are defined by the partial autocorrelation since the partial 
autocorrelation of ℛ( ) process is zero after + 1 and beyond this value. Therefore, the 
maximum order or lag of the ℛ( ) process is always equal to the value beyond which the partial 
autocorrelation vanishes. The parameters or coefficients of an autoregressive ℛ( ) process can 
be computed by using either the ordinary least squares procedure or method of moments (through 
Yule–Walker equations). A more advanced version of autoregressive is the combination of both 
autoregressive and moving average component, commonly known as autoregressive moving 
average (ARMA). It takes the moving average of an error components along with the 
autoregressive version. An ARMA (p, q) process defines an autoregressive components of order p 
and a moving average components of order q, as given below: = + ℰ + ∑ + ∑ ℰ    …………………………………………………….Eq.2 
Where  are the parameters of the autoregressive model,  are the parameters of the moving 
average model,  is a constant, and ℰ  is white noise. 
2.7. Moving window based z-score process 
Standard z-score computation is a widely accepted and used statistical procedure for comparing 
statistical variables of multiple units. The window based moving z-score process7 scores are 
capable of detecting anomalies in a univariate sequential dataset, often a time series. It is a very 
simple and easily repeatable model that can measure the deviation of each data point in a sequential 
datasets like a time series. It computes the running mean and standard deviation for a group of 
successive measurements, where the z-score value of the current measured blood glucose value 
are computed based on the previous window. This can capture any statistically significant 
deviations from the mean of the previous successive measurements in terms of its standard 
deviations. Given a window size of w, the moving z-score is defined as the number of standard 





deviations that each observation is found to be away from the mean, where the mean and standard 
deviation are calculated based on only over the previous w measurements. As given in the equation 
below, the z-score is the ratio of the difference between current observation and the moving mean 
and the moving standard deviation.  ( ) = ̅   ………………………………………………………………..Eq. 3 
Where the moving mean and moving standard deviation are given in the equation below:- ̅ = ∑    …………………………………………………………….Eq. 4 
= ∑ ( − ̅ )    ………………………………………………Eq. 5 
2.8. Disease surveillance systems  
2.8.1. Introduction  
Infectious diseases are an abnormality or disorder of the function of the body organs, which is 
caused by pathogenic microorganisms, such as bacteria, viruses, parasites or fungi (WHO, 2015b). 
Infectious diseases are characterized by their capability of passing from an infected person to the 
normal persons through different transmission media like air, water and physical contact. 
Infectious diseases are considered to be an outbreak when an excess number of cases occurs than 
normally expected within a community, geographical area or seasons. An infectious disease 
outbreak can be epidemics, pandemics or seasonal (WHO, 2015b).  It said to be pandemic when it 
occurs around the globe whereas epidemics involves only a certain city or country. Proper 
monitoring and early outbreak detection are the most important tasks of any public health 
surveillances as prevention is always better than cure. In order to accomplish this kind of proper 
monitoring and early outbreak detection, the use of disease surveillance systems are the ultimate 
choice, whether it is manual or automatic. 
2.8.2. What is disease surveillance system? 
The term “surveillance”, is consisted of two French words, ‘Sur’ which means over and ‘veiller’ 
which means to watch (Choi, 2012). Generally, it can be defined as ‘to watch over something’. 
Consequently, the term disease surveillance can literally be defined as ‘to watch over the 




precise and accurate definition of the term disease surveillance can be given as “an active ongoing 
systematic collection, analysis, interpretation and disseminations of health data for the use of 
public health purposes” (AMIA, 2002; Choi, 2012). According to this definition, the public health 
purposes encompasses planning, implementations and evaluation of public health actions (Choi, 
2012). This has an added value for taking an effective measures regarding public health actions 
such as vaccinations, quarantining or isolation and public training that involves creating awareness 
regarding the outbreak. Moreover, this can be helpful for the government to take the necessary 
action on policy making and implementations.  
2.8.3. Data sources and Timeliness of disease surveillance systems 
Various health related data at different point of time (timelines) starting from exposure (pathogens) 
to the point the person is diagnosed and treated can be used by the surveillance systems, e.g. 
absenteeism, lab tests, etc. As shown in Figure 2, the timelines of disease evolution begins when 
the individual is infected by a disease causing organisms (pathogens) and extends up to diagnosis 
and treatment of the patient (Botsis et al., 2009). During this period, the person who is exposed to 
a pathogens can be either infected or not. Shortly after infection, incubation and generation of the 
disease starts and may extend up to the onset of the systems and overlap to the contagious period. 
An infected person can be contagious even after consultation of their physicians.   
 
Figure 2: Timelines of disease evolution.  
( Figure 1, (Botsis et al., 2009)) 
Previously, most of the disease surveillance systems are dependent on data that are related to 
certain symptoms, which are confirmed by the physicians or laboratory technicians. Moreover, it 
follow paper based reporting systems, which is difficult to analyze and also a time consuming task 
(Wickramasinghe et al., 2012). This kind of disease surveillance systems have a great limitations 




the necessary actions so as to control the outbreak. As clearly indicated in Figure 3, the response 
is taken only after having the necessary lab confirmations, which might result in loss of lives before 
the right action is taken, i.e. vaccinations, quarantining or isolation, treatment and others.  
However, the advent of information and communication technology makes the data collection and 
analysis of disease surveillance systems to be fast and simple. This revolution has paved the way 
for different types of early disease outbreak detection systems to be developed by various 
researchers. The main advantage of an early outbreak detection systems is that it leaves a very 
ample space, as shown in the Figure 4, for monitoring and controlling measures to be taken since 
it detects the outbreak earlier before it spreads (Wickramasinghe et al., 2012). One of such a kind 
is syndromic surveillance, which is a kind of an early outbreak detection systems that merely 
depends on health data that is not yet diagnosed or recorded and confirmed by the physicians. 
 
 
Figure 3: Outbreak Detection and Response - the outcome of a delayed process.  
 (Figure 2, (Wickramasinghe et al., 2012)) 
Therefore, the approach behind syndromic surveillance is to collect a symptoms related patterns 
with in the population for the purpose of disease outbreak detection (Adam et al., 2007). This kinds 
of disease surveillance systems uses various kinds of data sources such as on the counter pharmacy 
drug sells, disease related search volumes in different search engine such as google, school 





Figure 4: Outbreak Detection and Response - the outcome of a rapid process.  
 (Figure 4, (Wickramasinghe et al., 2012)) 
2.8.4. Types of disease surveillance systems 
Any system that is intended for surveillance of diseases can be categorized under one of the 
following classification given by (Arana, 2010). This classification includes a more general 
systems such as vital records, disease reporting, surveys and more specialized systems such as 
sentinel surveillance, zoonotic disease surveillance, adverse events, syndromic surveillance, 
registries and laboratory data (Arana, 2010). Some of these systems are more useful to handle 
certain diseases than the rest but each systems works better to meet a certain specific needs. For 
example, vital records is a kind of surveillance systems designed to monitor the death and birth 
records of the population. However, disease reporting (morbidity data) systems is designed to 
report certain kinds of disease for the public health authorities that have a potential to be an 
international risk. Unlike these two, surveys are another kind of surveillance system that are 
designed to perform some kind of routine survey among the population to monitor chronic diseases 
and health related problems. In addition, sentinel surveillance is a kind of population based 
surveillance, which involves only a small group of the population called samples or reporting sites 
called sentinel to participate in the disease surveillance processes. Zoonotic disease surveillance 
systems is a bit different from the rest in that it involves detecting infected animals before the 




Computer Assisted Search for Epidemics (CASE), which is computer assistive disease 
surveillance system tailored for different disease groups including zoonosis. The adverse events 
surveillance is a kind of surveillance system that is designed to conduct and monitor the 
occurrences of any adverse reaction such as adverse drug reaction due to the previously taken 
prescribed drugs. For example, (Tripathy et al., 2015) developed a surveillance system that can 
detect adverse drug reaction through different data mining techniques. The most recent and 
advanced disease surveillance system is the syndromic surveillance that relays on using various 
clinical information that are related to the disease signs and symptoms before any diagnosis is 
made. This kind of outbreak detection uses different health data sources such as patients’ 
physiological indicators including reported symptoms, amount and types of medication sales, 
emergency calls and school absenteeism (Adam et al., 2007). The approach behind syndromic 
surveillance is to collect such patterns with in the population for the purpose of disease outbreak 
detection. For example, (Zhou et al., 2011) developed a syndromic surveillance systems that relays 
on Google search trends as a data source for detecting the outbreaks of tuberculosis (TB). Zhou et 
al. and his groups (Zhou et al., 2011) also formulated a dynamic detection algorithms that can 
detect and correct the «media effect» to reduce the condition of false alarming.  
2.8.5. Disease outbreak detection Algorithms 
An effective disease surveillance systems are expected to develop optimal disease outbreak 
detection mechanisms. A disease outbreak detection algorithms are said to be optimal when it 
possess reduced false alarm and good detection accuracy with minimum time lag, which is termed 
as specificity, sensitivity and timeliness. Generally, the approaches (algorithmic models) used to 
perform detection of disease outbreaks in disease surveillance systems are broadly categorized 
under three groups: regression methods, time series methods and statistical process control 
(Guillou et al., 2014). Currently, a lot of outbreak detection algorithms have been put in practice. 
For example, RODS project used a statistical approach for its outbreak detection mechanisms 
(Espino JU1, 2004; Wagner et al., 2004 ). Others types of algorithms such as Bayesian network 
(Yan et al., 2012; Yigzaw, 2012), Recursive-least-square (RLS) (Yan et al., 2012), Autoregressive 
Moving Average (ARIMA) (Yan et al., 2013), Hidden Markov Model (HMM) (Zhou et al., 2013), 
a Decision-Theoretic Model (Wagner et al., 2012) are also investigated and put in practice. A more 





Figure 5: General structure of temporal aberrancy detection algorithms.  
(Figure 6, (O'Connor et al., 2009)) 
2.9. Technical Evaluation Framework of Disease Surveillance Systems 
(Drewe et al., 2012; WHO, 2006) defines the technical evaluation framework of any disease 
surveillance systems including, specificity, sensitivity, positive predictive value (PPV) and 
timeliness.  Accordingly, “Specificity is defined as the proportion of true non-events correctly 
classified as such, the inverse being the false alarm rate” (Drewe et al., 2012).  “Sensitivity in 
surveillance refers to the proportion of actual cases in a population that are detected and notified 
through the system”(WHO, 2006). The sensitivity of a disease surveillance systems are described 




events for public health response and sensitivity of the notification system (WHO, 2006). The first 
level is sensitivity of the surveillance case definition, “which refers to the ability of the systems 
case definitions to encompass all the possible cases in the population”. The second level is 
sensitivity of the detection of events for public health response, “which refers the proportion of 
case detected and reported by the system” (WHO, 2006). The sensitivity here is defined as follows,  
=               × 100  ……………Eq. 6 
The third level is sensitivity of the notification system, “which refers to the proportion of cases 
meeting the case definition (regardless of the sensitivity of the case definition itself) that are 
detected and notified as they should be” (WHO, 2006). Moreover, “Timeliness is defined as the 
Speed between steps in a surveillance system. For outbreak detection, timeliness refers to the time 
between exposure to the infectious agent and the initiation of interventions to control infection” 
(Drewe et al., 2012). Positive predicative value (PPV) refers to the “proportion of the people, who 
actually have the disease and correctly classified as such by the disease surveillance system” 
(WHO, 2006). It can be considered in three levels, the PPV of the case definition, the PPV of case 
detection, and the PPV of outbreak detection. The first level, the PPV of the case definition is 
defined as (WHO, 2006): 
=         …………………………………………………….Eq. 7 
The second level, the PPV of case detection is defined as (WHO, 2006): 
=    (    )    × 100  ………………...Eq. 8 
The third level, the PPV of outbreak detection is defined as (WHO, 2006): 
=        /   ……………………………………………Eq.  9 
2.10. Related works and State of the art 
Recently, the advent of information technology and the availability of different bio-sensors have 
paved the way for the development of the next generation disease surveillance systems. These 




and real time access to patients’ health related information. By exploiting these technological 
advantage, a syndromic surveillance systems have been put in practice already (Chan et al., 2010; 
Chen et al., 2014; Chung-Kuo et al., 2005; Weng et al., 2015; Yan et al., 2013). However, 
nowadays, the situation is calling for more enhanced and early outbreak detection systems (during 
incubation period). Epidemiologists and researchers have been looking for more specific 
physiological indicators (patient observable parameters) to support early outbreak detection during 
the incubation period.   One of such a kind is the one that is based on blood glucose inputs from 
people with diabetes. Various researchers have tried to address the use of blood glucose data in 
the outbreak detection scenarios. For example,  (Botsis et al., 2007) has assessed the correlation 
between blood glucose levels and infection and also proposed a model for detecting infectious 
diseases in diabetes patients. However, the study didn’t develop any methods and only concludes 
by highlighting the presence of high correlation between the presence of infections and elevated 
blood glucose values. Moreover, (Lauritzen et al., 2011) highlights the requirements for detecting 
illness before the onset of the symptoms and illness, and an illness prediction model depending on 
patient observable parameters. Furthermore, (Liao et al., 2004) has developed a communication 
platform for diabetes surveillance. The idea is to promote the diabetes patients to measure their 
blood glucose regularly at home, and the system can provide the remote care persons with complete 
information about the patients measurement and conditions. Besides, (Årsand et al., 2005) have 
deeply and briefly described the system architecture, model and requirements of disease 
surveillance based on patient observable parameter, i.e. blood glucose. The study has addressed 
the data sampling, data repository, geographical location, and software agent technology, in 
developing disease surveillance system based on inputs from people with diabetes. In addition, 
(Botsis et al., 2009) also has assessed the development of electronic disease surveillance systems 
for detecting infections at the first stage of disease progression (during incubation period). The 
study has considered patient observable parameters like blood glucose values and count of white 
blood cells as an indicators. It also describes applying the bottom up approach for detection of an 
outbreak threat along with conceptual, organizational, architectural and technological issues of the 
dedicated electronic disease surveillance systems. Moreover, (Botsis et al., 2010) also describes 
the achievements in developing disease surveillance system based on data from people with 
diabetes. The study has performed an analysis using the data from two large-scale clinical studies 




examine the available point of care (POC) technology. The result indicates some interesting facts 
for further investigation, however the study reported that the available technological solutions have 




























Chapter Three: Literature Review 
An Early Outbreak Detection and Blood glucose prediction mechanisms:-
A Systematic review 
3.1. Introduction 
Recently, a lot of researchers are working towards detecting an infectious disease outbreak as 
earlier as possible, i.e. during the incubation period using blood glucose value of a diabetes patients 
(Botsis et al., 2009; Botsis et al., 2010; Lauritzen et al., 2011). These studies have shown a 
preliminary results on using blood glucose data of peoples with diabetes for detecting disease 
outbreak. Moreover, (Liao et al., 2004) briefly stated the necessary communication platform for 
developing a successful diabetes surveillance. However, a system which uses data within the 
incubation period, such as blood glucose data, is not yet developed and currently, it is a hot research 
topic. As part of this advancement in disease surveillance, the author is conducting a research on 
developing an early outbreak detection mechanism that relies on blood glucose inputs from people 
with diabetes. Therefore, it is the objective of this review to assess, analyze and report the current 
status of diabetes blood glucose prediction mechanisms and the state of the art in disease 
surveillance systems, which can be applied and geared towards achieving a successful disease 
surveillance system based on blood glucose inputs. Moreover, it tries to pinpoint the limitation and 
challenge imposed by the current methods. Furthermore, it gives recommendation for developing 
a successful outbreak detection mechanisms based on input from people with diabetes. The entire 
review are organized as follows: the first section discuss the method used along with the inclusion 
and exclusion for both blood glucose prediction and outbreak detection mechanisms. The next 
section discuss the results and the final section concludes the findings with some recommendation 
of the future systems. 
3.2. Method 
For the purpose of the study, we conducted a literature search in the following databases.  The 
databases included were Google Scholar, PubMed, Science Direct, MEDLINE, ACM Digital 
Library, IEEE Xplore, Journal of American Medical Informatics Association (JAMIA), PLOS 
ONE, and Munin, the proprietary database of the University of Tromsø – The Arctic University of 




effective searching strategy, several combination of string are used during searching. For blood 
glucose concentration profiles, several combination of the term such as “Blood glucose”, “profile”, 
“interval forecasting”, “interval”, “prediction”, “forecasting”, “trend prediction”, and “diabetes 
patient”, were used during searching. However, for the electronic disease surveillance systems, 
combination of strings such as “Electronic”, “disease”, “surveillance systems”, “syndromic 
surveillance”, “outbreak detection”, “diabetes patient”, and “mobile phone” were used during 
searching. First, we identified relevant articles by reviewing the titles, keywords and abstract for a 
preliminary filter with our selection criteria. We then reviewed full texts for articles that seemed 
relevant.  
3.2.1. Blood Glucose Prediction mechanisms 
Inclusion and exclusion criteria 
To be included in the study, the articles should possess one or more of the following criteria: 
 The model should be at least tested and evaluated 
 Evidence based research (i.e. RCT)  
 Should be data driven or black box model (based on the patient’s history) 
Articles that possess one or more of the following criteria are excluded from the study: 
 Published prior to 1995 
 Published in other language than English 
Data collection  
In this review, data collection and extraction from the identified literatures are carried by 
considering the following parameters of a typical blood glucose prediction systems. 
 Data types and source: This describes the source of the data and the type of the data 
communicated. 
 Diabetes type: This describes the type of diabetes patients the study considers. It can be type 
I (T1) or type II (T2) or both.  
 Input variables or parameters: This involves the number and type of the parameter used by 
the model. This could be diet, exercise, blood glucose concentration, amount of active 
insulin and others. 
 Participants: This describes the Evidence based research (i.e. RCT) nature of the studies. It 




 Model: This describes the kind of model the system implements, which can be 
compartmental or data driven models. 
 Algorithm or method: This describes the type of algorithm or methods implemented by the 
model.  
3.2.2. Early disease outbreak detection systems (Electronic disease surveillance systems) 
Inclusion and exclusion criteria 
To be included in the study, the articles should possess one or more of the following criteria: 
 The surveillance systems should be at least tested and evaluated 
 Should be entirely designed for human  
 Evidence based research (i.e. RCT)  
Articles that possess one or more of the following criteria are excluded from the study: 
 Published prior to 2000 
 Published in other language than English 
 Surveillance designed solely for veterinary medicine and others purposes  
Data collection  
In this review, data collection and extraction from the identified literatures are carried by 
considering the following parameters of a typical disease surveillance systems. 
 Data source: Signifies the source of the data. It can be EHR or any disease related report 
used to detect any trends for the disease outbreak detection.  
 Communication scenario: This includes the data type and format, means of exchanging 
data, and any real time monitoring systems. 
 Algorithms: For better identification of the disease outbreak, any disease surveillance 
systems should design and develop a good detection algorithms for the specific data types 
at hand. Therefore, the types of algorithms implemented on each literature is discussed 
under this section. 
 Case reporting: The purpose of any disease surveillance systems are to detect a disease 
outbreak and send a notification/report to the public health authorities and other healthcare 
workers. Therefore, having a good reporting mechanisms is relevant for the success of the 




 Type: Any disease surveillance systems can be designed to handle a certain disease types 
or it can be a group of disease with a certain parameter tuning for each disease case. 
Therefore, here the types of the disease each surveillance systems handles is discussed 
under this section. 
 Periodical updates: A disease surveillance systems are designed to report as soon as 
possible if any disease outbreak occurs. This involves a frequently updated data to be used 
for the analysis of surveillance. Depending on this a disease surveillance systems can be a 
real-time or periodical. Therefore, the freshness of data and its periodical update will be 
discussed under this sections. 
3.3. Blood Glucose Prediction mechanisms 
3.3.1. Result 
The search was conducted using the defined strings and refined using the keyword, title and 
abstract of the relevant articles, which resulted in 60 articles. After properly removing those 
duplicates resulted in 50 articles, which is screened with our inclusion and exclusion criteria. 
After screening, 42 articles are left, which are examined in full text. Finally, after full text 
assessment only 31 articles are included in this study. The details are given in Figure 6 and the 






































Figure 6: Flow diagram of reviewed literatures in blood glucose prediction.  




















   

















































(Andreassen et al., 1994) A probabilistic approach to glucose 
adjustment: description of metabolic 
study prediction and insulin dose 
T1 Plasma glucose (BG), 
carbohydrate intake, 
12 Causal probabilistic network 
(CPN) model 
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Records after duplicates removed  
(n = 10) 
Records screened  
(n =50) 
Records excluded  
(n =8) 
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model and pilot evaluation types, and doses of 
insulin injected 
(Daskalaki et al., 2012) Real-time adaptive models for the 
personalized prediction of glycemic 
profile in type 1 diabetes patients 
T1 Glucose and insulin 30* Autoregressive (AR), AR model 
with external insulin input 
(ARX), and an artificial neural 
network (ANN) 
(Georga et al., 2011)  Glucose Prediction in Type 1 and Type 2 
Diabetic Patients Using Data Driven 
Techniques 
T1 & T2 Glucose, Diet, 
Physical activity and 
insulin 
7 Compartmental models with 
support vector machines for 
regression (SVR) 
(Jabali, 2013) Prediction of Patient's Individual Blood 
Glucose Levels from Home Monitored 
Readings of Type I Diabetics 
T1 Glucose, Diet, 
Physical activity and 
insulin 
6 Autoregressive exogenous input 
(ARX) time-series model 
(Lauritzen et al., 2011) Towards a mobile solution for predicting 
illness in Type 1 Diabetes Mellitus: 
Development of a prediction model for 
detecting risk of illness in Type 1 
Diabetes prior to symptom onset 
T1 Glucose (BG) - - 
(Liszka-Hackzell, 1999) Prediction of Blood Glucose Levels in 
Diabetic Patients Using a Hybrid AI 
Technique 
T1 Glucose, Diet, 
Physical activity and 
insulin 
1 Hybrid AI technique combining 
the principal component method, 
wavelet transform and neural 
networks 
(Pappada et al., 2008) Development of a Neural Network for 
Prediction of Glucose Concentration in 
Type 1 Diabetes Patients 




(activities and events), 
and emotional states 
18 Neural networks 
(Pappada et al., 2011) Neural network-based real-time 
prediction of glucose in patients with 
insulin-dependent diabetes 
T1 Blood glucose, insulin, 
carbohydrate, lifestyle 
(activities and events), 
and emotional states 
10 Neural networks 
(Perez-Gandia et al., 2010) Artificial neural network algorithm for 
online glucose prediction from 
continuous glucose monitoring 
T1 Blood Glucose 15 Artificial neural network & 
Autoregressive model (ARM) 
(Quchani et al., 2007) Comparison of MLP and Elman Neural 
Network for Blood Glucose Level 
Prediction in Type 1 Diabetics 
T1 Glucose, Diet, 
Physical activity and 
insulin 
10 Multi-Layer Perceptron and 
Elman neural networks 
(Robertson et al., 2011) Blood Glucose Prediction Using Artificial 
Neural Networks Trained with the AIDA 
Diabetes Simulator: A Proof-of-Concept 
Pilot Study 
T1 Blood Glucose 22 A nonlinear auto-regressive 
neural network with 
exogenous inputs (NARX) 
(Shanthi et al., 2012) Prediction of blood glucose concentration 
ahead of time with feature based neural 
network 
T1 & T2 Glucose 20 Neural networks 
(Ståhl, 2012) Diabetes Mellitus Glucose Prediction by 
Linear and Bayesian Ensemble Modeling 
T1 Blood glucose, insulin, 
carbohydrate, meals 





(Stahl et al., 2009) Diabetes mellitus modeling and short-
term prediction based on blood glucose 
measurements 
T1 Blood glucose, insulin, 
meals 
1 ARMAX, NARMAX 
(Baghdadi et al., 2007) Controlling blood glucose levels in 
diabetics by neural network predictor 
- Exercise, stress, meal, 
injected insulin, blood 
glucose 
1 RBF & MLP neural network 
(Briegel et al., 2002) A Nonlinear State Space Model for the 
Blood Glucose Metabolism of a Diabetic 
- Blood glucose, insulin, 
meals 
- Artificial neural network, 
Monte-Carlo generalized EM 
(expectation maximization) 
algorithm 
(Eskaf et al., 2008) Predicting blood glucose levels in 
diabetics using feature extraction and 
Artificial Neural Networks 
T1 Blood glucose, 
Physical activity, 
meals 
- Artificial Neural Network, 
feature extraction procedures 
(Tresp et al., 1999) Neural-network models for the blood 
glucose metabolism of a diabetic 
- Blood glucose - Recurrent neural networks and 
time series convolution neural 
networks 
(Zainuddin  et al., 2009) A Neural Network Approach in 
Predicting the Blood Glucose Level for 
Diabetic Patients 
- Exercise, stress, meal, 
injected insulin, blood 
glucose 
1 Principal component analysis 
wavelet and neural network 
(Mougiakakou et al., 2006) Neural network based glucose - insulin 
metabolism models for children with 
Type 1 diabetes 
T1 Blood glucose, insulin, 
meals 
4 Compartmental Models (CMs) 
and artificial Neural Networks 
(NNs) 
(Wang et al., 2014) Personalized State-space Modeling of 
Glucose Dynamics for Type 1 Diabetes 
Using Continuously Monitored Glucose, 
Insulin Dose, and Meal Intake: An 
Extended Kalman Filter Approach 
T1 Blood glucose, insulin, 
meals 
5,30* Extended Kalman filter (EKF) 
(Efendic et al., 2014) Short-Term Prediction of Blood Glucose 
Concentration using Interval Probabilistic 
Models 
T1 Blood glucose, insulin, 
carbohydrate 
12 Gaussian Mixture Models 
(GMM) 
(Plis et al., 2014) A Machine Learning Approach to 
Predicting Blood Glucose Levels for 
Diabetes Management 
T1 Blood glucose, insulin, 
carbohydrate 
5 Support Vector Regression 
model 
(Rollins  et al., 2011) Forecast Intervals In K-Steps-Ahead 
Prediction Modeling Under Continuous-
Time Monitoring with Application to 
Blood Glucose Inference 
T1 - 20 Static linear regression function 
in a Wiener block-oriented 
structure 
(Kotz, 2011) Multiple disturbance modeling and 
prediction of blood glucose in Type 1 
Diabetes Mellitus 
T1 Insulin, Physical 
activity, meals 
15 Wiener block-oriented model 
(Lu et al., 2010) The Importance of Different Frequency 
Bands in Predicting Subcutaneous 
Glucose Concentration 
in Type 1 Diabetic Patients 
T1 Blood glucose 9 Data-driven autoregressive (AR) 
models 
(Bunescu et al., 2013) Blood Glucose Level Prediction using - Blood glucose, insulin, 
meal 




Physiological Models and Support Vector 
Regression 
Model, ARIMA 
(Hemmingsen et al., 2009) Prediction and Control of Blood Glucose 
in T1DM Patients 
T1 Blood glucose, insulin, 
meal 
- Autoregressive exogenous input 
(ARX) and Autoregressive 
moving average exogenous input 
(ARMAX) 
(Reifman et al., 2007) Predictive Monitoring for Improved 
Management of Glucose Levels 
T1 Blood glucose, insulin, 
meal 
9 Data-driven autoregressive (AR) 
models 
(Cescon, 2013) Modeling and Prediction in Diabetes 
Physiology 
T1 Blood glucose, insulin, 
meal, exercise 
- ARX-, ARMAX- and subspace-
based prediction 
(Cescon, 2011) Linear Modeling and Prediction 
in Diabetes Physiology 
T1 - 9 Autoregressive moving average 
with exogenous inputs 
(ARMAX) models and state-
space models 
 
3.3.2. Analysis and Evaluation 
Diabetes is a chronic disease, which needs proper managements of one’s blood glucose to prevent 
further complication from an abnormal state called hypoglycemia and hyperglycemia. Proper 
management of the disease involves controlling the diet, injecting proper amount of insulin, 
measuring blood glucose about seven times a day as a standard and performing physical activities. 
Besides, having an effective decision support systems, which can predict the immediate future 
values of blood glucose has a great impact on maintaining the wellbeing of the patients. Currently, 
a lot of researches have done on predicting blood glucose values of the diabetes patients’ for 
various purpose, such as helping the individual and the healthcare givers for a better decision 
making ability. The literature review done on blood glucose prediction shows that almost greater 
part of the study have developed a prediction models for type I diabetic patients. This might be 
due to the availability of frequent blood glucose measurements throughout the day. Moreover, 
equivalently most of the studies have relied on continuous blood glucose measurement devices 
(CGM), which has a great impact for a successful prediction within various horizons. Moreover, 
these studies have shown an evidence based research (RCT), with a significant amount of 
participants. Depending on the availability, different researchers have used various kinds of inputs 
like blood glucose, insulin, physical activity, diet and others. As shown in the Figure 7, around 
17% of the studies have used blood glucose, insulin, physical activity and diet. Majority of the 




have used blood glucose features only. Furthermore, 13% of the studies have used more than the 
four keystone of diabetes including stress level, medication and others.  
 
Figure 7: Types of input parameters used by the algorithm in literatures.  
 
Figure 8: Types of algorithm used in the literatures.  
Currently, there are a lot of available models for implementing blood glucose prediction, including 
neural network, autoregressive, support vector machines and others. As shown in the Figure 8, 
neural network ranked first and used by almost 41% of the studies. Autoregressive models are 
ranked second and used by 35% of the studies. Support vector machines are ranked third and 
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and used by 6% of the studies. Finally, Kalman filter, Gaussian mixture model and Weiner block 
oriented models equally ranked fifth and accounts 3% of most used algorithms. 
3.4. Disease Surveillance Systems 
3.4.1. Result  
The search was conducted using the defined strings and refined using the keyword, title and 
abstract of the relevant articles, which resulted in 346 articles. After properly removing those 
duplicates resulted in 305 articles, which is screened with our inclusion and exclusion criteria. 
After screening 89 articles are left, which are examined in full text. Finally, after full text 
assessment only 38 articles are included in this study. The details are given in Figure 9 and the 




















           Figure 9: Flow diagram of reviewed literatures in disease surveillance systems.  
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1 (Kling et al., 2012) Two Years of Computer Supported Outbreak Detection in 
Sweden: the User ’s Perspective 




2 (Zhou et al., 2011) Tuberculosis Surveillance by Analyzing Google Trends Syndromic surveillance using Google 
trends 
Tuberculosis (TB) 
3 (Tripathy et al., 2015) Detection of Adverse Drug Events through Data Mining 
Techniques 
Pharmacovigilance Adverse Drug Reaction 
(ADR) 
4 (Zhou et al., 2013) Monitoring Epidemic Alert Levels by Analyzing Internet 
Search Volume 
Syndromic surveillance using Google 
trends 
Epidemic outbreaks 
5 (Zhou et al., 2005) A Real-Time Continuous Cardiac Arrhythmias Detection 
System: RECAD 
RECAD Cardiac arrhythmia  
6 (Zheng et al., 2014) Epidemic Surveillance Using an Electronic Medical Record 
: An Empiric Approach to Performance Improvement 
Epidemic Surveillance Using an 
Electronic Medical Record 
Acute respiratory infections 
(ARI) 
7 (Yu-Sheng et al., 2010) Development of a Hospital-Acquired Infection 
Surveillance Information System by Using Service-
Oriented Architecture Technology 
hospital-acquired infections surveillance 
information system (BASIS) 
Hospital-acquired infections 
8 (Chu et al., 2011) UPHSM: Ubiquitous Personal Health 
Surveillance and Management System via WSN Agent on 
Open Source Smartphone 
Ubiquitous surveillance Chronic diseases 
9 (Liao et al., 2004) A Communication Platform for Diabetes Surveillance Diabetes Monitoring Diabetes 
10 (Yigzaw, 2012) Snow Integrated Communicable Disease Prediction Service Snow Integrated System Communicable Disease  
11 (Yang et al., 2011) A nationwide web-based automated system for outbreak 
early detection and rapid response in China 
China Infectious Disease Automated-alert 
and Response System (CIDARS)  
 Infectious diseases 
12 (Yan et al., 2012) Establishing a web-based integrated surveillance system for 
early detection of infectious disease epidemic in rural 
China: a field experimental study 
Integrated surveillance system (ISS) (W. 
Yan et al., 2013) :- Combination of 
syndromic surveillance and existing case 
report surveillance 
Infectious disease epidemic 
13 (Xiaohui et al., 2004) A bio intelligence system for identifying potential disease 
outbreaks 
Syndromic surveillance using Over-the-
Counter Pharmaceutical Sales Data  
"Gastrointestinal Diseases 
and Respiratory Illnesses" 
14 (Wong et al., 2007) Temporal Air Quality Monitoring Using 
Surveillance Camera 
Air Quality Monitoring Respiratory Illnesses such as 
heart disease, asthma, 
stroke, bronchitis 
15 (Weng et al., 2015) Early Detection for Cases of Enterovirus- and Influenza-
Like Illness through a Newly Established School-Based 
Syndromic Surveillance System in Taipei 
 School-based Infectious Disease 
Syndromic Surveillance System (SIDSSS) 
Most common pediatric 
infectious diseases such as 
enterovirus-like illness 





16 (Wagner et al., 2004 ) Syndrome and Outbreak Detection Using Chief-Complaint 
Data —Experience of the Real-Time Outbreak and Disease 
Surveillance Project 
Real-Time Outbreak and Disease 
Surveillance (RODS)  
Respiratory  and other 
illness 
17 (Wickramasinghe et al., 
2012) 
Nivārana: System design and implementation focused on 
rapid response to epidemics 
Communicable disease surveillance and 
analysis system 
Communicable disease 
18 (Sugawara et al., 2012) Real-time prescription surveillance and its application to 
monitoring seasonal influenza activity in Japan 
Prescription surveillance Influenza 
19 (Spencer et al., 2011) The detection of spatially localized outbreaks in 
campylobacteriosis notification data 
- Campylobacteriosis 
20 (Chan et al., 2010) Probabilistic daily ILI syndromic surveillance with a 
spatio-temporal Bayesian hierarchical model 
Syndromic surveillance influenza  
21 (Chen et al., 2014) Flu Gone Viral: Syndromic Surveillance of Flu on Twitter 
Using Temporal Topic Models 
Syndromic surveillance Flu 
22 (Chung-Kuo et al., 2005) An application of sensor networks for syndromic 
surveillance 
Syndromic surveillance  
23 (Cooper et al., 2005) Can syndromic surveillance data detect local outbreaks of 
communicable disease? A model using a historical 
cryptosporidiosis outbreak 
Syndromic surveillance diarrhea 
24 (Crubezy et al., 2005) Ontology-centered syndromic surveillance for bioterrorism BioSTORM  Trauma, Cardiovascular, 
Respiratory 
25 (Espino JU1, 2004) The RODS Open Source Project: Removing a Barrier to 
Syndromic Surveillance 
RODS/Syndromic surveillance Respiratory, flu, diarrhea 
and skin rashes 
26 (Eysenbach, 2006) Infodemiology: Tracking Flu-Related Searches on the Web 
for Syndromic Surveillance 
Infodemiology: Syndromic surveillance flu 
27 (G.Y. Hong, 2011) Ubiquitous Healthcare for Environmentally Linked Disease 
Syndromic Surveillance 
Syndromic surveillance chronic disease (asthma) 
28 (Gesteland et al., 2003) Automated syndromic surveillance for the 2002 Winter 
Olympics 





29 (Heffernan et al., 2004) Syndromic surveillance in public health practice, New 
York City 
Syndromic surveillance multiple categories such as 
respiratory, diarrhea, asthma   
30 (Hulth et al., 2009) Web queries as a source for syndromic surveillance Syndromic surveillance influenza and influenza-like 
illness 
31 (Lombardo et al., 2004) ESSENCE II and the framework for evaluating syndromic 
surveillance systems 
Electronic Surveillance System for the 
Early Notification of Community-Based 
Epidemics (ESSENCEII)  
Community-Based 
Epidemics 
32 (Ong et al., 2013) Syndromic surveillance for health information system 
failures: a feasibility study 
Syndromic surveillance  
33 (Perry & Van Allen, 2005) Causal Reasoning Engine: An Explanation-Based 
Approach to Syndromic Surveillance 
Syndromic surveillance multiple non-mutually 
exclusive diseases 





35 (van den Wijngaard et al., 
2010) 
Syndromic surveillance for local outbreaks of lower-
respiratory infections: would it work? 
Syndromic surveillance lower respiratory infection 
36 (Weng et al., 2015) Early detection for cases of enterovirus- and influenza-like 
illness through a newly established school-based syndromic 
surveillance system in Taipei, January 2010 ~ August 2011 
School-based Infectious Disease 
Syndromic Surveillance System (SIDSSS) 
"Enterovirus-like illness 
(EVI) and Influenza-like 
illness (ILI)" 
37 (Yan et al., 2013) ISS--an electronic syndromic surveillance system for 
infectious disease in rural China 
ISS infectious disease 
38 (Wagner et al., 2012) A Decision-Theoretic Model of Disease Surveillance and 
Control and a Prototype Implementation for the Disease 
Influenza 
SEIR  influenza 
             






















































1 SaTScan Poisson,SaTScan Space, Time 
Permutation, Outbreak, simple 
threshold algorithm 
 Swedish registry of notifiable 
diseases (SmiNet) 
Email Daily analysis The outbreak signal is sent by an email 
to the epidemiologist(s) in charge of the 
surveillance of the pathogen in question. 
2 A dynamic system in the form of the 
nonstationary Kalman filter  
 CDC reported TB and Google 
search engine" 
_ Weekly (Real 
time service) 
Estimated number of TB cases are 
reported in colored graphical maps 
3  Proportionality Reporting Ratio (PRR) 
and Chi-square function 
 US FDA database of past 
patient records, both safe and 
ADR cases 
_ _ /(Real time 
service) 
Accepts the doctor’s prescription as an 
input and provide recommendation on 
adverse drug events 
4 Continuous density HMM  CDC morbidity and Google 
search volume (hepatitis) data  
_ Weekly (Real 
time service) 
Estimated number of hepatitis cases are 
reported 
5 The AWES integrates an ECG 
diagnostic chip (optional) and is able to 
offer the capability of the real-time 
ECG diagnosis. 
 The ambulatory wireless ECG 
sensor (AWES) capture 4 
leads ECG signals sampled at 





When a cardiac abnormal event is 
detected, an alarm message will be sent 
to the cardiologists to examine the 
cardiac abnormal events and respond 
with the shortest latencies 
6 Eight previously characterized ARI 
case detection algorithms (CDA)  
 Anonymized and de-
identified Historical EMR 
data (Veterans Integrated 
Service Technology 
Architecture (VistA) 
repository)                                  
_ Daily analysis Early aberration reporting system’’ 
(EARS)  




Distributed EMR systems  Real time 
service 
Provide more complete infection 





8 The sensory data value will be 
compared with whether it is running 
beyond a preset threshold within a 
preset period or not. 
 Bio-monitoring sensor, 
wireless sensor network 
(WSN 
SMS Real time 
service 
SMS (short message) with concise 
information including GPS coordinates 
will be sent to physicians and relative to 
help user immediately to receive proper 
treatment as soon as possible 
9 Measured values are compared with the 
threshold (criteria) 
 Biological monitor module 
including Glucose meter and 
Pressure monitor are used to 







If the measured values are beyond the 
criteria, an Alarm will be sent to care 
persons. 
10 Bayesian Model CSV Aggregated laboratory 
confirmed cases from the 
SNOW system on weekly and 
monthly period 
 Weekly Various information regarding different 
disease predictions and ranking of 
algorithms 
11 Fixed-threshold detection method 
(FDM)   Temporal detection method 
(TDM)                       Spatial detection 
method (SDM) 
 Electronic National Notifiable 
Infectious Diseases Reporting 
Information System 
(NIDRIS) 
 Real-time and 
daily  
Automatically send signals on mobile 
phones by the SMS system 
12 Moving Average (MA), Exponentially 
Weighted Moving Aver-age (EWMA), 
Cumulative Sums (CUSUM), 
Recursive-Least-Square (RLS) Method, 
Shewhart Chart (P Chart), Small Area 
Regression and Testing (SMART), 
Bayesian spatial scan statistics, Space-
time Scan Statistics and What is 
Strange About Recent Event (WSARE) 
 Patients’ major symptoms 
from health clinics, 
pharmaceutical sales from 
pharmacies and absenteeism 
information from primary 
school 
 Daily and user 
specified   
The system send e-mail and/or SMS 
alerts automatically 
13 Rule-Based Alerting  OTC pharmaceutical sales  Daily and 
Weekly  
Specific alerting and the spatial and 
temporal characteristics of the outbreaks 
are reported by the embedded Internet 
GIS application 
14 threshold  Still images captured by 
camera 
 Real-time  Alerting systems 
15 Chi-square tests and the Pearson 
correlation coefficients and T-tests  
 Data collected from all school 
nurses or class teachers based 
on syndrome reports rather 
than absenteeism 
 weekly  A real-time text message alert through 
short message service (SMS) is 
immediately sent to the public health 
professionals for further epidemiologic 
investigations 
16 Mostly Bayesian classifier and others Health Level 
7 (HL7) 
Chief complaint data (the 
patient's reason for visit) was 
collected from different 
hospitals   
 Real-time  Alerting systems 
17 Automatically detect the suspicious 
situations based on the count and 
disease density for a given geographical 
area 
 Weekly Return of 
Communicable Diseases 
forms electronically 
 weekly Alerting the relevant public health 




18 Counting the number of anti-influenza 
drug prescribed by different physicians 
 Electronic records related to 
prescription drugs purchase 
data 
 daily  sharing the information related to 
influenza activity through the Internet 
with the participating pharmacies and 
public health authorities 
19 Bayesian hierarchical model and spatial 
scan statistic 
 The national notifiable 
diseases database, EpiSurv of 
New Zealand  and simulated 
data containing outbreaks 
 weekly displays Spatial distribution of the 
sporadic risk at the mesh block level on 
the map 
20 Bayesian posterior probability  The numbers of daily 
emergency room ILI visits at 
five community hospitals in 
Taipei City 
during 2006–2008 
 daily  The proposed algorithm recommends an 
alert for action if the posterior 
Probability is larger than 70%. 
21 Temporal topic model (HFSTM) for 
inferring hidden biological states for 
users, and an EMbased learning 
algorithm (HFSTM-FIT) for modeling 
the hidden epidemiological state of a 
user 
 User tweets  Real time 
service 
flu-trend prediction 
22 Bayesian analysis HL7 Data from 11 hospitals in five 
health systems. The system 
copies the data to an Indiana 
State Department of Health 
server each night and is 
reviewed daily. 
GUI daily The results are displayed on the GIS to 
demonstrate the spatial distribution of 
diseases 
23 Control chart method & Confidence 
interval method 
 Data were obtained from a 
cryptosporidiosis 
outbreak that occurred during 
the spring of 1997 in North 
London and Hertfordshire 
 daily  When the proportion n of diarrhea calls 
(simulated plus outbreak calls) exceeded 
the upper 99.5% control chart limit or 
upper 99.5% confidence interval this was 
termed an ‘exceedance’ 
24 Poisson Aberrancy Calculator  ER Chief Complaint, School 
Absenteeism 
 daily  Temporal and spatial distribution of the 
diseases 




Absenteeism data, sales of 
over the-counter healthcare 
products, and chief 
complaints  
GUI Real time 
service 
User interfaces  that can display 
syndromic data as time-series graphs, 
and work with a geographic information 
system (GIS) to view the data spatially 
26 Pearson correlation coefficients   Internet data for flu-related 
searches 
 weekly Alarm based on correlations and 
significance level 
27   indoor air quality  Real time 
service 
Upon detection of any abnormality, the 
system can also trigger an alert for 





28 Recursive least square (RLS) adaptive 
filter (RLS, a dynamic autoregressive 
linear model), Naı¨ve Bayes Complaint 
Coder (CoCo) 
HL7 Chief complaints data 
(encounter data were 
collected from 19 urgent care 
centers and nine emergency 
departments owned and 
operated by IHC and from the 
University of Utah Hospital’s 
emergency department and 






The signal alarm notifications for the 
primary detection algorithm—RLS—
were broadcast to system administrators, 
investigators, and public health officials 
through e-mail, alphanumeric paging, 
and short messaging service, where they 
can login and observe the time series and 
spatial distribution on the map. 
29 one-dimensional temporal scan statistic fixed-column 
or delimited 
ASCII text 
Chief complaint data Email  daily  A report consisting of graphs and a brief 
summary is distributed 
30 partial least squares regression  Search logs submitted to a 
Swedish medical web site for 
two influenza seasons 
  Alerting systems 
31 Early Aberration Reporting System, 
Exponentially weighted moving 
average and Scan statistics 
Health Level 
7 (HL7)  
Ambulatory records 
generated for Tricare, the 
military’s health-care system, 
chief-complaint records, 
school absenteeism data, 
over-the-counter (OTC) and 
prescription medication sales, 







daily  A map portal displays geographic 
distribution of raw data and clusters 
formed by scan statistics. 
32 Shewhart statistical control process 
charts 
 Hospital electronic health 
record system (laboratory 
information system) 
 daily  Alerting systems 




Synthetic data generated by 
an advanced data generator 
 Real time 
service 
alerts the health officials if any diseases 
are having an unusually high posterior 
probability 
34 trimmed-mean seasonal models, 
autoregressive integrated moving 
average (ARIMA) residuals 
 A decade of historical data at 
a major metropolitan 
academic, tertiary care 
pediatric emergency 
department and with 
simulated outbreaks 
 daily  Alerting systems 
35 space-time permutation scan statistic  ICD-9-CM Hospitalization data were 
collected from the Dutch 
National Medical Register 
 weekly Alerting systems 
36 spatio-temporal analysis  ICD-9-CM Data from the Emergency 
Department-based Syndromic 
Surveillance System (ED-
SSS) and the Longitudinal 
Health Insurance Database 
2005 (LHID2005) 
SMS Real time 
service 
Surface plot of weekly time series as a 
gradient interpolated between adjacent 




37 Temporal analysis (Shewhart Chart (P 
Chart), Moving Average (MA), 
Exponentially Weighted Moving 
Average (EWMA), Cumulative Sums 
(CUSUM)), spatial analysis (Recursive 
Least Square (RLS) Method, Small 
Area Regression and Testing 
(SMART), Bayesian spatial scan 
statistics), and spatial-temporal analysis 
(Space-time Scan Statistics and What is 
Strange About Recent Event 
(WSARE)). 
Excel files Main symptoms of patients 
who present at health 
facilities, medication sales 
from retail pharmacies and 
primary school absenteeism 
Email  
and SMS 
daily  When an alert is triggered, the system 
will automatically send e-mail 
notifications to subscribed 
communication groups. 
38 A Decision-Theoretic Model Excel  Electronic health record  daily  Visualizing the spread on a map 
 
3.4.2. Analysis and Evaluation 
During disease outbreak, early detection meant saving many lives from the incidence. Therefore, 
any successful disease surveillance should have a detection algorithm that is capable of detecting 
the outbreak within a short time after the beginning of the outbreak or incidence. This can be 
quoted with an excellent timeliness, specificity and sensitivity of the detection systems. To this 
end, various researchers have developed and implemented different outbreak detection 
mechanisms including Bayesian, regression, moving average, threshold and others as shown in the 
Figure 10. According to the result, spatio-temporal scan statistics and other models ranked first 
and accounts 37% of the most used outbreak detection algorithm. Bayesian model ranked second 
and accounts 15% of most used algorithm. Both the variety of the moving average and threshold 
mechanisms accounts 9% and ranked third most used detection algorithms. Moreover, both Chi-
square and Pearson correlation coefficient and regression models accounts 8% and ranked the 
fourth most used detection algorithms. Recursive least square is another detection mechanisms, 
which accounts 6% and ranked fifth. Furthermore, the use of control chart and confidence interval 
accounts 4% and ranked sixth. Besides, hidden Markov model (HMM) and Kalman filter ranked 





Figure 10: Types of an early outbreak detection algorithm used in the literatures.  
After detection of the outbreak, means of disseminating the necessary information for the 
concerned body is also crucial for the success of the disease surveillance system under 
consideration. There are a lot of mechanisms for information dissemination including email, SMS, 
phone, fax and others as shown in the Figure 11. Email is the most used form of communication 
(39%) followed by SMS (33%). Moreover, Fax accounts 6% followed by Phone calls, which 
accounts 5%.  
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As demonstrated above, both blood glucose prediction mechanisms and early outbreak detection 
techniques have seen advancements. Different researchers have tried different data driven 
mechanisms for successful prediction of blood glucose values within various prediction horizon 
and reported a success. Among them, artificial neural network and autoregressive models are the 
most practiced form of blood glucose prediction. Due to its simplicity and computational 
efficiency, an autoregressive models will be implemented in this thesis project. Moreover, 
researchers have tried different outbreak detection mechanisms, where each mechanisms have its 
own pro and cons. One outbreak detection techniques might be efficient with a specific disease 
surveillance systems, however it might be inefficient for the other kind. Therefore, choosing the 
right outbreak detection techniques depend on the kind of data used, the purpose of the surveillance 
and the kind of the surveillance implemented. As a result, even if it is least practiced in literatures, 
control chart, confidence interval and threshold will be explored and implemented in this thesis 
project. Furthermore, information dissemination are a crucial part of building a successful disease 
surveillance systems. Therefore, the most practiced form of information dissemination such as 
email and SMS are considered in this project. 
3.6. Conclusion 
Major public health treats are either naturally occurring or an artificially induced bioterrorists 
attack. Either way, it is necessary to detect the outbreak as early as possible to save lives. With the 
advent of information technology, the transition from paper based reporting into electronic form 
has revolutionized the disease surveillance systems. One of such a kind is the syndromic 
surveillance system, which uses data prior to diagnosis but after incubation period including 
absenteeism, internet search volume, over the counter pharmacy sells and others. However, a 
system which uses data within the incubation period is not yet developed and currently, it is a hot 
research topic. Among these early outbreak detection, which uses data within the incubation 
period, the one that depends on blood glucose inputs from people with diabetes and other 
physiological parameters from different health sensor networks are considered to be the next 
generation disease surveillance system. Moreover, the availability of successful blood glucose 
prediction models and outbreak detection mechanisms coupled with the availability of different 
physiological monitoring sensors such as heart activity (electrocardiogram (ECG)), muscle 
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activity (electromyography (EMG)), brain activity (electroencephalography (EEG)), blood 
pressure and continuous blood glucose sensor, white blood cells count, body temperature, 
breathing or respiration sensor can enhance the feasibility of the model in the near future. 
Furthermore, the inclusion of the available physiological parameters from other chronic patients 
such as COPD might result in an excellent detection accuracy of the developed system. Therefore, 
we foresee the use of health sensor networks comprising these physiological parameters will solve 




Chapter Four: Materials and methods 
4.1. Introduction  
This thesis project is concerned with developing an early aberration detection mechanism that rely 
on recorded blood glucose value, amount of insulin, diet and physical activity, and particularly 
continues blood glucose (CGM) data are used in this thesis project. This project has a couple of 
major components, research and application development components. The research component 
involves developing the underlying mathematical model, which is used to implement the system 
and is consisted of two consecutive phases, blood glucose prediction phase and outbreak detection 
phase. The first phase includes prediction of the step-ahead BG values using previously record 
CGM data. It also calculates the confidence interval of the predicted values, where the future 
measurement is most likely expected to lie within. The second phase is outbreak detection, where 
the actual BG values are compared with the predicted BG intervals. Additionally, it also involves 
calculating the z-score of the actual BG readings data with a moving window based z-score 
computation. The deviation is detected, when the current actual BG reading is found outside of the 
predicted intervals or when the current actual BG reading has a z-score value with a statistically 
significant deviation from a group of previous recordings. The total number of people (cluster), 
assumed to be in a specified region and timeframe is compared with the stated thresholds. If the 
number of people in the cluster is found to be above the pre-specified threshold, an alarm will be 
sent to the responsible body, such as public health authority or hospitals. Apart from the research 
component, the application development component tries to answer the necessary requirements 
specification for developing and implementing the prototype software system. This includes 
specifying the system requirements and developing the use case diagram along with the Unified 
Modelling Language (UML). However, the development of the software application itself is not 
considered in this project. 
4.2. Research Paradigm and Tools 
This thesis project has been conducted using both Friedman, the tower of achievements in medical 
informatics (Friedman, 1995) and an Engineering approach described by Denning et al. (Denning 
et al., 1989). This involves model formulation including defining requirement and specification, 




evaluation techniques including testing of the system for performance (Friedman et al., 2006). The 
requirement and specification are defined following Volere’s standards (Robertson et al., 2000). 
4.3. Materials  
In order to develop and test the system, a combination of software and hardware have been used. 
The system has been entirely developed based on two components, research component and 
application development component. The research component (development of BG prediction, 
interval calculation and outbreak detection) were developed based on Matlab programming 
language. The application development component involves specifying the system requirements 
and developing the use case diagram along with the Unified Modelling Language (UML), which 
is done based on a trial version of the Enterprise Architect v.10.0, SPARX Systems©8.  
Table 5: Software and Hardware used in the thesis 
Software Hardware 
Microsoft Window 10 Toshiba Laptop (Intel Core i3 2500s, 
4Gb RAM) 
Matlab R2015b  
Enterprise Architect v.10.0, SPARX Systems  
 
4.4. Data Collection and Experimental Methods 
4.4.1. Literature review & Related Work 
A comprehensive review of literatures and related works have been conducted, so as to formulate 
the functional and non-functional requirements of the system and also to formulate the 
mathematical models that are used for blood glucose prediction and outbreak detection 
mechanism. Moreover, a systematic review of literatures was conducted in order to grasp the 
current trend, advancements and state of the art in blood glucose predictions and outbreak detection 
mechanisms (see Table 1 and 2).  
                                                          
8Enterprise Architect website:- http://www.sparxsystems.com/products/ea/trial.html 
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4.4.2. Meetings with Diabetes patients and Diabetes expert 
Several meeting with diabetes patients, who have long standing experience in diabetes 
management technologies and experts at Norwegian center for eHealth research (previously 
known as NST), have been held. The meeting was arranged so as to formulate the simulated blood 
glucose deviations to resemble as close as possible to the real infections, such as respiratory 
infections, which is used in testing of the developed system.  
4.4.3. Testing 
The system was tested for detecting statistically significant deviations of BG reading that are 
associated with the presence of infections. Testing the system has been takes place in two 
partitions, where the first partition involves blood glucose prediction in which the system was 
trained and validated with unseen data. The second partition is the outbreak detection, which was 
tested with the simulated dataset. The performance was also analyzed in terms of its sensitivity, 
specificity, and positive predictive value. Moreover, the system was assessed in terms of its 
usefulness, acceptability, and generalizability.  
4.4.4. Data sources  
The quality of data used in developing early outbreak detection systems are crucial for the success 
of the system, which is measured in terms of its representativeness and, completeness. This thesis 
project was conducted using data collected from two type-I diabetes subjects/testers, from small 
group of people with diabetes. All these necessary data were collected from Dexcom - continues 
blood glucose monitoring (CGM) device, which records blood glucose data at every five minutes. 
The collected data were one month long, which were vertically divided into training and validation 
datasets. The training datasets were entirely used to train the developed system, whereas the trained 
system was validated using validation datasets (unseen during training). Additionally, these two 
subjects’ data were modified with artificially simulated blood glucose deviations of different size, 
shape and durations to be used in testing the performance of the developed early outbreak detection 
mechanism.  
4.5. Critics of the method used  
As a first remark, the author believes that the availability of limited diabetes subjects’ data has a 
major limitation to further test and validate the system. The developed system might be more 




the availability of a real individual’s BG data that is recorded with the presence of infection. This 
has a great effect on testing of the developed system for the defined surveillance case definition 
under real settings. Moreover, the presence of such kind of measurements have a great impact on 
making the developed system representative of the whole surveillance case definitions. 
Unfortunately, these kind of data were not considered here, since there were not such kind of 
measurement available during data collection. 
The prediction of blood glucose values was developed based on autoregressive model, using 
Autoregressive (AR), and Autoregressive Moving Average (ARMA) methods. This model was 
chosen, because this model relies on more recent values to predict the feature values, which is 
most important for our project, which is helpful to follow the persons’ cyclical habit within a day, 
week or more. Besides, during selection of the procedure more emphasis was given on the 
simplicity and repeatability of the models. In addition, it has a simple and well-defined procedure 
for calculating interval of the forecasts. Apart from this, interval prediction was chosen over point 
prediction so as to compromise for the uncertainty involved with other unexplained BG variations.  
4.6. System Evaluation  
The developed system has been evaluated based on available gold standard methods in literatures. 
The first partition, blood glucose prediction methods have been tested and evaluated using mean 
square errors (MSE) and root mean square errors (RMSE) functions. In addition, the performance 
of the outbreak detection mechanism is evaluated based on the accuracy of detecting the defined 
surveillance case definition (an individual’s consecutive high BG readings). Moreover, the optimal 
working threshold is determined using sensitivity, specificity, positive predicative value, which is 
based on the tradeoff between threshold values and the false-positive rate. 
4.7. Summary  
The following sets of methods were used in this thesis work: 
 Syestem Design (the Tower of achievements in Medical Informatics & an Engineering 
approach) 
 State requirements;  
 State specifications;  
 Design and implement the system;  




 Data Collection 
 Literature review 
 Meetings with diabetes patients and diabetes experts 
 Disccusion with other experts and collegues  
 Datasets collection  
 Evaluation (Quantitative methods) 
 Glucose prediction (MSE and RMSE) 
























































Chapter Five: Requirements specification 
5.1. Introduction  
In this chapter, an overall description of the requirements and specifications for the electronic 
disease surveillance based on inputs from people with diabetes are given. During development, 
main emphasis was given for developing the underline mathematical models for the early outbreak 
detection mechanisms, i.e. blood glucose prediction models and outbreak detection methods. 
However, we also gave emphasis for formulating a framework for developing the required system, 
without giving a due consideration on the development of the required software application (due 
to time constraint). First, the description of the system is given in relation to various assumptions 
taken, the presence of any dependences within the system, and the potential users of the system. 
Next, the main reason behind selecting the method used for specifying the necessary requirements 
and the sources of the requirements used are described. Afterwards, the specification of both the 
functional and non-functional requirements of the entire system are given. Finally, a summary at 
the end of the chapter gives a concluding remark. 
5.2. System Description 
The electronic disease surveillance system based on inputs from people with diabetes is a system 
that:  
 Enables monitoring of infectious disease, such as respiratory infection and others, within 
the diabetes population and the community in general. 
 Enables prediction of BG values for the individuals.  
 Gives a clear indication of the presence or absence of a detected outbreak in a way that can 
facilitate investigation and decision making. 
This early outbreak detection system uses data already being collected by the individuals with 
diabetes as part of his/her daily management of the disease. Currently, there are a lot of diabetes 
self-managements devices/apps on the markets, i.e. continuous blood glucose monitoring (CGM) 
– Dexcom products and few touch application (FTA) - the diabetes diary of Norwegian center for 
eHealth research (previously known as NST).   
5.2.1. Constraints 





 The outbreak detection system shall use aggregated measurements of daily blood glucose, 
amount of insulin injections, dietary, and physical activities.  
 Privacy/confidentiality: The outbreak detection system shall use users/actors consent for 
the data access policy. 
5.2.2. Stakeholder (Users)  
The developed system has a multi-dimensional uses and purposes, though the main users of the 
developed system are assumed to be: 
 Public health officials and various hospitals (Healthcare). 
 Individual Healthcare professionals (General Practitioner (GP), physician, Laboratory 
technicians, Pharmacist). 
 Individual diabetes patient and family or relatives. 
5.2.3. Interoperability & Communication 
The system is designed so as to use a common data exporting standards such as CSV file. The 
daily data from the user device are aggregated and imported to the system. A highly secured 
communication channels are used to implement the data exchange between the user mobile 
devices, i.e. Dexcom, and the developed system. Moreover, an intermediator between the data 
source and the developed system are considered. The purpose of the intermediator is to perform 
some kind of deidentification on the individual’s data to remove major identifiers and to preserve 
the confidentiality. 
5.3. Selection of requirements and specification method  
During development of a system, requirements and its associated specification processes are 
mandatory. Currently, there are a lot of requirements specification methods evolved through time, 
each with its own pros and cons. One requirements specification method can be effective for some 
kind of tasks, while it can be ineffective for others. Therefore, a compromise between the nature 
and type of problem at hand and the available requirements specification methods should be done 
during method selection. In a project, which needs an iterative approach that brings change at any 
course of time during development needs a method that can facilitate this kind of task. As a result, 
the Volere Requirements Process and its associated Specification Template (Robertson et al., 
2000) are found to be effective for this project. Therefore, this approach were used for organizing, 




5.4. Source of Requirements  
As part of requirements specification for a project, credible sources are mandatory for the success 
of the project. Functional requirements are the fundamental subject matters of the system; they can 
be measured by concrete means like data values, decision making logic and algorithms (Robertson 
et al., 2000). Non-functional requirements are the behavioral properties that the system must have, 
for example, performance, usability and others (Robertson et al., 2000). The main source of both 
functional and non-functional requirements were relevant literatures, including the state of the art 
in blood glucose prediction and disease surveillance systems, which were reviewed in Chapter 3. 
Moreover, discussion with diabetes patients, diabetes expert and colleagues were used to improve 
the requirements specification. 
5.5. Functional Requirements 
This section briefly describes the specification of the functional requirements. Based on the 
available sources of requirements described above, the specification of requirements for the 
prototype are briefly described below. 
Table 6: Functional Requirement number 1 
Requirement #: 1                                                                        Event/Use case #: 1 
Description: The system shall load data from the individual device’s database, i.e.  
Dexcom CGM device, to the central repository (database). 
Rationale: To make the data accessible to the system. 
Source: Author and Background knowledge from Literatures  
Fit Criterion: The data shall be accessed by the system components. 










Table 7: Functional Requirement number 2 
Requirement #: 2                                                                       Event/Use case #: 2 
Description: The developed system shall make daily monitoring of infectious disease 
outbreak. 
Rationale: Daily make monitoring of infectious disease outbreak based on the inputs.  
Source: Author 
Fit Criterion: The daily monitoring and the detected outbreak results shall agree with 
the preset timeframe.  
Dependencies: None                                            Conflict: None 
 
Table 8: Functional Requirement number 3 
Requirement #: 3                                                                       Event/Use case #: 3 
Description: The developed system shall make a prediction of future BG values. 
Rationale: To follow the individual’s BG evolution.  
Source: Background knowledge from Literatures 
Fit Criterion: The prediction shall agree with the actual BG reading.  
Dependencies: 1                                            Conflict: None 
 
Table 9: Functional Requirement number 4 
Requirement #: 4                                                                     Event/Use case #: 4 
Description: The developed system shall make comparison of the individual’s predicted 
BG values and the measured BG values.  
Rationale: To detect deviation of the individual’s BG from the normal.  
Source: Author and Background knowledge from Literatures 
Fit Criterion: The prediction result shall agree with the measured blood glucose.  






Table 10: Functional Requirement number 5 
Requirement #: 5                                                                Event/Use case #: 5 
Description: The developed system shall detect the individual’s significant 
deviation of BG. 
Rationale: Enable to detect the presence of any infectious disease outbreak.  
Source: Author and Background knowledge from Literatures 
Fit Criterion: The system should detect the presence of BG deviation with infected 
individual.  
Dependencies: 1,2,3, and 4                                     Conflict: None 
 
Table 11: Functional Requirement number 6 
Requirement #: 6                                 Event/Use case #: 6 
Description: The developed system shall send a notification signal to the concerned 
bodies using SMS. 
Rationale: Enable users to be aware of the infectious disease outbreak.  
Source: Background knowledge from Literatures 
Fit Criterion: The users should receive the notification signal.  
Dependencies: 1,2,3, and 4                                     Conflict: None 
 
Table 12: Functional Requirement number 7 
Requirement #: 7                                               Event/Use case #: 7 
Description: The developed system shall send an Email containing the detected 
outbreak depicted on a regional map of interest. 
Rationale: Enable users to view the spatio-temporal distribution of the outbreak.  
Source: Background knowledge from Literatures 
Fit Criterion: Users shall receive and view the outbreak patterns.  






Table 13: Functional Requirement number 8 
Requirement #: 8                                               Event/Use case #: 8 
Description: The developed system shall store the daily results of monitoring and 
analysis.  
Rationale: Enable users to view it at any point of time in the future. 
Source: Author 
Fit Criterion: The user can query and search past daily analysis.  
Dependencies: 1,2, 3 and 4                                                Conflict: None 
 
Table 14: Functional Requirement number 9 
Requirement #: 9                                                 Event/Use case #: 9 
Description: The product shall allow other systems to access the detected outbreak 
patterns.  
Rationale: Enable decision support systems to access the patterns. 
Source: Background knowledge from Literatures 
Fit Criterion: Users shall view the spatio-temporal distribution of the detected outbreak 
patterns. 
Dependencies: 7                                                Conflict: None 
 
5.6. Use Case  
The system boundary are defined along with the interaction between the developed system and 
different actors (users). Based on the above requirements specification, a use case is developed 
as shown in the Figure 12. The use case entirely shows the interaction of the actors (users) with 
the system and also the connection among them and the system component itself. A trial version 
of the Enterprise Architect v.10.0, SPARX Systems©9 was used to create the use case diagram 
given in Figure 12. 
 
                                                          




Use Case#:1 Get the measured blood glucose data  
Purpose: Read the daily measured data from the mobile device, i.e. Dexcom CGM, and store it in 
the system repository. 
The procedural events are executed in the following ways:  
 System check calendar for data extraction.  
 System reads the data from the individual’s mobile device, i.e. Dexcom CGM device’s 
database.  
 System formats the data.  
 System stores the data.  
Use Case#:2 Daily Outbreak Detection 
Purpose: Make time triggered detection of outbreak based on daily measurements from the mobile 
devices, i.e. Dexcom CGM device.  
The procedural events are executed in the following ways:  
 System checks the calendar.  
 System compares the current time with the preset time.  
 Execute the detection algorithm if the current and the preset time agree.  
Use Case#:3 Blood Glucose prediction  
Purpose: The system predicts the individual’s blood glucose based on the available information 
of the history of blood glucose evolution.  
The procedural events are executed in the following ways:  
 System checks the calendar.  
 System retrieves stored data from the mobile devices, i.e. Dexcom CGM device’s database 
in to the system database.  
 System makes a prediction based on these data. 
 System calculates prediction interval. 
 System stores the result.  
Use Case#:4 Compare the predicted and measured blood glucose 
Purpose: The system compares the individual’s measured and predicted blood glucose intervals.  
The procedural events are executed in the following ways: 




 System makes a comparison. 
 System stores the result.  
Use Case#:5 Outbreak detection 
Purpose: The system counts the number of individuals with statistically significant deviated BG 
readings and issues outbreak if necessary.  
The procedural events are executed in the following ways:  
 System retrieves the individual comparison result.  
 System counts the number of individual with significant deviation. 
 System compares with the preset threshold. 
 System sends a notification signal if necessary and stores the result.  
Use Case#:6 Notification signal 
Purpose: The system sends a notification signal with SMS indicating the presence of some form 
of infections.  
The procedural events are executed in the following ways:   
 System retrieves address or phone numbers.  
 System prepares the information to be sent. 
 The system send the notification signals for the users. 
Use Case#:7 Email 
Purpose: The system sends an email containing the spatio-temporal distribution of the detected 
patterns.  
The procedural events are executed in the following ways: 
 System retrieves email address.  
 System prepares and plots the pattern on the map if any outbreak pattern is detected. 
 The system send the information for the users. 
Use Case#:9 Store Daily Analysis 
Purpose: The system should store the overall analysis and results performed at each day.  
The procedural events are executed in the following ways:   
 The system checks for calendar to check the specific date.  










Use Case#:8 Query Detected patterns 
Purpose: The system should allow other systems to use the detected patterns and the blood glucose 
prediction results.  
The procedural events are executed in the following ways:   
 User enter a query with specified date.  
 System searches the database. 
 System returns the result. 
5.7. Non-functional requirements  
5.7.1 Scalability  
Scalability of a system defines its ability to respond to any future expansion and integration of 
other functionalities. Therefore, the developed system shall incorporate an ability to include more 
region under the surveillance system. Moreover, additional subjects and their associated data into 
the surveillance system.  
5.7.2 Extensibility  
The developed system shall be easy for extension of components and their functionalities, 
whenever such a need arises. Moreover, it shall be open for improvements and inclusion of more 
outbreak detection algorithms and mechanisms. 
5.7.3 Usability  
The developed system shall provide the required information regarding the detected patterns in a 
way that is easily understood by its users, as this will provide good opportunity for further 
investigation and quick decision making. 
5.7.4. Security 
Health data are private and sensitive when it comes to third party usage, therefore, security is the 
major concern while working on these data. The users’ data are sensitive and shall be protected 
throughout the entire course of the systems. Therefore, during accessing the data from the user’s 
mobile device, i.e. Dexcom CGM device or FTA app, a mechanism that protects the user’s privacy 
should be implemented. This can be implemented through the users’ consent and applying some 
form of deidentification procedures, where the user vital identifiers such as name, age, sex and 





During transmission of the personal health data, it is necessary to have the consent of the users. 
This requires to persuade the individual users that their privacy and confidentiality are preserved 
during the entire course of the system. Therefore, it is necessary to prepare an individual consent 
form that comply with the international standards on the third party usage of personal health data. 
Moreover, it is necessary to consider highly secured means of transmitting the user information to 
the system database. 
5.8. Summary  
This chapter entirely describes the specification of the functional and non-functional requirements 
of the system based on Volere’s requirements specification template. Most of the requirements 
were developed mainly from literatures, discussion with diabetes patients, diabetes experts and 





















































Chapter Six: System Design 
6.1. Introduction  
The purpose of this project is to design and develop an electronic disease surveillance system based 
on inputs from people with diabetes. The main idea is to use people with diabetes as the source of 
information for disease surveillance purpose. The main inputs of the system are the four keystone 
of diabetes, which include BG values, insulin injection, dietary and physical activity. However, 
due to limited availability of such data, we base our development on continuous BG readings 
(CGM) from Dexcom device. The whole aspects of the system are divided into development 
component and research component. The development component involves the development of 
the required software application based on the previously given requirements specification (see 
chapter 5). The research component involves developing the necessary mathematical models and 
determination of its associated parameters. However, due to time constraint we left the 
development of the required software application for future research and therefore is not 
considered in this thesis project. Consequently, this chapter describes the research component, 
which is the design aspects of the system including the architectural design and its associated 
components. Moreover, design consideration of the mathematical model along with the proposed 
solution are presented, including the BG prediction, moving window z-score process and outbreak 
detection mechanism. The developed system can predict the individual’s BG values with a certain 
confidence interval and asses these predicted and observed BG readings for the presence of any 
aberrant patterns. Moreover, it also calculates the z-score value of each individual’s BG readings 
based on a moving window and asses these values for the presence of outliers from a recent trend. 
If there is detection of a cluster of people with any aberrant patterns within a specific region and 
timeframe, it can send a notification signal for the concerned body or authorities and help to 
investigate by displaying the cluster on the map of the interest. The entire chapter presents the 
details of the design consideration under the following sections, data source design, architectural 
design, design of mathematical models (prediction model, prediction interval, moving window 
based z-score computation and surveillance). 
6.2. Data Source Design 
The data used in this project were collected from a small group of type I diabetes individuals, 




monitoring (CGM) – Dexcom devices. The datasets are consisted of continuous blood glucose 
readings recorded on every five minutes’ intervals for a period of one month. To make effective 
use of the data sets, vertical partition was carried out. The vertical partition involves separating the 
whole data sets in to two groups, i.e. training and validation data sets. The training datasets were 
used to compute and determine the autoregressive coefficients, whereas the validation datasets 
were used to test the validity of the system with unseen data. The BG datasets used for training 
and validating the developed system are shown in Figure 13. The whole dataset are consisted of 
8495 consecutive data points, where the first 4000 (47%) data points were used for training and 




Figure 13: Plot of the entire sets and the first 200 data elements of the continuous blood glucose 
data of the first subject.  
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Moreover, an artificially simulated datasets were created and used for testing the performance of 
the system in detecting any statistically significant deviations of BG values. The simulated datasets 
are consisted of blood glucose shots/surge of varies size, duration and shape through a course of 
time, i.e. a day or more. It is simulated so as to resemble the elevated blood glucose evolution of 
an infected individuals, by considering various increments per minutes ( ∆ ( )) and various
time intervals of elevated BG. The blood glucose shots that resemble the case in response to an 
infections are simulated. The first simulated datasets as shown in Figure 14, are a type of steady 
growth, where the individual’s blood glucose are shown to raise a maximum of 0.1 mmol/l per 
minutes and stays high for some consecutive hours, where thereafter shows a steady decays to the 
normal BG levels. 
Figure 14: Artificially simulated steady growth of an individual blood glucose values in response 




The second simulated datasets, shown in Figure 15, are a type of sudden shot, where the 
individual’s blood glucose readings are shown to attain high values out of a sudden and stays there 
for some consecutive hours, where it shows immediate decays thereafter. 
 
Figure 15: Artificially simulated sudden shots of an individual blood glucose values in response 
to an infections.  
6.3. Architectural Design  
System architecture can be centralized, distributed as two-tired or multi-tiered architecture. 
Though, in this study, we consider a centralized architecture, where the users’ data are expected 
to be submitted to a centralized server, where the execution of aberrancy detection is also expected 
to be performed. In this approach, the privacy of the patients’ data is a concern and therefore, it is 
necessary to use the patients’ consent and to implement some kind of deidentification procedure 
to protect the data confidentiality of the patients. However, since we are using already extracted 




consisted of various modules: data collection, personalized health model, and analysis, reporting 
and information dissemination modules, as shown in the Figure 16. This architecture is partially 
adopted from the work of  (Wickramasinghe et al., 2012), known as Nivārana, which is a system 
design and implementation focused on rapid response to epidemics. 
I. Data Collection module: This module is required to collect data from the diabetes individuals 
residing in a given region, which is divided into equal cells (see section 6.8). The user’s data 
are collected in a form containing of a user ID, BG values and geographical location (Årsand 
et al., 2005). The data are stored in its associated database after stamping with their 
corresponding cell identifier. The size of the data repository will depend on the size of the area 
the system covers.  After proper data acquisition, it is necessary to record the geographical 
position where each samples were taken. This can facilitate the processing of the data 
depending up on its geographical location. The geographical location of the patient are 
determined by using GSM/3G network nodes for adequate positioning, which is described in 
Årsand (Årsand et al., 2005).   
II. BG profile (Personalized health model):  This modules is expected to carry out prediction of 
blood glucose values depending on a set of input parameters, such as previous BG values, 
dietary data, amount of physical activity, amount of insulin injection, and others. It involves 
modelling a personalized health model, which mimic the blood glucose dynamics of the 
individual diabetes subjects. It keeps track of the individual’s blood glucose fluctuations. This 
model needs to include as much parameters as possible, which affects blood glucose 
concentration, the like of insulin, physical activity, history of blood glucose value, body mass 
index, stress level, sleeping time , dietary intake, presence of illness and some other 
medication, smoking habit, periods (menstruation), alcoholism, allergies, effect of altitude and 
others.  
III. Analysis module: At the time of computing, the analysis modules will carry out data analysis 
and outbreak detection. It is consisted of mathematical models such as interval and z-score 
computation that can compare and detect any statistically significant deviation. Moreover, 
aggregational analysis is capable of counting the maximum number of events based on three 
different approach, such as temporal cluster detection, spatial cluster detection, and spatio- 
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Figure 16: System Architecture of the developed system. 
[Adapted from (Wickramasinghe et al., 2012)]  
Temporal cluster detection is the process of identifying a maximum number of events within the 
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spatial cluster detection involves identifying a maximum number of events within a specified fixed 
region of interest. It is also possible to implement both temporal and spatial cluster detection at the 
same time to have a spatio-temporal cluster detection, which involves identifying a maximum 
number of events within a fixed and moving time window and also within a fixed region of interest. 
In this project, spatio-temporal cluster detection are considered. 
IV. Reporting: if there are any detected patterns of outbreak, the system should organizes the
information and make it ready for dissemination to the responsible body. Therefore, in order
to meet the principal function of any disease surveillance systems, we need to implement a
means of reporting. As a result, the function of this module is to prepare and organize the
information about the current disease outbreak, using various means of presenting information,
such as tables, graphs and mapping module.
V. Information Dissemination: After having packed all the necessary disease outbreak related
information, the information dissemination module is responsible for distributing the necessary
information to the concerned bodies or authorities. The information dissemination module has
two means of disseminating the necessary information, i.e. SMS and Email. For first
notification purpose, SMS will be sent and then email containing adequate information
regarding the outbreak will also be sent to the responsible persons. The email will contain
information such as spatial and temporal distribution of the disease outbreak on a map of the
region, the degree of severity and others.
6.4. Method selection 
Broadly, the method used in literature for prediction (follow up) of blood glucose trends are 
grouped into two categories, physiological and black box (data-driven) model (see chapter 2, 
section 2.4). The former group include formulating mathematical model that simulate the 
underlying physiology of the glucose – insulin regulatory system. The second group provides data-
driven model, which can predict BG concentrations based on only the historical records 
(information) of existing input-output data. In recent times, black-box model has shown to achieve 
good prediction with a specific prediction horizon (PH), among which time series approaches are 
found to be reliable for prediction (Jabali, 2013; Stahl et al., 2009). There are various kinds of such 
models used in literature, such as structural, state space, neural network, and others (Pappada et 
al., 2011; Shanthi et al., 2012; Stahl et al., 2009). During method selection, we give emphasis on 




interval.  Moreover, the capability of the method to determine the predicted values based on more 
recent data or history are also considered. Based on the literature review (see chapter 3), a linear 
time series model, a version of AR model is found to predict well in a limited prediction horizons 
(Jabali, 2013; Stahl et al., 2009). For example, (Jabali, 2013) have reported the success of 
Autoregressive Moving Average (ARMA) in predicting of BG levels and also (Stahl et al., 2009) 
achieves a 99.9% accuracy in a single step prediction horizon with Exogenous input 
Autoregressive Moving Average (ARMAX) method. Consequently, AR model is considered for 
developing our model, where we proposes to predict intervals rather than point values. It is obvious 
that supplementing point predictions with an interval predication is one way of assessing the 
uncertainty involved with the other diabetes related parameters (Chatfield, 2000). Therefore, the 
method is implemented so as to predict a certain range of value, prediction interval (PI), using a 
point prediction value along with the variance of the empirical error distribution between the set 
of step ahead BG predictions and actual BG readings. 
Moreover, a moving window based z-score process is selected since it is capable of detecting 
deviation that can be quantified in terms of the number of standard deviation from the mean (see 
chapter 2, section 2.5). Moreover, the moving window version is considered to follow the trend in 
blood glucose dynamics of the individual’s subject using the most recent trends, which is necessary 
to capture the subject’s cyclical habits within a day, week or longer periods.  
6.5. Design of Mathematical Models 
In this section, the proposed mathematical solutions for the electronic disease surveillance system 
based on inputs from people with diabetes are given. 
6.5.1. Task overview and the proposed Algorithms 
The high level block diagram representation of the blood glucose deviation detection algorithm is 
given in the Figure 17 and 18. The proposed algorithms are of two types, blood glucose prediction 
and moving window z-score process. The blood glucose prediction based model, as shown in the 
Figure 17, is consisted of different tasks such as compute expected BG value, obtain current BG 
measurement, compute test and evaluate test. For instance, the value generated from the compute 
expected BG value and obtain current BG measurement tasks is used to compute the test value and 


























Figure 17: Blood glucose prediction and detection Algorithm.  
The moving window z-score model, as shown in the Figure 18, is consisted of different tasks such 
as Moving window based z-score computation, Obtain Current BG measurement, Compute Z-
score values and Evaluate Test. The Moving window based z-score computation is used to 
compute the running mean and standard deviation of the BG values in the current window, . 
Therefore, the mean and standard deviation are used to compute the z-score of the current blood 
glucose reading. This z-score value will be compared against a preset threshold value, which is 
determined by analyzing the respective sensitivity vs. threshold and specificity vs. threshold 
characteristics. The final result is used to decide the need of any alarming signal based on the 
current analysis. 
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Figure 18: Moving window based z-score process and the detection Algorithm.  
6.5.2. Blood glucose prediction based model 
The first model, the blood glucose prediction model, is based on an interval prediction mechanism 
that can compute confidence intervals based on the point prediction and the empirical distribution 
of errors between the set of predicted and observed BG values, as shown in the Figure 19. The 
detailed design of the mathematical model, the prediction model and the prediction interval, are 
given under the model building section. 
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Figure 19: The prediction interval based model.  
6.5.2.1 Model Building  
The BG prediction model is the mathematical representation of the glucose-insulin dynamics 
related to an individual subject. It serves to describe the BG evolution of an individual by modeling 
the systematic variation and the unexplained variation (or ‘error’ component). The systematic 
variation can facilitate computation of good point predictions, while the unexplained variation will 
help to compute prediction intervals (Chatfield, 1993). As shown in Figure 20, the logic of the 
developed system is to use the systematic variation of the most recent BG records so as to predict 
the future blood glucose values.  Moreover, the unexplained variation (or ‘error’ component) are 
exploited by computing the empirical distributions of errors between the set of actual and predicted 
BG values, which is used to construct a prediction intervals. To solve this logic with time-series 
approach, it is necessary to take BG values as a time series random variable. Let ,  be random 
time series variables as described below: let  be the set of measured or observed blood glucose values let  be the set of predicted blood glucose values  = { , , , , , … … … … … . }  ∴ (ℎ) = ℱ( )  ……………………………………………………..Eq. 10 
where ℱ( ) is the prediction model that takes the random variable input (blood glucose readings) 
to make prediction of the future blood glucose values. 
Current Prediction  




 Previous values {n-q… n-1, n} Current values {n+1} 
 






Figure 20: State of the developed model.  
The prediction error is the difference between the observed or measured blood glucose values and 
the predicted blood glucose values with in the same prediction horizon, as given in the equation 
below: ℯ (ℎ) =  (ℎ) − +ℎ   …………………………………………………Eq. 11 
The prediction errors are mostly dependent on the specified prediction horizon considered during 
computations. Therefore, it is necessary to compute the empirical distribution of error ℯ (ℎ) for 
each prediction horizon considered. 
6.5.2.2. The Prediction model 
The prediction model is based on two version of Autoregressive (AR) models, Autoregressive 
(AR) and Autoregressive Moving Average (ARMA) (see chapter 2, section 2.5.2.1). The kind of 
prediction is an interval based with a certain confidence of seeing the future values in the predicted 
range, where the interval are calculated based on the recent empirical distribution of errors between 
the actual value and the predicted value. The type of model considered here is goodness-of-fit to 
past data. 
o Autoregressive using Yule Walker Algorithm 
The autoregressive equation (see chapter 2, section 2.5.2.1) used in this scenario has the following 
form: ( + 1) = ( ) ( )  ………………………………………………………Eq. 12 
= + + + … … … … 
 




Where  are the autoregressive coefficients and  are the blood glucose values at time n. 
o Autoregressive using Ratio of consecutive data points 
Here an autoregressive equation that can capture the trends based on the ratio of consecutive 
readings are proposed. It uses the rate of change of the ratio between two consecutive data points 
to estimate and predict the future blood glucose values.   
The autoregressive equation used in this scenario has the following form: 
− 1 = + + + … … … … 
Where  are the autoregressive coefficients and  are the blood glucose values at time n. 
Therefore, the next step blood glucose value are computed as follows.  = ∗ ( + + + … … … … )  …………………Eq. 13 
o Autoregressive Moving Average using Yule Walker Algorithm 
The autoregressive equation (see chapter 2, section 2.5.2.1) used in this scenario has the following 
form: ( ) ( ) = ( )ℯ( )  ……………………………………………….Eq. 14 
= + + + … + ℰ + ℰ + ℰ +. .. 
Where  is autoregressive coefficients,  is moving average coefficients and  is the blood 
glucose values at time n and ℰ  are normally distributed Gaussian noise with zero mean and 
standard deviation σ.  
6.5.2.3. Model order selection 
One of the necessary and important step in developing autoregressive model is identification and 
selection of an appropriate model order. A system identification toolbox along with the partial 
autocorrelation function (PACF) was used to identify the optimal model order. For example, as 
shown in Figure 21, the values of the partial autocorrelation sequence that reside outside the 95% 
confidence bounds occur at lags 1, 2, 3,4 and 5. This indicates that the correct model order for the 
AR process is 6, where beyond this point there is no correlation between terms. 
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Figure 21: Partial autocorrelation function (PACF). 
6.5.2.3. Prediction interval 
The prediction intervals are computed for a certain level of significance α based on the empirical 
distribution of error between the measured and predicted values. (  100(1 −)% .   ) is given by assuming an unbiased prediction with PMSE as defined with 
Eq.15.  [ ( ) ]  = [ ( )]  ℎ      
∴ ( ) = ( )+   [ ( )]  ………………………………..Eq.  15 
Where (n) is the point prediction obtained from the prediction models and (n) is the final 
predicted interval to be used in the electronic disease surveillance systems. Generally, there are 
two ways of computing [ ( )] and the required prediction intervals, known as Model based 
PI (Theoretical PMSE Formula) and empirically based PI (Chatfield, 1993). The former PMSE 
(Prediction Mean Square Error) based computing requires to have put an assumption that the fitted 
model is optimal. However, the latter empirically based computing generally require fewer (or 




from the distribution of the errors from past data and have much promise, and are starting to be 
used (Chatfield, 1993). Therefore, we use empirically based PI to compute our prediction intervals. 
The simplest type of procedure involves applying forecasting method to past data, finding the 
within-sample ‘forecast’ errors (i.e., the residuals) at 1, 2, 3 ... steps ahead for forecasts made from 
all available time origins in the period of fit, and then finding the variance of these errors at each 
lead time. Let Se,h denote the standard deviation of the h-steps-ahead errors. Then an approximate 
empirical 100 (1 −α) % P.I. for  is given by  y (h)+z S , . Generally, we consider both the 
within and out of sample ‘forecast’ errors as a base of calculating our prediction intervals.  
6.5.3 Moving window based z-score process  
The second model, the moving window based z-score process compute the z-score values using 
the current blood glucose reading and the mean and standard deviation computed from previously 
recorded blood glucose data in a certain window size , where the running mean and standard 
deviation are calculated for the data in the window (see chapter 2, section 2.5). 
6.6. Outbreak detection mechanism (Surveillance) 
Generally, the approach (algorithmic model) used to perform detection of disease outbreak in a 
disease surveillance systems is broadly categorized under three groups: regression methods, time 
series methods and statistical process control (Guillou et al., 2014). An outbreak detection 
mechanism that resembles the statistical process control and the time series method are developed 
using the interval prediction and the moving window z-score model respectively.  
6.6.1. Prediction Interval based 
The proposed solution is like a control chart/statistical process control algorithm, where the 
controls are determined by the intervals predicted from the individual’s records of blood glucose 
readings defined by the AR models given above. From the equation of the interval prediction given 
above, the upper and lower limit can be defined as follows:    ( ) = (ℎ) + ,   ( ) = (ℎ) − ,   ……………………………Eq. 16 where y (h) is the one step prediction of BG value and S ,  are standard deviation of errors  
 
Logic: The immediate future actual BG reading/measurement is expected to lie within these limit, 




≤ ≤ ,  ………………………………………Eq. 17  ℎ    ℎ     .  
 As can be seen from the Figure 22, the actual blood glucose values can be effectively monitored 






Figure 22: Proposed solution for the detection algorithm of the disease surveillance (blood 
glucose prediction based).  
6.6.2. Moving window z-score process based 
The proposed solution is like a time series based outbreak detection algorithm, where the detection 
of aberrant patterns are determined by a specific threshold values. The threshold is defined by the 
number of standard deviations from the mean value. For example, as shown in Figure 23, to detect 
a pattern of anomalies or outliers in the presented data a threshold value of three standard 
deviations are sufficient. Therefore, by setting a window dependent threshold value one can 
effectively and efficiently detect the aberrant patterns for an individual’s blood glucose readings. 
However, setting the threshold values require a compromise between accuracy and timeliness; 
setting high threshold might ignore true positive values and using low threshold might allow false 
positive cases to be considered.   
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Figure 23: Proposed solution for the detection algorithm of the disease surveillance (moving z-
score based).  
6.7. Performance metrics  
Performance metrics are important for evaluating the system, which should be based on widely 
accepted scientific standards and methods. The performance of the developed system is evaluated 
based on the metrics defined in this section. Since our solution is consisted of two components, 
i.e. prediction and outbreak detection, therefore, a separate evaluation metrics are used for each of 
the components. The first component is the prediction mechanism, which is evaluated based on 
the Root Mean Square Error10 (RMSE) and Mean Square Error11 (MSE) functions as defined in 
the equation below: 






= ∑ − ,  ………………………………………..Eq. 18 
= ∑ − ,  ……………………………………Eq. 19 
 where Y  and Y  are the actual and predicted BG values respectively 
However, the second component, the outbreak detection mechanism is evaluated based on 
different performance evaluation criteria. The developed solutions for the outbreak detection 
mechanism are of two types, interval prediction based and the moving window z-score process 
based algorithm. The first approach, the interval prediction based algorithm is evaluated based on 
the accuracy of capturing deviated BG readings using the predicted upper and lower control limits. 
However, the second approach, the moving window based z-score process is evaluated based on 
specificity, sensitivity, positive predictive value (PPV) (see chapter 2, section 2.8) (Drewe et al., 
2012; WHO, 2006). In this project, due to the absence of large sample size so as to simulate an 
artificial outbreak scenario, specificity, sensitivity, and PPV of the surveillance case definition are 
used to evaluate the system and also used to determine the best operating threshold of the system. 
6.8. Geographical location of the diabetes subjects 
It is important to locate the geographical location of diabetes subjects’ so as to estimate the accurate 
number of cluster with an elevated blood glucose value (surveillance case definition). Therefore, 
the region of interest is partitioned into different small equal cells as shown in Figure 24, where 
the accurate location of the users are determined with GPS/GSM mobile network’s address. The 
user is first placed into one of the cells based on the address input at the time of submitting the 
necessary data, as shown in the Figure 24. This is a kind of dynamic mechanisms, where the user’s 
location is resolved by the time of data submission and also it puts the mobility of the users into 
consideration. As a result, the number of subjects in each cells that meets the surveillance case 
definition (elevated blood glucose value) can easily be computed and tested for the presence of 
any cluster above the specified threshold (expected number of people meeting the surveillance 
case definition). For example, let us say that C1 can encompass some part of the city as just the 
other do. Any users, who reside in C1 during the time of data submission are resolved to be C1. 
However, any user might move to a different cell, say C14, next time when he/she submits the 














Figure 24: Partitioning the entire region of the map into equal cells.  
6.8.1. Outbreak Detection Matrix 
In order to detect subjects meeting the surveillance case definition (elevated BG values) at the 
same sampling time, a mechanism that can make the process simple and easy is necessary. 
Therefore, an outbreak detection matrix is proposed so that at each sampling time the individual’s 
status is updated on its allocated slot on the outbreak detection matrix. Each row from the 
corresponding detection matrix is designated to indicate the status of an individual. Let Z be MxN 
detection matrix, where M is the sequence of sampling time and N represents the status of each 
individuals as shown in the matrix below:  
 /
0 1 0 0 1 00 0 1 0 0 11 1 1 1 1 10 0 0 1 0 01 0 1 0 1 10 1 0 0 0 00 0 1 1 0 0
 
For example, from the above outbreak detection matrix all subjects have elevated blood glucose 
















ℎ  @    ( ) . Therefore, ( ) is always compared to a pre-
set threshold value for that particular cells. 
6.9. Timeliness and Accuracy 
The accuracy and timeliness of the outbreak detection mechanism are the two most important 
variable that needs careful investigation for building a successful disease surveillance system. 
Early detection and accurate detection are a complimentary issue in disease surveillance systems. 
According to our surveillance case definition, accurate detection requires series of elevated blood 
glucose readings before issuing an alarm, whereas early detection (timeliness) requires the use of 
the individual’s first elevated BG reading without further waiting for more conformation. Relying 
on the individual’s first elevated BG reading might affect the accuracy of the detected pattern. In 
order to solve this complimentary issue, it is necessary to make a compromise and to develop a 
mechanism that is capable producing an acceptable solution. For example, as shown in Figure 25, 
the outbreak detection system is expected to detect a high number of people within a single cell to 
operate only with the individual’s first elevated BG reading. However, relying on the individual’s 
previous consecutive elevated blood glucose readings for conforming outbreak can reduce the 
number of expected people within a cell to a small value as this might guarantee the presence of 
some form of infection.       
 




Chapter Seven: Implementation and Testing 
7.1. Introduction  
This chapter gives brief descriptions of the implementations for the electronic disease surveillance 
system based on inputs from people with diabetes. The entire descriptions are given based on the 
system design given in the previous chapter. The first section gives brief description of software, 
programming languages and technologies used to implement the system. After presenting the 
implementation techniques, afterwards brief description of test settings and testing results are 
presented.   
7.2. System Implementation 
7.2.1. Software and Programming Languages 
The system was developed using MATLAB version R2015b software. MATLAB12, also known 
as MATrix LABoratory, is a high-performance language mainly used for technical computing. 
The interesting concept of Matlab is that one can express the problem and the solution in familiar 
mathematical notation, mainly used for algorithm development, modelling, simulation, data 
analysis, exploration, and visualization and others. Matlab eases simulation through its 
comprehensive toolboxes that support different kinds of purposes. One of such a kind is the 
Econometrics toolbox, which is capable of simulating various prediction models including the 
autoregressive (AR) models. The availability of these toolboxes along with the author’s experience 
with this software were the reason for choosing this language platform. From the Econometric 
toolboxes, various types of Autoregressive model were used to implement prediction of the 
individual’s blood glucose dynamics.  
7.2.2. Data sources 
The developed system was implemented and tested based on two types of datasets, genuine 
(observed) and artificially simulated datasets. The first datasets, shown in Figure 13, the genuine 
(observed) datasets were used to train and validate the system for fitting the dynamics of the 
individual’s blood glucose evolution. The whole dataset consisted of 8495 consecutive data points 
(recorded BG values), where the first 4000 (47%) data points were used for training and the rest 
4495 (53%) data points were used for validating the model and to construct the prediction intervals. 






Figure 26: Plot of the entire sets and the first 200 data elements of the continuous blood glucose 
data of the first subject.  
The second datasets, the artificially simulated datasets were used for testing the performance of 
the system in detecting any statistically significant deviations of blood glucose values from the 
recent observed trend. The simulated datasets as shown in Figure 14 & 15 (see the previous 
chapter), are a type of steady growth and sudden shot and simulated to resemble blood glucose 
evolution during the presence of infections. 
 
Figure 27: Artificially simulated steady growth of an individual blood glucose values in response 





Figure 28: Artificially simulated sudden shots of an individual blood glucose values in response 
to an infections.  
7.2.3. Auto-regression model 
An Auto-regression model generally tries to relate and specify the output variable by a linear 
relationship of its previous values and a certain unexplained variation, known as a random 
disturbance signal.  We developed an Auto-regression models, which predicts the single step ahead 
blood glucose evolution of an individuals. Both an Autoregressive (AR) and Autoregressive 
Moving Average (ARMA) were explored.  
7.2.3.1. Autoregressive (AR) 
Autoregressive (AR) is a single output with no inputs function, which uses the previous 
consecutive blood glucose readings to predict the next value in the sequence. The autoregressive 
coefficients were determined using the training datasets and the model were used to predict the 
unseen validation datasets. For example, the following Matlab command was used to determine 
the autoregressive coefficients. Ayrule is an autoregressive function, which uses a Yule-Walker 
algorithm to compute the respective coefficients. 
Coeff = aryule (data, p); 
The above command returns Coeff, which is AR model with computed coefficients to be used for 
prediction. The aryule () function takes input parameters, data and p. The first input parameter is 
data, which is a matrix vector containing consecutive blood glucose readings. The second input is 




autocorrelation function. The prediction of the future blood glucose values in the time series 
sequence is computed using Coeff, which is evaluated by the above ayrule function.  
7.2.3.2. Autoregressive Moving Average (ARMA) 
This technique predicts the future blood glucose evolutions based on a moving average 
autoregressive model (ARMA). It uses an autoregressive coefficients and moving average of the 
error terms to predict the blood glucose evolution of an individuals. Both the autoregressive 
coefficients and the moving average terms are calculated based on Yule-Walker algorithm using 
the training data set. The model is validated with the unseen validation datasets, where it is tested 
to predict the unseen datasets. For example, the following Matlab command was used to determine 
the autoregressive coefficients and moving average terms:  
Model = armax (data, [p, q], 'approach', 'yw'); 
The above command returns Model, which is an ARMA model with computed AR and MA 
coefficients to be used in prediction. The armax () function takes input parameters, data, p, q, and 
approach. The first input parameter, data is a matrix vector consisted of consecutive blood glucose 
readings. Both p and q are the order of autoregressive coefficients and moving average terms. The 
optimal values of these model order are determined using Matlab system identification toolbox-
polynomial approximation. The third input parameter ‘approach’, specifies user selected algorithm 
for computing the required coefficients. In this case, ‘yw’ indicates that the Yule-Walker algorithm 
was used for computing the coefficients. The prediction of the future blood glucose values in the 
time series sequence is computed using Model, which is evaluated by the above armax function.  
7.2.4. Prediction Interval 
The prediction interval is computed by using the empirical distribution of errors between the recent 
blood glucose readings and predictions. The interval based prediction algorithm were implemented 
using Matlab following these procedures:  
I. Define the window size , let = − 1  , 1 < <  
II. Collect the first − 1   , { , , … … … } 
III. Make prediction for these data points from the prediction model (predicted) 
IV. Calculate the difference (errors) between the predicted and these data points 
Error = X - predicted 




 , =  ∑ (Error )  
VI. Obtain the current  BG reading and current BG prediction (nextValue) 
VII. Calculate the prediction interval using the current prediction and the standard 
deviations of errors.  
UCL (Upper Control Limit) = nextValue + × ( , ); 
LCL (Lower Control Limit) = nextValue - × ( , ); 
Where  the level of significance, and all the models were tested for =0.01, 0.05  0.1. 
VIII. Check the current measurement ( ) is inside the predicted interval?  
 If yes continue to the next step (IX) 
 If not use/take =  and continue to the next step (IX) 
IX. Shift the window  one step forward 2 < < + 1 
X. Repeat from step III up to VI for the whole datasets 
7.2.5. Moving Window based z-Score 
The z-score value of each BG data points are calculated based on a moving window, . The 
following algorithm was implemented on Matlab.  
I. Define the window size , let = − 1  , 1 < <  
II. Collect the first − 1  , { , , … … … } 
III. Calculate the mean ,  and standard deviation ,  for these data points. 
, = 1  ,  , =  ∑ ( − , )   
IV. Obtain the current  blood glucose reading 
V. Calculate the standard z-score of  using ,  and ,  
 ( − ) =   ,  ,    
VI. Shift the window  one step forward 2 < < + 1 
VII. Repeat from step III up to VI 




7.3. System Testing and Results 
The electronic disease surveillance system based on people with diabetes was developed based on 
Matlab programming environment. From the four modules of our system architecture, we 
developed and carried out the simulations for the core part, blood glucose prediction module, 
outbreak detection module. Consequently the blood glucose prediction (point and interval) 
module, outbreak detection (interval comparison and moving window based z-score) module were 
tested and evaluated. Three approaches for predicting an individual’s blood glucose evolution have 
been developed and tested. This module was tested for predicting the validation datasets (unseen 
datasets during learning) for both type-I diabetes subjects, as a point and interval prediction. The 
outbreak detection module was also tested for detecting the abnormal deviation of blood glucose 
values, from the simulated dataset, using the predicted interval and the moving window based z-
score computation.   
7.3.1. Blood glucose prediction: Point and Interval prediction  
For all of the prediction approaches, the performance of the individual approach was evaluated 
and compared for different model order. The chosen optimal model for the individual approach is 
then used for predicting the validation datasets. Moreover, the prediction interval was computed 
and compared for various values of window size and level of significance. The chosen optimal 
window size and level of significance are used to construct the intervals for that individual 
approach. Furthermore, during interval calculation, we tested our assumption that the error 
distribution should follow a normal distribution. The result suggest that the error distribution 
follows a shifted version of a normal distribution, which is reasonably enough for calculating the 
prediction intervals. 
7.3.1.1. Autoregressive (AR) 
This approach was designed and developed using the raw blood glucose data without any data 
preprocessing. For the first subject, an autoregressive model of order five ( p = 5) was found to be 
the optimal for the point BG prediction and fitted best with a mean square error (MSE) of  0.0466 
and a root mean square error (RMSE) of 0.2159.  The autoregressive polynomial approximation 
of this subject takes the form: ( ) =  1.2611  –  0.1296  − 0.0423 − 0.0497  −0.0430 . The prediction interval was found to be optimal with a window size of = 100 and 




point BG prediction at p = 5 with a mean square error (MSE) of 0.0942 and a root mean square 
error (RMSE) of 0.3068. The autoregressive polynomial approximation of the second subject takes 
the form: AR(z) = 1.2328 −1 –  0.1239 −2  − 0.0258 −3 − 0.0562 −4  − 0.0281 −5. The prediction 
interval was found to have a reasonable size with a window size of = 200 and a statistically 
significance level of = 0.01. The point and interval prediction of both subjects are given in the 









Figure 29: Subject one- point and interval prediction using autoregressive (AR) model. a) Point 








Figure 30: Subject two- point and interval prediction using autoregressive (AR) model. a) Point 
prediction and b) Interval prediction.  
7.3.1.2. Autoregressive (AR) with Ratio inputs 
This model was designed and developed after applying some data preprocessing techniques on the 
raw blood glucose data.  Ratio of the consecutive blood glucose data points were computed and 
used for training and testing. For the first subject, an autoregressive model of order p = 4 was found 
to be  the optimal order for the point BG prediction and fitted best with a mean square error (MSE) 
of  0.0102 and a root mean square error (RMSE) of 0.1010.  The autoregressive polynomial 
approximation of this subject takes the following form: ( ) =  0.5477  –  0.2530  −0.1176 − 0.0805 . The prediction interval was computed using an optimal window size of = 100 and a statistically significance level of = 0.01. The second subject also attains its 
optimal order for point BG prediction at p = 4 with a mean square error (MSE) of 0.0115 and a 
root mean square error (RMSE) of 0.1074. The autoregressive polynomial approximation of the 




200 and a statistically significance level of = 0.01.  The point and interval prediction of both 
subjects are given in the Figure 31 & 32 below.  
 
a) 
      
b) 
Figure 31: Subject one- point and interval prediction using autoregressive (AR) model with ratio 








Figure 32: Subject two- point and interval prediction using autoregressive (AR) model with ratio 




7.3.1.3. Autoregressive Moving Average (ARMA)  
This approach is different from the above models in that it incorporates a moving average 
component for the error terms. It was developed without considering any preprocessing of the 
blood glucose data. The approach was also evaluated and compared for different model order 
(autoregressive and moving average coefficients) along with the window size. For the first subject, 
the autoregressive moving average was found to be optimal with an autoregressive order of 6 and 
a moving average order of 2. It generates accurate enough prediction with a mean square error 
(MSE) of 0.0447 and a root mean square error (RMSE) of 0.2114. The discrete-time ARMA 
model A(z)y(n)  =  C(z)e(n) of this subject takes the following polynomial approximation form 
with A(z) =  1 –  1.318 z  +  0.2129z +  0.02436z  +  0.03331z +  0.1295z − 0.04759z  and C(z) =  1 −  1.042z + 0. 04253z .  The prediction interval was found to be 
effective with a reasonable width with a window size of = 100 and a statistically significance 
level of = 0.01. The second subject also attains its optimal prediction with an autoregressive 
order of 6 and a moving average order of 2 with a mean square error (MSE) of 0.0850 and a root 
mean square error (RMSE) of 0.2915. The discrete-time ARMA model for this subject follows the 
following polynomial approximation: A(z) =  1 –  0.3934 z−1 –  1.084z−2   +  0.3003z−3  + 0.09445z−4 +  0.09712z−5 +  0.008629z−6 and C(z) =  1 –  0.001844z +  − 0.9945z  . For 
this individual, the prediction interval was found to be effective with a reasonable width with a 
window size of = 200 and a statistically significance level of = 0.01. The point and interval 








Figure 33: Subject one- point and interval prediction using autoregressive moving average 




Figure 34: Subject two- point and interval prediction using autoregressive moving average 
(ARMA) model. a) Point prediction and b) Interval prediction. 
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7.3.2. Outbreak detection/Surveillance 
The developed outbreak detection algorithms are a type of statistical control and a moving window 
based z-score process. The former involves blood glucose point and interval prediction for 
computing the outbreak detection while the later involves the computation of z-score values for 
each BG readings based on a moving window and comparison of each score with a pre-specified 
threshold value.  
7.3.2.1. Prediction interval based 
The developed prediction interval based blood glucose deviation detection algorithm is tested with 
the artificially simulated datasets (consecutive high blood glucose values), as shown in the Figure 
35 a; these resemble the individual’s blood glucose readings with the presence of infections. The 
developed algorithm successfully detected the deviated blood glucose readings as shown in the 
Figure 35 b. As clearly shown, the algorithm is highly sensitive to the slope, and clearly captures 
the rise and fall of the individual’s blood glucose readings, which is the requirements for initiating 







Figure 35: The statistical control type algorithm. a) The artificially simulated blood glucose 
readings used for testing the algorithm. b) The detection capabilities of the developed statistical 
control algorithm on the testing data. 
7.3.2.2. Moving window z-score based 
The developed moving window based z-score process was also tested against the simulated 
dataset. The algorithm was capable of successfully detecting the consecutive high blood glucose 
reading of both subjects as shown in the Figure 36a & b. The algorithm is found to be highly 
affected by the variability of the blood glucose readings and needs to be tuned towards the 
individuals with the optimal window size. For example, as shown in the Figure 36a & b, the 
variability of the blood glucose readings involved in the first subject is minimal (only a window 








Figure 36: The moving window based z-score process. a) The observed blood glucose, simulated 
dataset, and the detection accuracy for the first subject. b) The observed blood glucose, simulated 




Moreover, in order to further validate the moving window based z-score process, it was tested for 
an abrupt change (maximum rise within a single interval) within the blood glucose readings. This 
was conducted using data from the first subject as an illustration. As clearly seen in the Figure 37, 
the algorithm was capable of successfully detecting the elevated blood glucose readings. Due to 
major fluctuations in the z-score values, as shown in the Figure 37, forward difference of the z-
score values is used to generate an impulse function as a result of the elevation in blood glucose 
values, which can be used for initiating the required alarm. All these results demonstrate the 
success of our approach. 
 
 
Figure 37: Simulated based on the data from the first subject. The observed blood glucose, 
simulated dataset, and the detection accuracy of the moving window z-score with respect to an 




Besides, in order to meet the defined surveillance case definition (capturing successive elevated or 
high blood glucose readings) with the moving window based z-score process, it is necessary to 
determine the optimal working value of the threshold to initiate the required alarm. This can be 
achieved by computing and plotting the sensitivity (Probability of being test positive when the 
blood glucose is higher than normal), specificity (Probability of being test negative when the blood 
glucose is in a normal amount) and positive predicative values (tells us how many blood glucose 
readings tested to be deviated are actually deviated) against various threshold values. The optimal 
threshold value is selected in a way to improve the capability of the system for detecting and 
differentiating outliers (deviated blood glucose readings) from the normal blood glucose readings 
and at the same time discarding small and short duration blood glucose increments so as to suppress 
unwanted and false alarm. For example, as shown in the Figure 38a & b, a threshold value of 1.5 
has discarded all the normal blood glucose readings (regarded as a True Negative) and however, 
rejects some of the elevated blood glucose readings (regarded as True Positive). Therefore, during 
selection of the working threshold, it is necessary to make a compromise between the presences of 











Figure 38: Parameters associated with the moving window based z-score process. a) Sensitivity 




Chapter Eight: Discussion 
8.1. Introduction  
Early detection of disease outbreaks is the central goal of any public health surveillances, to afford 
ample time for controlling and prevention action to be taken by the responsible bodies, i.e. public 
health authorities and hospitals. Currently, a large number of disease surveillances and control 
algorithms are industrialized and deployed for detecting potential disease outbreaks. Practically, 
all of these systems have benefited from the advancements in information technology. They make 
use of electronically available data that are generated before diagnosis and laboratory or physician 
verification, such as chief-complaint data (Wagner et al., 2004 ), disease related search volumes in 
different search engine such as google (Zhou et al., 2013; Zhou et al., 2011), over-the-counter and 
prescription pharmacy sales (Xiaohui et al., 2004), school absenteeism (Weng et al., 2015), and 
emergency calls (Adam et al., 2007), and other different reported symptoms. Nevertheless, disease 
outbreak detection systems that focus on the incubation period, before the onset of the first 
symptoms, have not been developed yet. Besides, the common denominator of the existing 
approaches are that they mainly target the general population giving less consideration to those 
groups, who are referred here as Sensitive Population Groups - SPGs, such as people suffering 
from COPD (Chronic Obstructive Pulmonary Disease) or diabetes, who may be at heightened risk 
even in non-outbreak settings (Botsis et al., 2007) and can easily spread an infection under certain 
circumstances (Baker et al., 2006). To fill these research gaps, this thesis project proposes and 
argues the use of blood glucose data as an indicator for the presence of infections. Recently, 
researchers have demonstrated the presence of positive correlation between elevated blood glucose 
levels (for both type 1 and type 2 diabetes individuals) and an infections (due to Influenza, Cholera, 
Plague, Ebola, Anthrax, or SARS viruses) (Årsand et al., 2005; Botsis et al., 2007; Lauritzen et 
al., 2011). Therefore, it is the objective of this thesis to design and develop an early outbreak 
detection algorithm based on inputs from diabetes individuals, and that can track the blood glucose 
values of each individuals separately and detect a cluster of people with statistically significant 
deviation. The main goal here is to use people with diabetes as a source of information in a disease 
surveillance system and to effectively detect infectious disease outbreaks during the incubation 
period. 
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8.2. Experimental Analysis and Results 
8.2.1. System Architecture 
In this section, we will discuss the solution put forward for the defined main problem [P113]. The 
developed system architecture is a centralized system, where the data from individual diabetes 
users are submitted to a central repository (database), see Figure 16. It is consisted of four modules, 
data collection module, blood glucose prediction module, outbreak analysis module and 
information dissemination and reporting module. The individual diabetes user data are consisted 
of the four keystones (blood glucose, dietary, physical activity and insulin injection) along with 
the geographical location and the time stamp, the time at which the data are recorded. The 
geographical location is determined on a dynamic (late) binding bases, where the address of the 
user is resolved at the time of data submission using the GSM network. The dynamic binding 
concept is implemented by dividing the entire region under surveillance into equal cells stamped 
with their unique cell identifiers. The cellular address of the individual user is resolved during data 
submission by comparing the unique cellular identifiers with the address received from the GSM 
network, without the need of static address, thereby allowing user mobility. Besides, blood glucose 
prediction module tracks the individual blood glucose fluctuations (evolutions) and computes the 
baseline data for surveillance purpose. The output from the prediction module is input to the 
outbreak detection module, where the current blood glucose reading is compared with the baseline 
generated by the blood glucose prediction module. Depending on the outbreak detection result, 
presence of a cluster of people with statistically significant blood glucose deviation, the 
information dissemination and reporting module deliver the outbreak information for the 
concerned bodies (i.e. public health authority, physicians and family and relatives) via SMS and 
email. The SMS is used as a first remainder concerning the current outbreak and email is used to 
provide adequate information, such as the degree of severity and the spatio-temporal plot of the 
detected cluster of people (affected region) on a map of interest. 
13 Main Problem Definition (See problem definition, Chapter one) 
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8.2.2. Blood glucose prediction 
This section discusses the solution put forward and results achieved for the defined sub-problem 
one, [SP114]. The personal blood glucose profiling involves forecasting the expected (probable) 
blood glucose values of an individual based on various parameters referred to as the keystones of 
diabetes, i.e. blood glucose, dietary, insulin injection, physical activities and others. The central 
purpose of profiling is to compute the expected (probable) blood glucose values based on the recent 
history. It is a vital component of the disease surveillance system, which enables the system to 
track the individual blood glucose evolution. Practically due to the limited availability of the 
necessary data, we developed a univariate (one variable) prediction algorithm that depends only 
on continuous blood glucose monitoring (CGM) data. The prediction model uses an autoregressive 
model for predicting the single step blood glucose value of the individual. These models are 
tuneable towards the individual’s blood glucose dynamics with its polynomial orders. This model 
was selected for a number of reasons, due to its capability of predicting the future based on the 
most recent data, and its simplicity and its well defined procedure for computing prediction 
intervals. The former is important to capture the habit of the individual based on a daily or weekly 
basis. Three version of autoregressive model were developed, i.e., Autoregressive (AR), 
Autoregressive (AR) with Ratio inputs and Autoregressive Moving Average (ARMA). These 
models were trained and validated based on data from two type-one diabetes subjects, where 
during validation the trained model were tested with unseen datasets. The first model, 
Autoregressive (AR) achieves optimal prediction for both subjects with model order of p = 5 and 
capable of predicting the single step blood glucose values with RMSE of 0.2159 and RMSE of 
0.3068 for the first and the second subjects respectively. The second model, Autoregressive (AR) 
with Ratio inputs was found to be optimal for both subjects with model order of p = 4 and predicts 
the single step blood glucose values with RMSE of 0.1010 and RMSE of 0.1074 for the first and 
the second subjects respectively. The third model, Autoregressive Moving Average (ARMA) also 
was found to be optimal with an autoregressive order of 6 and a moving average order of 2. It 
generated accurate enough prediction with a RMSE of 0.2114 and RMSE of 0.2915 for the first 
and the second subjects respectively.  Among these models, the second model predicts well as 
compared with the other models attaining the minimum RMSE for both subjects, which 




demonstrates the advantage of using ratio of successive data points for training rather than the raw 
blood glucose data. The RMSE attained by the second subject in all these models are higher than 
the first subject, which is mainly due to the significant fluctuations of blood glucose readings as a 
result of the personal behavior in managing his/her diabetes. 
8.2.3. Prediction interval  
This section presents the solution and results achieved from our approach, which combines the 
individual’s BG prediction with the proposed early outbreak detection mechanism as defined in 
both sub-problem one and two, [SP1 & SP2]. The main purpose of the prediction interval is to 
compute the baseline for controlling and detecting blood glucose deviations at an individual level 
and generally at population levels. The prediction interval is computed based on the most recent 
measurements, which is helpful for evaluating the current status of the individual relying on the 
most recent status. The empirical distributions of error between the previous recent measurements 
and predictions are used to construct the prediction intervals. Prediction intervals were computed 
for all of the prediction models, stated above, with an experimentally determined significance 
level  and window size . All these models are capable of producing an optimal prediction 
intervals for both subjects with a significance level of = 0.01. Nevertheless, produced 
reasonable interval size with a window size of = 100  200  for the first and the second 
subjects. The reason behind this window size is due to the significant fluctuations of blood glucose 
readings as a result of the personal behavior in managing his/her diabetes. 
8.2.4. Outbreak detection/Surveillance  
In this section, we will discuss the thesis solutions and results achieved for the early outbreak 
detection mechanism as defined in sub-problem two, [SP215]. Outbreak detection mechanism plays 
the central role in any disease surveillance systems. To have a better detection efficiency, the 
system should have an optimal detection algorithm that can and accurately detect the defined 
surveillance case, i.e. consecutive high blood glucose readings. We developed two outbreak 
detection algorithms, type of statistical control and moving window based z-score process. The 
former involves blood glucose point and interval prediction for detection whereas the later involves 
the computation of z-score values based on a moving window along with a specified threshold 
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value. The first mechanism, prediction interval based is capable of detecting consecutive high 
blood glucose readings (see Figure 35a & b), which was tested on simulated deviations of such 
kind (BG values simulated to resemble the pattern during infections). It is more efficient in 
detecting the slope (from the beginning up to the end of successive increments or decrements), 
where the blood glucose evolution shows more variability. However, it shows shortcoming in 
detecting peak blood glucose values with zero slope, where there is no variability between 
successive readings. This is due to the absence of other supporting parameters such as insulin 
injection, dietary and physical activity in calculating the prediction intervals, which were not 
considered in our approach due to absence of these data. The second mechanism, moving window 
based z-score process is also capable of detecting the individual blood glucose deviations (see 
Figure 36a & b). However, the detection accuracy of this algorithm is highly affected by the 
variability of the blood glucose readings and needs to be tuned towards the individuals by properly 
selecting the optimal window size. As shown in the Figure 36a & b, the variability of the blood 
glucose readings involved in the first subject is minimal (only a window size of n = 600) as 
compared to the second subject (a window size of n = 800). The working threshold value of the z-
score is determined by computing Sensitivity vs Threshold and Specificity vs Threshold (see 
Figure 38a & b). During selection of the optimal working threshold, a compromise between 
immediate detection of the case (with small consecutive deviations) and the generation of false 
alarm rate should be considered. Generally, as compared to the first approach, the moving z-score 
process is simple and can be easily adapted to the individual blood glucose dynamics. 
8.3. Assumptions, Biases and Limitations 
This early outbreak detection system is a near real time system that is developed based on an 
assumption that the user updates his/her status by measuring and recording the CGM data. 
Additionally, the patients’ data is very personal and sensitive, therefore some form of privacy 
preserving mechanisms such as secured data transmission medium, data deidentification and the 
consent of the patients’ are required. On the other hand, sample size was the major limitation of 
this project. We based our experiments and simulation on two individuals with type 1 diabetes, 
and more data is needed to further validate our approach. Besides, the “holiday effect” has not 
been considered in this study. The “Holiday effect” is the bad eating style of the majority of the 
population including people with diabetes in the holiday season (Lauritzen et al., 2011) and usually 




given the absence of frequent measurements for other supporting parameters, such as the white 
blood cell counts and temperature readings from these individuals (Botsis et al., 2009; Botsis et 
al., 2010). Considering the fact that body temperature, count of white blood cells and blood 
pressure can be an indicator for the presence or absence of infection with in the body, these 
measurement can be used to compromise the elevated BG value so as to bypass the generation of 
false alarm during holidays. Currently, there are a lot of sensors on the market, which can be used 
for a variety of health monitoring purposes (Chu et al., 2011), such as heart activity 
(electrocardiogram (ECG)), muscle activity (electromyography (EMG)), brain activity 
(electroencephalography (EEG)), blood pressure and glucose sensor, breathing or respiration 
sensor. However, the data source we are using, currently doesn’t provide such kind of 
measurements. 
8.4. System evaluation and characterization  
In this section, we discussed some of the intended features and attributes of the developed disease 
surveillance system. These main points are used to characterize and evaluate our system as 
compared to other disease surveillance systems available in literatures (see Chapter 3). 
8.4.1. Acceptability of the system or components 
Acceptability refers to the willingness of the people and different organizations to participate or 
use the developed system. The main participants of the developed system are people with diabetes, 
who are required to sign an informed consent form prior to entry into the system. The form is 
developed so as to motivate the individual by incorporating all those elements required by the 
International Conference on Harmonization (ICH), the Good Clinical Practice (GCP), and also 
adhere to the ethical principles that have their origin in the Declaration of Helsinki of the World 
Medical Association (2000). The developed system could be used in evaluating the infection 
“threats” for not only other diabetes individuals in a region but also to the general population in 
the same area. The system is intended to be used by public health authorities, hospitals and 
physicians. The developed system is not used for any clinical decision support practices; such as 
treatment, advice for the individual patients, and others.  
8.4.2. Privacy or Confidentiality  
Health related data are very sensitive and needs to be confidential; the privacy of the patients 




channel dedicated for this purposes. The participants are expected to sign a consent form, which 
is developed based on the current most practiced international and national regulation, to 
participate in the developed system. In order to guarantee the participants privacy, an intermediate 
system that can arbitrate between the sending and receiving end is considered. The purpose of the 
intermediator is to process and remove the most significant personal identifiers, such as name 
(commonly known as deidentification procedure). Therefore, the intended system can receive the 
deidentified data and possibly without any privacy problems. 
8.4.3. Compliance with Standards  
Compliance with standards means the extent to which a system makes use of standards for data 
representation, message format, code sets, and case definitions. The intended system is developed 
based on a common data representation format (such as CSV), since the system is entirely 
dependent on data transferred from mobile diabetes self-management apps (such as the Few Touch 
Application (FTA)) and continuous glucose monitoring devices (CGM). A dedicated messaging 
server is considered that can manage the messages from the individual device, which is sent either 
manually or automatically. The messaging server is intended to have multiple features; 
send/receive on multiple channels simultaneously, scripting support, to enhance processing of 
incoming multipart messages, traffic limitation option and others. 
8.4.4. Support for outbreak characterization   
The main purpose of building a disease surveillance system is not only detecting cases and 
outbreaks but also the characterization of the outbreak for a better public health response. We 
proposed and developed a system that can identify set of affected individuals, the geographic scope 
on a spatio-temporal bases (map of a region) and severity of the cases. However, our system is not 
capable of characterizing and recommending a single biological agent as the source of the 
outbreak. The developed system is intended to deliver the outbreak information so as to facilitate 
the investigation on the specific areas reported. 
8.4.5. Time latencies  
Time latencies refer to the time delay between the generations of data by the user and is received 
by the system for processing. Moreover, it signifies the time gap between the generation of 
outbreak reports by the system and the time it takes the user for further processing. The developed 




data over a secure communication medium. Besides, in order to avoid delays at the receiving end, 































Chapter Nine: Further works/Recommendations 
The electronic disease surveillance system based on inputs from people with diabetes is a system 
that can track the blood glucose evolution of an individuals and capable of detecting a cluster of 
people with elevated blood glucose in a specific region within a pre-defined timeframe. In the 
course of this project, the author identified areas, which needs further research. Therefore, any 
enhancements in two or more of the following issues can be considered as potential improvements:  
 Blood glucose prediction is the heart of the developed disease surveillance system. Due to the 
limited availability of the necessary data, we developed a univariate prediction algorithm that 
depends only on continuous blood glucose monitoring (CGM) data. However, in order to 
improve and achieve a better and accurate prediction result, it is necessary to develop a multi-
variate prediction algorithm by incorporating more input parameters such as insulin, dietary 
and physical activity for both the point and interval prediction of the blood glucose dynamics. 
 The blood glucose prediction can be carried out using either of these prediction approaches, 
i.e. Structural and Black box approaches. The first approach, structural, requires an extensive 
knowledge of the underlying systems dynamics, which in this case requires modeling of the 
internal blood glucose-insulin dynamics. The second approach, black box, doesn’t require an 
extensive knowledge about the internal systems dynamics, however, it only requires playing 
with the input and output data from the system to model a satisfactory prediction. In this 
project, we carried out the blood glucose prediction based on the black box approach, 
specifically using the autoregressive models. Therefore, it is necessary to research other 
approaches including both the Structural and Black box (other than the autoregressive models 
used in this thesis project) for any performance improvement. 
 The “Holiday effect” is the bad eating style of the majority of the population including people 
with diabetes in the holiday season and usually leads to high blood glucose values. In such 
cases our system may generate false alarms, especially given the absence of frequent 
measurements for other supporting parameters, such as the white blood cell counts and 
temperature readings from these individuals. Therefore, it is necessary to consider means of 
alleviating this problem. Moreover, the use of large sample size should considered to solve any 




 The main task of the developed disease surveillance system is to provide an adequate 
information regarding the current infectious outbreak. As a result, the system should provide 
the outbreak information in a simple and an easy way to understand. Therefore, it is necessary 
to consider designing and implementing a proper user interface (GUI) or application. The 
developed application should have an interface to allow the user to view the spatiotemporally 
plotted outbreak information on the map of interest, degree of severity and others.  
 The developed system is capable of following the individual blood glucose evolution. 
Sometimes one can achieve a good management of his/her blood glucose values within a 
certain days of the week and fail to do on the next time. Therefore, it is necessary to consider 
a mechanisms that can make analysis of the recent management practice and give feedback as 
how he/her is doing now as compared to the recent practice. The feedback information should 
be delivered to the individuals, physicians and family about recent behavioral changes based 
on the available historical data. 
 The performance of the developed system is highly dependent on the strict behavior of the 
individual in managing his/her blood glucose values and built on the assumption of good self-
management practice. However, having a poor self-management practice can potentially affect 
the false alarm rate. As a result, it is necessary to discard these individuals from the system. 
However, it is much needed to look in detail about these kind of people and research a 
mechanisms that can possibly consider them in the developed system without affecting the 
false alarm rate.  
 The developed system is kind of a system, which provide disease outbreak information in a 
more general format (only notifies the presence of a disease outbreak) without specifying and 
giving a clue about the possible type of pathogens involved. Therefore, it is necessary to look 
into the possible disease outbreak characterization mechanism. The research should consider 
the length of the incubation period for each distinct pathogens and make possible associations 
between patterns of blood glucose evolution with the presence of infections and its causative 






Chapter Ten: Conclusion 
Major public health treats are either naturally occurring or artificially induced bioterrorists attack. 
In any case, it is essential to detect the disease outbreaks as early as possible (before it spreads) to 
save peoples’ life. With the advent of information technology, the transition from paper based into 
electronic reporting has revolutionized the disease surveillance systems. The most up-to-date 
advancement due to this transition is the syndromic surveillance systems, which use health related 
data prior to diagnosis (after the onset of the first symptoms) but after incubation period including 
absenteeism, internet search volume, over the counter pharmacy drug sells and others. However, 
a system which uses health related data during incubation period is not yet developed and currently, 
it is a hot research topic. As part of this advancements in disease surveillance, we proposed the use 
of inputs from people with diabetes and to detect infectious disease outbreaks during the incubation 
period. The main idea here is to use people with diabetes as source of information by taking the 
advantage of blood glucose elevation with the presence of infections. The developed system is 
expected to detect a cluster of people with elevated blood glucose readings within a specified 
region and pre-defined timeframe. For example, assume that you are working as both 
epidemiologist and public health official in a large city, where you are the focal person of the city’s 
office for monitoring and controlling of infectious disease outbreaks. It is obvious that your office 
will be definitely looking for an early outbreak detection system that can detect any infectious 
disease outbreak within days after the first person is infected. Let us say on a certain day of the 
week, there were some peoples infected with respiratory infections such as influenza in a specific 
part of the city. Moreover, among those infected individuals, let us say ten of them are diabetes 
individuals with elevated BG readings due to the influenza infection. The individual’s elevated 
BG readings are the result of the influenza infection and appeared before the onset of any 
symptoms (during the incubation period), even the infected diabetes individuals have no clue about 
his/her infection status. Therefore, our proposed system is capable of detecting the elevated BG of 
those ten individuals and sends the necessary alarm for the public health authority, which includes 
the specific area of the city where the outbreak is detected, the number of infected diabetes 
individuals and the degree of severity. The proposed system is unique from the rest of the disease 
surveillance system in that it is capable of detecting the situations within days of its onset (during 




We designed and developed a system that can perform the proposed task, detect disease outbreak 
during the incubation period, by identifying the consecutive high blood glucose readings at an 
individual and population levels. We present a system consisted of four modules, data collection, 
blood glucose prediction, outbreak detection, and information dissemination and reporting 
module. We developed novel approaches for detecting consecutive high blood glucose readings at 
an individual and population levels.  Our approaches are of two types, a type of statistical control 
algorithm and a moving window z-score process. These approaches are developed based on two 
type-one diabetes subjects, and the data were collected from continuous glucose monitoring 
(CGM) device for a period of one month. Moreover, both of these approaches were tested against 
a simulated blood glucose values (containing consecutive high blood glucose values), which 
resembles the BG readings of an individual’s with the presence of infections. 
The first approach, a type of statistical control algorithm, is based on an interval prediction 
mechanism, where the controls are determined by the predicted intervals. The prediction models 
are a type of autoregressive model, i.e., Autoregressive (AR), Autoregressive (AR) with Ratio 
inputs and Autoregressive Moving Average (ARMA). These methods were trained and validated 
(during validation the trained model was tested with unseen datasets) and were capable of 
predicting the single-step ahead blood glucose evolution of both subjects with better accuracy. 
Besides, these methods have also generated optimal prediction intervals for both subjects with a 
significance level of  α = 0.01 and, window size of = 100 and = 200 for the first and the 
second subject respectively. These results indicate that lack of strict behavior in diabetes self-
management has a direct effect on the construction of the prediction intervals and one needs to 
carefully select the optimal window size for the individuals. During testing with the simulated 
datasets, this approach has performed well in detecting deviated BG values, which shows the 
effectiveness of our approach. It is more efficient in detecting the slope (from the beginning up to 
the end of successive increments or decrements), where the BG evolution shows more variability. 
However, it shows shortcoming in detecting peak BG values with zero slope, where there is no 
variability between successive readings. This is due to the absence of other supporting parameters 
such as insulin injection, dietary and physical activity in calculating the prediction intervals, which 
were not considered in this thesis project due to the limited availability of these data from our 
subjects. The second approach, the moving window based z-score process involves the 
computation of z-score values based on a moving window. This approach has also performed well 
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in detecting deviated BG readings, which shows the effectiveness of our approach. However, the 
detection accuracy of this algorithm is highly affected by the variability of the individual’s BG 
readings and needs to be tuned towards the individual’s BG dynamics by properly selecting the 
optimal window size.  
Generally, both of our early outbreak detection approaches have produced optimal detection results 
and were capable of detecting statistically significant BG deviation of various size and duration. 
Both of these approaches are found to be affected by the quality of personal behavior towards 
diabetes self-management and this needs to be taken into account during large scale 
implementations. However, considering flexibility, simplicity, computational time, and needs of 
computational power, the moving window based z-score process is found to be better than the 
prediction interval based algorithm. Apart from this, these results have clearly shown the 
effectiveness of the proposed approaches for detecting a cluster of people with similar patterns. 
Consequently, after validating these approaches on a large scale basis, this promising results will 
hopefully lead the way for the development of the early outbreak detection system (prototype) 
based on inputs from people with diabetes, which is considered to be the next generation electronic 
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The use of mobile diabetes self-management applications (apps) is rising. However, current 
reviews mainly focus on clinically relevant features, and very little on those that affect a user’s 
perception. This review highlights recent developments of these systems, coupled with user 
perceptions, public presence and availability. After including novel review criteria, we found 
that most apps have a comprehensive range of features and received good scores from 
public reviewers. However, the visibility of apps in social media or press is scarce, and few 
Practice points
  Although the related studies are well documented, they mainly focus on clinically 
relevant features and very little on those that affect a user’s perception.
  This review highlights novel criteria like the perception of an app by users, the 
popularity and ranking given by users, press releases and the presence in social 
media.
  In order to identify the relevant studies matching our criteria, we searched in the 
major literature databases, in web search engines and in the vendors’ online app 
stores.
  We found 26 relevant studies in the literature and 53 publicly available systems and 
apps. The results have shown a relatively high number of well-designed systems 
with a comprehensive set of features and a good average scoring by reviewers. Few 
have been recommended by medical specialists but the majority have been tested 
by patients. Outside of app stores, an app’s presence in social media and the press is 
generally scarce.
  We observed that an increasing number of publicly available systems are integrated 
with cloud-based solutions and offer interoperability with smartwatches or 
Bluetooth blood glucose meters. Few systems have obtained any kind of certification 
or clearance, and we noticed that the certified systems have a higher number of 
users and a better ranking.
  We suggest that future systems comply with certification authorities and the 
development be evidence-based, in order to reach a higher level of popularity 
among users and aim for medical specialists’ recommendations.
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Diabetes is escalating globally and, according 
to the WHO [1], affects more than 347 million 
people. While predictions say that the number 
of cases will double by 2030, the burden can 
be reduced through prevention and early diag-
nosis as well as through proper control of the 
four keystones of self-management: blood glu-
cose and insulin levels as well as physical activity 
and diet [2]. The rapid advancement and wide 
spread use of pervasive technologies such as 
smartphones have paved the way for develop-
ment of systems potentially helpful in diabetes 
self-management. The use of mobile apps to sup-
port an individual’s self-management has been 
strongly suggested to improve their quality of 
life [3].
Recently, many reviews have been published 
regarding mobile diabetes self-management 
systems [4–8]. Chomutare et al. [9] reviewed 
the salient features of mobile applications for 
diabetes care, in comparison with clinical rec-
ommendations for diabetes self-management. 
El-Gayar et al. [4] reviewed the functional 
and nonfunctional requirements of applica-
tions that were developed between January 
1995 and August 2012 together with related 
issues necessary for large-scale adoption of such 
interventions. Arnhold et al. [6] used experts to 
evaluate the usability of diabetes applications, 
and their appropriateness for use by an elderly 
population. Others include results of surveys or 
questionnaires that are intended to provide an 
understanding of users’ perceptions. However, 
because of the structure and formality of these 
survey proceedings, designed to answer-specific 
research questions, there is limited consideration 
of unbiased or unsolicited responses. In effect, 
reviews conducted by clinical research are unbal-
anced, giving more weight to the medical use of 
these tools instead of the core of sustainable and 
effective use: the users’ perceptions of a tool’s 
usability and relevance to their specific needs. 
Indeed, patients decide what tool stays or goes 
in the commercial markets.
The concept of usability is a major determi-
nant of a tool or product’s sustainability. This is 
subsequently one of the largest concerns of indi-
viduals and health professionals alike regarding 
the use of mobile apps for diabetes self-manage-
ment. Because these diabetes self-management 
tools have a larger presence in the commercial 
environment than within the medical environ-
ment, users’ perceptions are shared just as they 
would be with any other consumer product: 
openly and honestly through social media and 
other public sources. In order to best assess their 
impact and potential, research reviews should 
take advantage of the candid and unbiased 
reviews of actual users in addition to targeted 
surveys through traditional research methods.
The objective of this review is to present a 
novel approach and an updated review of the 
most recent self-management solutions found in 
the literature and in the publicly available mar-
kets. Our approach emphasizes an app’s appear-
ance in public and social media in order to gain a 
greater understanding of user needs and an app’s 
adherence to user demands. Our goal is not to 
predict an app success, but to investigate what 
apps offer and what patients are asking for. This 
could show where apps are falling short and in 
which ways they should be further developed. 
We also considered the incorporation of recent 
cloud-based services, emerging wearable devices 
and fitness apps to illustrate new developments. 
We describe each app’s features according to 
the four keystones and symptom areas critical 
to diabetes outcomes [10,11], and to other criteria 
such as user-friendliness, interoperability, qual-
ity controls, popularity in social media and in 
the vendor online stores, and availability of the 
systems in terms of languages and platforms. 
Ultimately, we aimed to use these parameters 
to determine any correlation between certain 
app characteristics and its popularity or success 
among users.
Methods
The coauthors have extensive research expe-
rience with mobile applications and have a 
multidisciplinary background ranging from 
healthcare and business, to health informatics, 
statistics, computer science and electrical engi-
neering. Search criteria, categories of assess-
ment and finally the structure of our results are 
a combination of input from these coauthors and 
their experience in their fields as they pertain to 
mobile diabetes self-management systems.
We reviewed a variety of systems such as 
mobile applications, standalone systems and 
systems are recommended by medical specialists. While we noticed that certified systems 
are more desired, very few obtained certification or regulatory approval. We foresee that 
these criteria will be influential in user perceptions and ultimate success of future systems.
KEYWORDS  
 diabetes mellitus   lifestyle  
 mHealth   mobile apps 
 self-management
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prototypes, including systems that are classified 
as medical devices. We conducted our search 
between March and April 2015 using Google 
search engine, frequently referenced journal 
databases and the online app stores of the most 
commonly used platforms. We decided to sepa-
rate search methods and their results by their 
origin to illustrate the differences in informa-
tion available between research and publicly dis-
seminated reviews, to further demonstrate the 
added value of data derived from social media. If 
a system appeared in more than one source, the 
results were combined to consider a comprehen-
sive set of information about that system in our 
review, such as inclusion of available languages 
and the evidence-based background. Based on 
available data and our novel set of criteria, we 
performed evaluation and scoring on each of 
the selected apps, which is described under each 
search method type.
Selection criteria & search strategy for 
scientific publications
In order to be included in the review, the scien-
tific publications had to exhibit the following 
characteristics:
 Patient-operated mobile self-help system 
(e.g., smartphone app, smartwatch app, etc.)
 Support at least one of the self-management 
tasks (i.e., blood glucose, insulin, physical 
activity, diet)
 Include an evaluation or description of the 
system or the app written in English.
Publications excluded from the review 
were either designed to be exclusively used by 
healthcare professionals or were published prior 
January 2010. This ‘cut-off date’ was based 
upon the probability of outdated technology. 
The databases included were Google Scholar, 
PubMed, ScienceDirect, MEDLINE, ACM 
Digital Library, IEEE Xplore, DBLP Computer 
Science Bibliography, Diabetes Management 
Journal, Web of Science, Cinahl, PLoS ONE, 
Cochrane and Munin, the proprietary data-
base of the University of Tromsø– The Arctic 
University of Norway. Searches were performed 
on peer-reviewed journals and journal publica-
tions of conference proceedings. The terms used 
were ‘diabetes,’ ‘mobile,’ ‘smartphone,’ ‘system,’ 
‘phone,’ ‘app,’ ‘application,’ ‘self-management’ 
and ‘self-help.’ Logical operators ‘AND’ and 
‘OR’ were used to combine the terms in multiple 
ways. First, we identified relevant articles by 
reviewing the titles, keywords and abstract for a 
preliminary filter with our selection criteria. We 
then reviewed full texts for articles that seemed 
relevant.
Selection criteria & search strategy for 
publicly available systems
We searched for information regarding publicly 
available mobile diabetes systems on Google 
search engine, blogs and patient association 
websites. Publicly available systems are available 
on major vendor app stores, including Google 
Play Store as well as app stores specific to various 
mobile phone platforms including Blackberry 
App World, Apple iTunes, Nokia Ovi Store and 
Windows Phone Store. We used the terms ‘dia-
betes’ AND ‘mobile’ OR ‘app’ OR ‘self-manage-
ment’ on the search engines and webpages, but 
only used the unique term ‘Diabetes’ on the app 
stores. We included systems that were attached 
to insulin pumps directly, which we separately 
classified as standalone ‘Proprietary’ mobile sys-
tems. Inclusion criteria for the publicly available 
systems are defined as follows:
 Mobile apps and systems that have a user 
interface in English
 Mobile apps and systems that are publicly 
available for free or for purchase
 Mobile apps and systems that provide at least 
the function for self-monitoring of blood 
glucose (SMBG)
 Mobile apps and systems that had a rating of 
more than three stars.
We excluded the mobile apps and systems 
that could only be considered as educational 
or informational tools, meaning those that did 
not provide any direct functionality for the 
self-management of diabetes-related issues.
Selecting studies & apps for inclusion
From the search completed in the literature 
databases, one coauthor (AZ Woldaregay) vet-
ted the initial hits to assess their relevance to 
our inclusion criteria by evaluating the titles, 
the keywords and the abstracts. Next, the two 
primary-authors (AZ Woldaregay and D-Z 
Issom) independently evaluated the full text 
of the selected studies. The inter-rater agree-
ment was measured using the Cohen’s Kappa 
test, and disagreements were resolved through 
discussion.
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Data categorization & data collection
Categories, upon which we extracted relevant 
app information, were based on previous research 
a literature reviews and further elaborated upon 
via iterative brainstorming among the coauthors. 
The agreed upon categories are as follows:
 Diabetes-related features: Diabetes self-man-
agement functionalities such as the tracking 
of physical activity, dietary habits, insulin 
doses and/or blood glucose measurements, 
among others. We used the following scoring 
mechanism to assess depth of the features:
 0 was assigned if no chart, statistics or trends 
were available.
 1 was assigned if the system or app was able to 
show trends, charts, lists or statistics.
 2 if the system had more advanced graphs or 
statistics such as averages, deviations, 
distributions.
 Popularity and presence in social media: Pop-
ularity is also characterized by user feedback 
and comments, the number of installations, 
the number of ratings by reviewers and the 
score they gave as well as a system or app’s 
presence on social media characterized by the 
number of likes on Facebook, the number of 
re-tweets and the number of Press releases.
 Availability: The platforms available, their 
cost and the languages in which a system or 
app can be used.
 Interoperability and 'shareability': Interoper-
ability is defined by the ability for a system to 
communicate with other systems for data 
input or for data export. A main feature asso-
ciated with this criterion is data export, which 
enables the app or system’s ability to share 
data, thus taking into account the openness to 
other systems. We identified the information 
related to the format of data export, the com-
patibility with third-party apps, cloud-based 
solutions for the backup of data, the ability to 
transfer data to an electronic health record, 
compatibility with blood glucose meters or 
with other wearable devices such as smart-
watches. We also considered the concept of 
‘shareability,’ which describes the possibility 
for an app or system to mutually share infor-
mation, for instance, on social media like 
Facebook or Twitter and also through other 
apps. It includes the ability of a system to be 
used by more than one user through, for 
instance, several accounts.
 User friendliness: This is defined by one main 
criterion; the type of data input, which can be 
manual or automatic. We did not assess the 
User Interface (UI) design or the quality of 
presentation.
 Quality assurance and regulatory oversight: 
This criterion identifies systems that are CE 
marked, FDA cleared or HIPAA compliant. A 
CE marking means that the system has been 
verified and complies with the safety and 
health standards defined in the European 
Union. The FDA clearance means that the use 
of the system or app for clinical treatment or 
prevention of the diabetes has been approved. 
A HIPAA compliant product follows the 
American law on the protection of personal 
healthcare information. This is also character-
ized by the level of maintenance of a system 
or app, including information regarding last 
update.
 Research based: This category identifies if the 
development of the system or app is driven by 
evidence-based research and if patients or cli-
nicians have evaluated the system or app. For 
instance randomized clinical trials, or valida-
tion or evaluation tests done by individuals or 
groups other than the developer.
Results
Search results for literature systems 
& apps
The literature review search retrieved a total 
of 287 papers (Google Scholar, n = 140, ACM 
n = 23, PubMed n = 51, IEEE Xplore n = 15, 
Medline (PMC) n = 36 and Munin n = 22). 
After removing duplicates, there were 272 
records remaining. As illustrated in Figure 1, 
screening, which was based on our inclusion and 
exclusion criteria, eliminated 196 papers, leav-
ing 76 relevant papers (Google Scholar n = 29, 
ACM n = 3, PubMed n = 21, IEEE Xplore n = 
13, Medline n = 5 and finally Munin n = 5).
The inter-rater agreement, calculated using 
the Cohen Kappa test, was 0.595. According to 
Landis and Koch [12], this score is considered as 
a moderate agreement. Finally, 26 articles were 
accepted by consensus, and the study characteris-
tics are shown in Table 1. Most of the studies 77% 
(20/26) were about design of the application or 
usability evaluations, and only 23% (6/26) were 
clinical trials or pilots assessing health outcomes. 
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Figure 1. Flow chart of reviewed articles.
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Two studies had a specific focus on children with 
Type 1 diabetes, and the follow-up period for 
clinical studies was 6 months or less. We pre-
sent the literature-extracted studies and publicly 
available systems in two different tables, because 
most of the literature systems are prototypes, 
not publicly available for patients. We identi-
fied three applications used in the studies, which 
were also available on public vendor markets.
Search results for publicly available 
systems & apps
The search for systems and apps occurred in 
April 2015 (Google Play store n = 261 apps, 
Apple iTunes n = 4000 apps, Windows Phone 
n = 240 apps, Blackberry App World n = 66 
apps and the conference proceedings search n = 
5 apps and systems). Searches in blogs, websites 
and patients associations’ websites retrieved 81 
apps and systems. After screening with the inclu-
sion criteria, comparing the papers’ abstracts, 
full texts, apps descriptions, testing the apps and 
discussing with the coauthors, 53 eligible apps 
remained, as illustrated in Figure 2.
Evaluation of the systems & apps
Diabetes-related features
From the 26 relevant studies, 46% (12/26) have 
functionalities that support all four keystones of 
diabetes self-management, 16% (4/26) support 
at least two of the four keystones. We found that 
systems only supporting SMBG without another 
keystone accounted for 23% (6/26). The sys-
tems support nutrition 65% (17/26), exercise 
62% (16/26) and medication management 
needs 58% (15/26).
The majority of the relevant studies extracted 
from the literature, 57% (15/26), provided statis-
tics to the users. We gave one point to 30% (8/26) 
of the studies and the maximum two points to 
27% (7/26) of the studies, based on our grading 
scheme for advanced graphs or statistical features.
From the 53 publicly available systems, 72% 
(38/53) have features that support the four key-
stones. Of these apps, 85% (45/53) allowed the 
user to manage their medication, while 77% 
(41/53) have a physical activity functionality 
and 85% (41/53) have a nutrition management 
feature.
We gave at least one point to most of the 
charts offered by the publicly available systems 
based on presence of basic statistics or trends. 
However, a few 28% (15/53) of the systems 
offered more advanced graphs or statistics.
Interoperability aspects of the systems
Of the 26 relevant literature studies, only 8% 
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mechanisms. Harris et al. [35] describe the use 
of Extensive Mark-up Language (XML) and 
Årsand et al. [14] describe the use of CSV, XLS, 
PDF or a formatted e-mail for the export of data. 
Approximately 35% (9/26) used a Bluetooth 
interface for wireless data input from blood 
glucose meters. In terms of standards-based 
data interchange, only one study 4% (1/26), 
Takenga et al. [23], implemented the Health 
Level Seven International (HL7), Web Services 
Description Language (WSDL), Clinical 
Document Architecture (CDA) and XML 
standards. Cafazzo et al. [28] integrated their sys-
tem with a cloud-based electronic health record 
(TELUS) powered by Microsoft’s HealthVault, 
and Årsand et al. [14] integrated their system with 
Pebble smartwatch, RunKeeper fitness app and 
also with Bluetooth blood glucose meters. In 
contrast, 54% (14/26) did not use any kind of 
wireless data transfer standard.
The majority of the publicly available systems 
offer some form of data export 81% (43/53). 
However, few offer a raw data format for export 
like CSV 23% (12/53) or XLS 34% (18/53). 
The most common form was via e-mail 45% 
(24/53). Of the less common data export options 
were iTunes (n = 1), Twitter (n = 1), web plat-
form (n = 5), desktop (n = 1) or plain text (n = 3).
In publicly available systems, we found that 
many apps offered a wide variety of interoperabil-
ity options, but less than half 34% (18/53) offered 
any kind of support for other systems or devices. 
The apps were compatible with cloud-based ser-
vices offered by Apple Health Kit, Microsoft 
HealthVault, Google Fit, Google Drive, OneDrive 
or Dropbox. Two of the smartphone-based apps 
(NST’s Diabetes Diary and Diabetes:M) and one 
standalone system (Dexcom G4) include a user 
interface designed for smartwatches like Android 
Wear, Apple Watch or Pebble.
Table 1. Included studies from the literature, sorted by year of study.
Study Participants Follow-up 
(months)





Quinn et al. (2015) 7 1 Type 2, elderly Clinical study 2015 Yes [13]
Årsand et al. (2015) 6 N/A Type 1 Design, usability 2015 Yes [14,15]
Padman et al. (2013) 8 2 Type 1, children Clinical study, usability 2014 – [16]
Bin-Sabbar (2013) - - N/A Design, usability 2014 – [17]
Waki et al. (2014) 5 3 Type 2, adults Clinical study 2014 – [18]
Dohr et al. (2012) - - Type 2 Usability 2014 – [19]
Mougiakakou et al. (2010) 12 1/3 Type 1 Design 2014 – [20]
Gittens et al. (2014) 45 N/A N/A Usability 2014 – [21]
Tsui et al. (2014) 60 6 Type 1, Type 2, 
adults
Clinical study 2014 – [10]
Le et al. (2011) 5 1/6 N/A, adults Design, usability 2013 – [22]
Takenga et al. (2014) 40 2 Type 2, adults Clinical study 2013 – [23]
Villarreal et al. (2014) 20 N/A N/A, adults Design 2013 – [24]
Stroulia et al. (2013) - - - Design 2013 – [25]
Tsai et al. (2012) 5 2 Type 1, adults Clinical study, design 2012 – [3]
Cai et al. (2012) - - - Design 2012 – [26]
Batool et al. (2014) 276 N/A N/A Design 2012 – [27]
Cafazzo et al. (2012) 20 3 Type 1, children Usability 2012 Yes [28]
Gislason et al. (2012) N/A N/A N/A Design 2012 – [29]
Alhazbi and 
Alkhateeb (2012)
- - - Design 2012 – [30]
Pandey et al. (2012) 5 1/2 Type 1, Type 2 Usability 2012 – [31]
Lee (2011) 27 N/A Type 2 Design, usability 2011 – [32]
Kim and Seo (2014) N/A N/A N/A Design, usability 2011 – [33]
Rollo et al. (2011) 10 1/10 Type 2, adults Design, usability 2011 – [34]
Harris et al. (2010) 14 N/A Type 1, Type 2, 
adults
Usability 2010 – [35]
Curran et al. (2010) 6 1/2 N/A Design 2010 – [36]
Valdez et al. (2010) 22 N/A Adults Design, usability 2010 – [37]
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Figure 2. Flow chart of the publicly available systems.
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Availability of the systems
Based on extracted information from the litera-
ture studies, Figure 3 (left) shows the distribu-
tion of available platforms. As shown, many of 
the systems have been exclusively developed on 
Android 42% (11/26). However, not all spec-
ify the platform of development 19% (10/53). 
Complete results are displayed in Supplementary 
Data 1.
The publicly available systems show a differ-
ent distribution. Most of the systems are avail-
able on Android 51% (27/53) and/or iOS 53% 
(28/53), with some available on multiple plat-
forms. As shown in Figure 3 (right), the less com-
mon platforms included Blackberry. We found 
only three standalone systems: one Blackberry 
app, one app on Nokia Ovi Store and one for 
Amazon Kindle. More details on the platform 
availability are in Supplementary Data 2. We 
found that most publicly available apps were 
free 81% (43/53), and 30% (16/53) of the apps 
were available in an additional language other 
than English.
User-friendliness
In the 26 studies from the literature, 54% 
(14/26) support both automatic and manual 
data input, while 42% (11/26) support only 
manual entry and 4% (1/26) support only 
automatic only data entry. Among the publicly 
available systems and apps, the majority 89% 
(47/53) offered manual data input, while 38% 
(20/53) offered automatic and 25% (13/53) 
offered both.
Quality assurance & evidence-based 
research
Of the literature studies, 46% (12/26) per-
formed some form of evaluation. Interviews 
and questionnaires, mainly for clinicians, were 
used in 35% (9/26) of the studies, while 23% 
(6/26) assessed clinical outcomes. Regarding 
the publicly available systems, 8% (4/53) 
were FDA approved, 4% (2/53) were HIPAA 
approved and 6% (3/53) were CE approved. 
Most 89% (47/53) of the systems found in the 
publicly available places have not been evaluated 
by patients through questionnaires, usability or 
acceptance studies.
Social media presence
Of the systems found in the literature, we found 
that only the system by Årsand et al. [14] had an 
appearance on Facebook (502 likes) and the app 
made by Cafazzo et al. [28] on Twitter (78 times).
28% (15/53) of the publicly available apps 
have been reviewed by more than 400 users. 
64% (34/53) of the apps have a score of at least 
four stars. 84% (21/26) of the Android apps 
have a score above four stars in the Google Play 
Store, while 70% (18/26) of the iOS store have a 
score above four stars. We observed that the apps 
on Android have the highest scores, while iOS 
and multiplatform apps are the most popular on 
social networks (see Supplementary Data 2).
Most of the apps found in the literature did 
not have any press releases 96% (23/26). We 
also found that 68% of the papers are neither 
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Figure 3. Platforms for literature-extracted studies (left) and publicly available systems (right).
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media such as ResearchGate or Facebook, while 
88% did not have any social media presence. 
Twitter and Facebook are equally represented 
and press releases are the most popular way of 
communicating about the apps. We noted that 
only the Google Play store provides information 
regarding number of current installs. The mean 
score of the apps that have not been updated 
since January 2014 is 3.8 stars and that of more 
recently updated apps is 4.2 stars.
Discussion
From these results, we were able to make addi-
tional inferences about apps than were not 
evident through research and literature-based 
studies alone. While clinical research provides 
essential information regarding relevance to the 
medical realm, by including such novel sources 
as social media and public reviews, we introduce 
a number of features of the apps, and charac-
teristics surrounding the apps themselves, that 
influence an app’s relevance to users’ needs, in 
other words, the context in which they are used.
An important finding is the absence of most of 
the literature-extracted studies in social media or 
press releases, limiting the possibilities of evalu-
ating the users’ perception of literature papers 
and limiting it to the clinicians’ perception and 
approval. Overall, the most popular methods 
of dissemination were via press release on tech 
blogs or public information from companies 
and communications through popular science 
articles. And, while we expected much more 
information from Twitter and Facebook sharing, 
consistent with their prevalent use, most apps 
are not shared or discussed on social networks. 
However, of those that were present, we found 
that the most commented on or ‘liked’ apps on 
social media tended to have a comprehensive set 
of features. This supports previous accounts by 
Quinn et al. [13,38–39], who reported that patients’ 
self-efficacy could be improved by using apps 
that incorporate a comprehensive set of features.
It is difficult to demonstrate it, but compli-
ance with standards and the use of gamification 
concepts seem to result in more comprehensive 
and well-received apps. Additionally, despite 
the fact that more evidence is need, clinical 
approvals and regulatory authorities compliance 
might ensure that an app is harmless. Moreover, 
patients who use only few of the publicly avail-
able apps such as MySugr Diabetes Logbook, 
NST Diabetes Diary, WellDoc BueStar 
Diabetes or BANT are founded on evidence-
based research [14,28,40]. Such systems are often 
validated by randomized clinical trials that help 
to convince medical experts to recommend the 
apps to patients. Furthermore, based on exam-
ples we found, like BlueStar and mySugr, an 
app may be used and recommended more likely 
if it is integrated within the healthcare sector 
or showed a compliance with evidence-based 
practice and certifications authorities like the 
US FDA or CE.
Following with more granular details of an 
app’s context, we observed that timing of release 
and the presence of more recent updates directly 
corresponded with the number of ‘likes’, com-
ments or similar displays of attention during that 
time. We also found that iOS and multiplatform 
apps receive the most ‘likes’ within social net-
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of the price on an app’s download trends or posi-
tive feedback from users. Moreover, nonfree apps 
have a mean score of 4.3/5 stars within app 
stores. This suggests users are willing to pay for 
apps of good quality.
Unexpectedly, we observed that an app’s pres-
ence in social media was not necessarily depend-
ent upon the level of usability. Some apps we 
judged to be less user-friendly had a strong social 
media presence. This finding seemed rather 
counter-intuitive because we expected apps with 
inferior design elements to have less social media 
visibility. This suggests that social media pres-
ence must be considered in the context of other 
metrics such as number of installs, ratings by 
users and recommendations by fellow patients 
or medical specialists.
We selected our ten ‘favorite’ apps (see Table 2) 
based on the design elements discussed in this 
study.
Risk of bias & other limitations
Selected literature studies mostly focused on 
design and usability, and only a few assessed 
clinical outcomes. In spite of more than a dec-
ade with mobile applications, we have not seen 
many credible clinical trials. The studies that 
assessed clinical outcomes were poorly designed, 
with very short follow-up periods, and many had 
just a handful of participants, yet they made 
extraordinary claims. This poor evidence may 
partially explain why we have not seen many 
mobile application recommendations from 
clinicians or clinical guidelines.
In terms of search for publicly available sys-
tems, some online markets have restrictions on 
selected applications. There are applications with 
region restrictions that could not be found by 
normal search in the Norwegian Google Play 
market. This may have limited our reach, but 
it is unlikely that this limitation significantly 
affects our overall findings as we were able to 
contact developers directly for information 
for most apps in our review. Additionally, we 
omitted apps that did not include SMBG, put-
ting the focus on the patients with the biggest 
self-monitoring needs.
The exclusion of the apps that have been 
ranked under three stars add bias in the calcula-
tion of the average rankings and should be taken 
into account. Furthermore, we do not know who 
is rating the apps, adding another risk of bias.
Conclusion & future perspective
An EU-funded report [41] found that, among 
individuals with diabetes, the most important 
Table 2. Top ten most user-friendly diabetes self-management apps in rank order.
  Developer Product Platforms Highlights
1 mySugr GmbH Diabetes 
Logbook
iOS, Android, Web 
Browser
Growing list of compatible Blood Glucose Monitoring (BGM), 
compatible with Apple Health Kit, automatic data entry, large 
possibilities of data export, GUI full of gamification items, evidence-
based, standard compliant and FDA, CE marking, praised by 
communities and the press, notable popularity and generally 
supported in social media. doi:10.1177/1460458214537511
2 WellDoc, Inc BlueStar Diabetes iOS Comprehensive features, FDA cleared, the UI gives an immediate 
feedback on the automatic glucose data entries. It is supported by 
evidence-based research, and is highly recommended by doctors but 
must be prescribed. doi:10.1089/dia.2014.0341
3 NST Diabetes Diary iOS, Android Effective and simple UI, very good interoperability, CE marking 
pending, based on research, evidence-based, RCT, automatic data 
entry. doi:10.1089/dia.2014.0276
4 MyNetDiary Diabetes Tracker iOS Attractive design, full platform compatibility, follows best practices, 
praised in social media, regularly updated
5 Nicholas Martin Diamedic iOS Follows best practices, sleek and simple UI, regular updates
6 FridayForward Diabetes Diary iOS Large data export possibilities, very pleasant UI, charts and functions
7 MedHelp Sugar Sense iOS, Android Many compatible devices, clear UI, lack of data export
8 Coheso Track3 iOS Sufficient level of interoperability, low level of maintenance
9 Taconic System Healthsome G iOS Excellent possibilities of data export, large set of health data tracked, 
dated UI that can be difficult to read
10 Sanofi-Aventis iBGStar Diabetes 
Manager
iOS Pluggable BGM compatibility, simple UI but lack of updates and 
additional information
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aspects of a diabetes app are the trustworthiness 
and accuracy of data or information. These are 
concepts which are tested throughout traditional 
research methods for health authority approval. 
Design approaches that take into account com-
pliance with standards such as HIPAA, FDA 
clearing and CE marking, seem to enhance the 
quality of the apps and increase the chances of 
success among the users. Although research-
based apps help build quality evidence for 
informing related clinical guidelines, they were 
not necessarily the determining factor of success 
among real-time users. Herein lies the potential 
for expanded review methods.
This review highlights areas which may con-
tribute to sustainable use by patients, therefore, 
what will influence the greatest positive impact, 
and which much be considered by medical and 
commercial researchers. We have demonstrated 
that social media can be a positive tool for rais-
ing awareness of high-quality products. As more 
common trends suggest, we predict that in order 
to remain relevant and maintain the interest 
of users, developers must constantly attend to 
user comments, fix issues and update systems 
according to state of the art APIs available on 
the platforms. An outdated system that, for 
instance, does not offer any possibility for auto-
matic data export or entry can become obsolete 
or undesirable the long-term and, thus, not rel-
evant to patients and current users. Furthermore, 
although the number of user comments can 
be overwhelming, the feedback loop fosters 
attractive designs that are sensitive to user needs.
Our approach is a pilot study in itself of what 
is available and what should be included in the 
review of patient-empowering and patient-oper-
ated tools for disease self-management. Future 
trends that we expect to make a great impact 
on the medical realm as well as an individual 
patient’s life include the observed growing trend 
in the use of wearable devices. From our results, 
we can predict that patient’s will welcome the 
ease of use, ever presence and possibilities that 
this next generation of mobile and personal-
ized health will offer. Therefore, we expect to 
see more concerted efforts toward the develop-
ment of systems that are compatible with sev-
eral devices and platform standards, like Apple 
Health Kit, Microsoft HealthVault or Google 
Fit. We foresee that greater interoperability by 
integrating platform standards [42] will be a 
valuable feature for future developments [43]. 
This ability facilitates the integration of more 
advanced features and could allow for the use 
of data for clinical decision support systems. 
Previous studies have reported that such fea-
tures can lead to better long-term use, a greater 
interest, higher user ratings, higher number of 
users and, overall, better acceptance level among 
users [44].
Supplementary data
To view the supplementary data that accompany this paper 
please visit the journal website at www.futuremedicine.
com/doi/full/10.2217/dmt.15.40
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Abstract 
Pandemics or epidemics are serious concerns for any public 
health authority and mandate for proper monitoring and early 
detection strategies. In this study, we focus on people with 
diabetes and propose the use of continuous blood glucose, 
insulin, and dietary data, to develop an algorithm for the early 
detection of infections during the incubation period (i.e. be-
fore the onset of the first symptoms).  
We present a system that consists of three modules: the blood 
glucose prediction, the outbreak detection, and the infor-
mation dissemination and reporting module. The novel ap-
proach incorporated in the system is an interval prediction 
mechanism that is based on a set of autoregressive models 
and predicts the blood glucose values for an individual with 
diabetes. The actual blood glucose value is compared against 
the predicted interval, which is generated using auto-
regressive (AR) and Autoregressive moving average (ARMA) 
methods. The system was trained and validated based on con-
tinuous blood glucose measurements (CGM) from two indi-
viduals with type 1 diabetes. The single step point prediction 
was found to be accurate with a Root Mean Square Error 
(RMSE) of 0.2121 mmol/l.  Moreover, we accurately moni-
tored the blood glucose fluctuations for an individual with a 
significance level of α =0.01. The model was also tested 
against an artificially simulated dataset, which resembles 
blood glucose evolution of an infected individual with diabe-
tes, and successfully detected statistically significant devia-
tions from the normal blood glucose values. Our prototype 
system is still under development and has not been fully tested 
yet. Our initial findings though are promising and we plan to 
further test and validate our approach.
Keywords:  
Diabetes Mellitus, Continuous blood glucose measurement,
Self-management system, Blood glucose prediction, Outbreak 
detection, Electronic disease surveillance.  
Introduction 
Most of the existing self-management applications for people 
with diabetes include modules for continuous monitoring of 
the blood glucose measurements (CGM) to assist individuals 
in better controlling their blood glucose (BG) levels. Mobile 
devices and smart phones offer considerable advantages to-
wards the development of sophisticated apps [2, 9, 11, 14]. 
Recently, mobile self-management applications for people 
with diabetes have been integrated with Electronic Health 
Records [4, 13, 15]. If this integration is coupled with timely 
CGM data from people having diabetes, it can further enhance 
the establishment of efficient and effective disease surveil-
lance systems.
Previous findings indicated that BG levels are elevated due to 
any exposure to pathogens [10]. Årsand et al. demonstrated an 
elevation in BG levels for both type 1 and type 2 diabetes
individuals after the infection by Influenza, Cholera, Plague, 
Ebola, Anthrax, or SARS viruses [3]. Botsis et al. also de-
scribed the positive correlation between BG elevation and 
infections in people with type 1 diabetes [7]. These findings 
suggest the potential use of the BG parameter for the early 
detection of disease outbreaks in the general population [3, 7].
Other parameters (such as body temperature, white blood cell 
count and blood pressure) are directly associated with the 
presence of infections in the body [6, 12]. Multiple incidents 
with abnormal values for the above parameters in the popula-
tion may indicate the presence of an outbreak [1, 10]. We 
therefore argue that the incorporation of all these parameters 
into advanced modeling solutions can potentially support the 
early detection of outbreaks. The objective of our research is 
the development of a reliable electronic disease surveillance 
system for the analysis of diabetes data at both the individual 
and the population level. In this paper, we describe our initial 
exploration and our first-hand results.
Materials and Methods 
Datasets
This research was conducted using data from two individuals 
with type 1 diabetes. The Dexcom CGM and the diabetes 
diary1 that have been developed by Norwegian Center for E-
health Research (previously known as NST) were used for the 
data collection. These modules are part of a mobile applica-
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tion designed for diabetes management. The collected data 
included continuous BG measurements from the Dexcom 
CGM (in 5 minutes intervals) for one month and BG, insulin, 
diet and physical activity data from the diabetes diary for one 
year1. We used these datasets to train and validate the devel-
oped system for its goodness of fit to the BG dynamics of the 
two subjects in their non-infection status. We subsequently 
tested our system with a simulated dataset that included con-
secutive patterns of high BG values; this resembled the CGM 
during the infection period. Various increments per minutes 
( ∆ ( )) and various time intervals of elevated BG were 
considered.
Methods  
The system can predict the BG values with a confidence inter-
val and assess this prediction against the actual BG values. It 
can further analyze the measured and predicted BG values for 
the presence of any aberrant pattern. If there is a detection of 
any abnormality, the system will generate and send a notifica-
tion signal to the concerned bodies or authorities and support 
the investigation by displaying this on the map of the interest. 
The system consists of a BG prediction module, an outbreak 
detection module, and an information dissemination and re-
porting module. 
Blood glucose prediction module 
This module includes a personalized health model that moni-
tors the BG fluctuations of the individual with diabetes. It 
predicts the single step BG value using the previous BG, insu-
lin, diet and physical activity records. This module also calcu-
lates the confidence interval of the predicted values based on 
the recent empirical distribution of errors between the actual 
value and the predicted value. The prediction module utilizes 
a black box approach using an autoregressive model that in-
corporates Autoregressive (AR), Autoregressive with Exoge-
nous input (ARX), Autoregressive Moving Average (ARMA), 
and Autoregressive Moving Average with Exogenous input 
(ARMAX) methods. Autoregressive models were selected 
because they rely on the most recent information to forecast 
the future values. In our approach, it is very important to fol-
low the persons’ cyclical habit on a weekly or longer-period 
basis. The model simplicity and reproducibility were the fac-
tors that were considered in our selection. The well-defined 
procedure for calculating the intervals of the forecasts is defi-
nitely important as well. We evaluated and compared the 
performance of these models using the Root Mean Square 
Error (RMSE) function.  
Outbreak detection module 
The outbreak detection module is necessary for comparing the 
actual BG values with the predicted intervals. This module is 
built on mathematical models that can compare and detect any 
statistically significant deviations between the measured and 
the predicted BG values. This outbreak detection mechanism 
evaluates whether the actual BG values are outside of the 
predicted interval for the individual. Moreover, moving win-
dow z-score are used for better detection accuracy. The pur-
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pose of this moving window z-score is the detection of any 
significant deviations (anomalies in the data) based on the 
moving mean and standard deviation. Given a window size , the mean and standard deviations are used to check the 
agreement of the actual BG measurement with the previous 
trend in . This module also performs an aggregation analy-
sis, which counts the maximum number of events on a spatio-
temporal basis. In other words, it detects a disease outbreak in 
both space and time using a specified threshold that is defined 
based on the region it covers (space) and occurrence of statis-
tically deviated BG values (time) for a number of individuals. 
If the number of people in the cluster exceeds the threshold, 
an alarm will be sent to public health authorities or hospitals. 
The performance of this module is evaluated based on the 
accuracy of detecting the cluster in a timely manner. A Re-
ceiver Operating Characteristic (ROC) curve is used to deter-
mine the best operating threshold of the system. 
Information dissemination and reporting module
A principal function of the disease surveillance system is the 
generation of reports containing information about the detect-
ed disease outbreak. The related information is presented in 
tables, graphs and maps. The corresponding module submits 
the reports to the authorities and other interested parties via 
SMS and Email. Initially, an SMS is sent followed by an 
email to the responsible persons with the adequate information 
regarding the outbreak. The email contains information about 
the spatial and temporal distribution of the disease outbreak 
on a map of the region, the degree of severity and other criti-
cal data.
Design and Implementation 
Prediction Model and Interval Prediction  
The prediction of the BG values is based on an Autoregressive 
model including autoregressive with Yule Walker Algorithm, 
Autoregression using ratio of consecutive data points and 
Autoregressive Moving Average using Yule Walker Algo-
rithm. 
Figure 1: The Proposed Algorithm 
Based on the point prediction and the empirical error distribu-
tion between the measured and the predicted value, a predic-
tion interval is calculated with a certain confidence interval (1-
α)*100%, where α is the level of significance [8].
Current Prediction 
Predicted Interval 
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As shown in Figure 1, the proposed algorithm computes the 
predicted intervals based on the previous recent predictions 
and measurements along with the current point predictions. 
The empirical distributions of errors between the previous 
predictions and measurements are the basis for the current 
interval prediction. This is clearly shown in Figure 1, where 
the predicted intervals are compared with the current meas-
urements.  
The system was developed in MATLAB version R2015b. A
system identification toolbox along with the partial autocorre-
lation function (PACF) was used to identify the optimal model 
order. The autoregressive (AR) and autoregressive moving 
average (ARMA) were developed based on the CGMs that are 
shown in the Figure 2.   
Figure 2: Plot of the entire sets and the first 200 data ele-
ments of the continuous blood glucose data.
     
Figure 3: The proposed solution for the detection of the blood 
glucose deviation for an individual patient.
Outbreak Detection/Surveillance 
The proposed solution is similar to a control chart/statistical 
process control algorithm, where the controls are determined 
by the intervals predicted from the individual blood concentra-
tion profiles defined by the AR models. As shown in Figure 3, 
the next BG value can be effectively controlled by the predict-
ed upper and lower control limits with a reasonable accuracy. 
Moreover, as described in the above section (see outbreak 
detection module), the output results from the moving window 
z-score and the output results from the predicted intervals
mechanism are augmented for better accuracy.
Results  
We used the autoregressive models to predict the BG values 
using CGMs in 5-minute intervals. Autoregressive model 
using Yule-Walker algorithm, autoregressive model using 
ratio of the consecutive data points and autoregressive moving 
average with Yule-Walker algorithm were implemented and 
tested for 8495 data points. The RMSEs were calculated for 
4495 testing data points. The first model, a fifth order auto-
regressive (AR), efficiently predicted the single step BG val-
ues with a RMSE equal to 0.9727 mmol/l. The second model,
a fifth order autoregressive, is also capable of predicting the 
single step BG values. The prediction produced interesting 
results with a RMSE equal to 0.3413 mmol/l. Furthermore, the 
third model, an autoregressive moving average with a third 
order autoregressive terms and a second order moving average
terms, is also capable of predicting the single step BG values.
The prediction generated promising results with a RMSE
equal to 0.2121 mmol/l. The prediction interval calculated 
from these models was constructed with a significance level 
of α = 0.01, which means that one is 99% confident that the 
future values fall within the predicted intervals. Both the first 
and the second models produced intervals with reasonable 
sizes. However, the third model had a shortcoming in produc-
ing a good prediction interval, which is too narrow.
Figure 4: The predicted and measured blood glucose. 
The point prediction and its interval prediction for the single 
diabetes subject are given in the Figure 4 and 5. These results 
were generated from the first model, the Autoregressive model 
using Yule-Walker algorithm.
--Measured BG Values
 --Predicted BG Interval
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Figure 5: The predicted interval, predicted and measured 
blood glucose. 
The moving window z-score process is also capable of detect-
ing high BG values based on trends for various periods and 
rates of growth. For example, as shown in Figure 6, it can 
detect BG values over a long period of time. Therefore, an 
outlier can be detected by setting threshold values of three and 
more standard deviations from the mean value. 
Figure 6: Measured blood glucose, simulated outbreak and 
the moving window z-score.
Assumptions, Biases and Limitations
The major limitation of this project is the sample size. We 
based our experiments and simulation on two individuals with 
type 1 diabetes, and more data is needed to further validate 
our approach. Moreover, the “holiday effect” has not been 
considered in this study. The “Holiday effect” is the bad eating 
style of people with diabetes in the holiday season [10] and 
usually leads to high BG values. In such cases our system may 
generate false alarms, especially given the absence of frequent 
measurements for other supporting parameters, such as the 
white blood cell counts and temperature readings from these 
individuals [5, 6].  
Conclusion
With the advent of information technology, the transition from 
paper- into electronic-based reporting has revolutionized the 
disease surveillance systems. Our system should be grouped 
under the syndromic surveillance systems that also use certain 
data (absenteeism, Internet search volume, over the counter 
pharmacy sells and so forth) prior to the confirmation of infec-
tions through diagnosis. However, this information is generat-
ed after the onset of the first symptoms and syndromic surveil-
lance systems that focus on the incubation period have not 
been developed yet. This is the novel and unique characteristic 
of our work. Our system incorporates a BG prediction mecha-
nism that can both predict the BG values for an individual and 
efficiently detect an infection during the incubation period.
Even though we have not fully tested and evaluated our ap-
proach, we believe that our initial findings are very promising 
to support our next steps. The systematic evaluation and vali-
dation of our system is among our future plans. We also hope 
to pave the way for the next generation disease surveillance 
systems.  
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